data_1ib9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ib9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -62.84 150.33 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.021 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.516 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 22.3 p -138.41 135.83 35.66 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.546 -2.116 . . . . 0.0 111.759 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -84.76 -57.73 3.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -115.32 173.48 6.49 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.874 -1.966 . . . . 0.0 106.882 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.5 m-20 -56.31 -52.06 65.93 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -73.6 5.64 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.61 -16.7 59.51 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.77 147.02 38.2 Favored Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.15 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.2 Cg_exo -70.7 165.86 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.829 1.686 . . . . 0.0 109.703 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 71.67 -160.51 54.07 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.53 20.26 2.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.622 -1.289 . . . . 0.0 108.729 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 65.6 m -67.43 170.8 6.85 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 113.628 -1.624 . . . . 0.0 114.139 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.58 -167.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.2 t -126.35 128.12 46.58 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -77.37 170.18 17.0 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.284 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.94 -12.55 83.89 Favored Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.597 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -79.63 -5.62 55.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.37 40.45 Favored Glycine 0 N--CA 1.496 2.692 0 O-C-N 123.723 0.64 . . . . 0.0 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 53.2 m-85 -141.14 159.8 41.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.114 0.537 . . . . 0.0 109.749 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.3 m -40.69 159.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.533 1.771 . . . . 0.0 114.663 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 CA-C-N 115.402 -0.817 . . . . 0.0 114.557 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -81.2 153.52 27.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.331 -0.947 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.6 p -143.03 134.52 26.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.404 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -93.88 -41.86 9.39 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -128.59 167.4 17.21 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.499 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -49.15 -51.29 33.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 88.8 p -90.06 27.08 1.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.24 -15.82 39.6 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.272 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.605 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 t -88.85 151.64 47.63 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.2 Cg_endo -73.93 164.65 34.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.182 1.921 . . . . 0.0 109.733 169.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -162.36 54.4 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.938 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.1 21.54 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.923 -1.139 . . . . 0.0 108.153 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 96.4 m -71.63 153.17 42.28 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 174.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.2 t -100.97 118.98 38.05 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.236 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.42 170.77 5.64 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.23 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.09 -14.93 74.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.868 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -84.59 -10.52 57.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.934 0.432 . . . . 0.0 111.742 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.65 13.51 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 123.786 0.679 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.0 m-85 -141.71 155.01 45.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.49 0.662 . . . . 0.0 109.747 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.8 m -48.75 146.32 3.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.597 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 O-C-N 124.287 0.992 . . . . 0.0 115.063 179.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -75.79 152.91 37.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.116 0.885 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.573 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 19.0 p -139.56 133.27 30.54 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.966 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.7 -34.8 18.27 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -134.8 169.26 17.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.472 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.3 m-20 -53.21 -54.33 37.62 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.1 p -72.52 1.44 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -76.06 -12.64 60.16 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.1 t -89.0 146.85 37.37 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.887 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.3 Cg_exo -68.54 162.69 39.79 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.882 1.722 . . . . 0.0 110.124 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.01 -160.39 54.01 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.672 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.1 18.17 3.22 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.966 -1.117 . . . . 0.0 108.684 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.4 m -62.57 168.83 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.74 -166.48 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.53 -2.577 . . . . 0.0 104.365 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.472 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.3 t -132.77 131.5 41.21 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -88.45 168.33 12.71 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.717 1.26 . . . . 0.0 111.755 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -12.52 56.63 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 112.805 -1.998 . . . . 0.0 114.377 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -79.56 -8.61 59.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.835 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.6 24.86 27.09 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 57.0 m-85 -143.49 158.63 43.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -37.71 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.794 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.484 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 151.78 28.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.574 -1.251 . . . . 0.0 113.66 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.0 p -141.19 129.63 22.51 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.557 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.81 -62.92 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -110.94 174.3 5.93 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.36 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.453 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.8 m-20 -54.42 -53.53 52.86 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.2 p -73.84 3.81 6.12 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.65 -16.89 61.7 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 49.2 t -88.65 146.7 37.79 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.739 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 Cg_exo -69.62 164.24 35.15 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.885 1.724 . . . . 0.0 109.748 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.5 -160.97 54.0 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.852 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.23 19.82 3.02 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.777 -1.212 . . . . 0.0 108.679 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.571 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 75.6 m -65.1 171.01 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.807 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -169.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 46.6 t -123.39 126.96 47.76 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.65 169.55 17.82 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -13.96 75.2 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.021 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -79.63 -6.06 56.34 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.754 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.79 23.62 38.31 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 123.82 0.7 . . . . 0.0 112.131 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 83.7 m-85 -144.78 157.24 44.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.169 0.57 . . . . 0.0 109.902 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 56.5 m -37.31 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.598 0 CA-C-N 114.851 -1.068 . . . . 0.0 115.192 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -92.0 154.98 18.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.981 0.801 . . . . 0.0 110.24 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.1 p -150.35 125.92 10.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.632 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -55.06 5.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -117.55 173.95 6.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.025 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.8 m-20 -50.19 -55.19 16.21 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.8 p -75.96 1.36 15.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.33 -17.22 62.45 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.554 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 t -88.48 145.69 36.01 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.049 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.6 Cg_exo -68.87 164.4 33.7 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.85 1.7 . . . . 0.0 109.931 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -158.95 52.72 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.102 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.92 18.13 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.719 -1.24 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 85.3 m -63.47 160.89 15.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.406 ' N ' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.91 -168.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.46 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.9 t -131.15 129.9 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.079 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.23 168.0 18.21 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.145 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.07 -14.5 80.35 Favored Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.846 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -81.18 -8.09 59.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 21.92 30.68 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 123.804 0.69 . . . . 0.0 112.252 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 8.7 m-85 -134.31 153.57 51.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -40.93 154.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.363 1.664 . . . . 0.0 115.317 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.574 0 CA-C-N 114.931 -1.031 . . . . 0.0 114.498 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 mttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 14' ' ' LYS . 10.0 mptt -74.55 149.22 40.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.352 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.7 p -134.45 127.41 31.43 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -80.42 -59.24 2.77 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -114.09 171.27 7.71 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.665 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 59.0 m-20 -51.59 -52.36 48.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -80.61 9.66 5.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.37 -15.47 61.37 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.598 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.75 149.15 43.27 Favored Pre-proline 0 N--CA 1.485 1.309 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.9 Cg_exo -65.14 154.66 72.43 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.892 1.728 . . . . 0.0 110.335 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.81 -165.97 54.49 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.54 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.85 16.36 0.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.652 -1.274 . . . . 0.0 109.676 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.531 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 93.8 m -63.36 154.56 31.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -178.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.5 t -111.89 115.59 29.25 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.068 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -65.39 168.58 6.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.491 1.119 . . . . 0.0 111.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.87 73.18 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.836 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -82.11 -4.06 56.11 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 19.93 48.45 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 123.631 0.582 . . . . 0.0 113.138 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -139.4 158.45 44.12 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.757 0.789 . . . . 0.0 110.478 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.9 m -41.14 153.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 112.511 -2.131 . . . . 0.0 114.808 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.96 0 O-C-N 124.071 0.857 . . . . 0.0 114.204 179.591 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HZ1' ' HZ3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 2.0 mppt? -72.17 154.2 41.19 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.225 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.6 p -138.61 130.32 27.79 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.686 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -82.16 -49.17 10.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -128.13 173.4 10.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.517 -2.128 . . . . 0.0 106.79 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.47 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 18.5 m-20 -53.45 -53.2 54.74 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.4 p -74.32 4.47 5.77 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.22 -14.06 59.83 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.57 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 52.3 t -88.84 148.63 41.89 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.113 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.545 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.61 166.46 28.57 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.93 1.753 . . . . 0.0 109.65 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.02 -161.06 54.32 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.99 16.85 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.159 -1.02 . . . . 0.0 108.696 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 63.3 m -61.15 171.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.26 -163.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -130.75 129.31 42.34 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.58 170.13 17.14 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.32 84.7 Favored Glycine 0 N--CA 1.496 2.652 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -80.0 -5.16 55.24 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.57 20.85 39.27 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 123.747 0.655 . . . . 0.0 112.541 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.3 m-85 -141.12 157.6 45.06 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.612 0.72 . . . . 0.0 110.17 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.1 m -39.95 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 112.704 -2.043 . . . . 0.0 114.957 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.954 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 88.2 tttt . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -81.59 152.57 27.13 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.267 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.35 127.54 24.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.697 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 ttm-85 -80.04 -60.05 2.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -116.31 172.91 6.89 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 113.027 -1.897 . . . . 0.0 107.007 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 12.8 m-20 -57.13 -52.37 65.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.228 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.0 p -74.37 12.67 0.71 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.91 -18.48 50.46 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 39.1 t -89.02 148.75 41.8 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.311 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -71.53 159.83 50.15 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.338 2.025 . . . . 0.0 110.887 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.49 -163.33 54.77 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.872 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.26 17.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.877 -1.162 . . . . 0.0 109.443 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 68.9 m -67.67 167.22 13.57 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.167 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.67 -175.53 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 19.6 t -105.16 124.12 49.0 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -70.42 170.56 11.7 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.405 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.41 77.97 Favored Glycine 0 N--CA 1.495 2.602 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -82.67 -9.82 59.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.003 0.473 . . . . 0.0 111.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.25 23.7 28.66 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 123.929 0.768 . . . . 0.0 112.727 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -137.56 158.11 45.08 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.158 0.504 . . . . 0.0 109.841 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 21.4 m -46.1 150.1 0.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.75 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.375 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.3 mmtm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -69.16 149.37 48.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.949 0.781 . . . . 0.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.576 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 29.0 p -146.25 133.6 20.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.522 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -93.17 -37.05 12.31 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -132.09 169.47 16.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.474 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.6 m-20 -53.81 -51.61 62.96 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -75.73 5.01 6.78 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.83 -12.19 59.78 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.9 t -88.89 150.3 45.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.782 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.69 166.3 29.22 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.919 1.746 . . . . 0.0 109.727 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.68 -163.02 52.08 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.235 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.63 16.59 3.13 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.857 -1.171 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.59 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 62.8 m -61.72 168.92 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.04 -159.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 44.8 t -138.25 128.25 25.56 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 41.8 mmt180 -79.32 169.08 18.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.268 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.4 -8.49 66.41 Favored Glycine 0 N--CA 1.495 2.619 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.537 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -84.96 -8.17 58.86 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.604 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' HD21 ' A' ' 30' ' ' ASN . . . 91.5 26.35 20.81 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 20.2 m-85 -141.19 152.33 44.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 66.0 m -40.62 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.266 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.002 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.6 151.04 37.9 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.499 -1.281 . . . . 0.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.7 p -138.09 136.19 36.54 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.255 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.451 HH12 HH22 ' A' ' 17' ' ' ARG . 34.3 mtp-105 -87.65 -65.53 1.01 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.451 HH22 HH12 ' A' ' 16' ' ' ARG . 9.6 ptp85 -105.21 173.62 6.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.9 m-20 -59.02 -46.84 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 85.5 p -81.77 13.82 3.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.006 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.83 -14.3 59.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 48.7 t -89.27 151.57 46.66 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.438 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -71.73 161.59 44.69 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.104 1.869 . . . . 0.0 110.216 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.68 -164.93 54.71 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.312 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.5 14.39 2.55 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.729 -1.236 . . . . 0.0 109.561 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.497 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.7 m -61.28 166.26 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.23 170.43 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.414 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 36.8 t -102.51 122.88 45.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.22 166.77 22.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -13.07 61.53 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.811 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -81.03 -10.04 59.75 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.513 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.04 26.78 23.15 Favored Glycine 0 N--CA 1.496 2.649 0 O-C-N 123.895 0.747 . . . . 0.0 111.591 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 58.7 m-85 -142.83 157.24 44.8 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.543 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.7 m -46.78 161.15 0.07 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.029 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -76.84 153.57 34.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 123.816 0.697 . . . . 0.0 111.212 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.6 p -142.19 120.64 12.42 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.56 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 -37.82 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.18 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -132.75 166.47 22.15 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.26 -52.83 32.92 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.312 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.0 p -86.75 32.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.65 -18.55 22.04 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 113.326 -1.761 . . . . 0.0 106.828 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 20.8 t -88.96 150.52 45.55 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.381 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.2 Cg_endo -76.1 168.14 24.64 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.288 1.992 . . . . 0.0 110.05 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.56 -160.47 53.69 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.764 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.24 18.74 4.83 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 71.2 m -71.24 162.11 29.98 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.77 -178.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.01 130.11 51.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.402 HH21 ' HB2' ' A' ' 32' ' ' TYR . 88.1 mtm180 -81.3 170.88 15.5 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.1 -13.41 83.25 Favored Glycine 0 N--CA 1.495 2.59 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -81.63 -7.2 59.56 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.58 26.0 28.71 Favored Glycine 0 N--CA 1.498 2.786 0 O-C-N 123.83 0.707 . . . . 0.0 111.899 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 34.2 m-85 -142.97 154.12 43.71 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.765 0.793 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.0 m -48.43 153.89 0.7 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.611 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 O-C-N 124.221 0.95 . . . . 0.0 114.1 179.703 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 2.0 mptp? -101.31 152.76 20.31 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.986 0.898 . . . . 0.0 112.632 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.5 p -144.46 142.08 30.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.333 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.87 -34.27 9.87 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.85 167.11 21.49 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.431 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 14.0 m-20 -51.99 -52.79 48.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.7 p -79.62 20.88 0.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -87.07 -19.83 28.02 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 38.1 t -88.76 146.78 37.71 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.4 Cg_endo -75.53 167.34 26.73 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.202 1.934 . . . . 0.0 110.177 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.07 -162.53 54.48 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.56 14.12 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.514 -1.343 . . . . 0.0 109.467 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.8 m -67.71 170.7 7.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.825 1.298 . . . . 0.0 114.455 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -175.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.431 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.7 t -113.16 126.14 55.11 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -69.01 171.43 8.15 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.168 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.27 -18.09 77.9 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.93 8.26 18.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.062 0.507 . . . . 0.0 111.811 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.8 25.43 75.75 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.789 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 16.4 m-85 -131.09 153.49 49.28 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 m -47.6 157.24 0.25 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 C-N-CA 119.268 -1.444 . . . . 0.0 116.114 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.24 149.16 38.62 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.847 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -135.22 128.74 32.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.944 -1.935 . . . . 0.0 112.047 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -81.85 -58.7 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -111.53 171.74 7.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.252 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.2 m-20 -56.38 -49.29 74.89 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -81.49 13.15 3.18 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.485 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.93 -16.39 60.02 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.856 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -88.79 151.16 47.16 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.475 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.4 Cg_exo -72.42 162.56 41.13 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.036 1.824 . . . . 0.0 110.058 170.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.55 -166.82 54.83 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.053 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.47 7.38 6.72 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.007 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.434 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 71.4 m -54.68 166.19 0.5 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.67 171.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.403 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.8 t -101.81 119.97 39.63 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -72.21 168.98 17.12 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.911 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.14 68.69 Favored Glycine 0 N--CA 1.495 2.568 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.639 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -81.94 -7.63 59.62 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.602 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.43 19.74 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -145.87 154.66 42.21 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.744 0.783 . . . . 0.0 110.097 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -44.49 154.35 0.13 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.54 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 C-N-CA 119.642 -1.266 . . . . 0.0 115.633 179.68 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.57 149.94 49.73 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.457 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 25.4 p -130.37 133.78 46.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.113 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -84.93 -45.65 12.02 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -132.32 172.11 12.85 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 112.766 -2.015 . . . . 0.0 107.29 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.474 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 10.5 m-20 -53.82 -53.37 53.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -73.98 3.25 7.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.09 -18.14 61.94 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.613 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.3 t -89.11 148.95 42.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.614 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.5 Cg_endo -73.06 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.166 1.911 . . . . 0.0 110.355 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.33 -157.82 53.4 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.408 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.33 18.85 2.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.648 -1.276 . . . . 0.0 108.348 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.584 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 69.3 m -65.95 164.36 15.26 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.83 -1.532 . . . . 0.0 114.732 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.461 ' N ' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -131.63 -165.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 111.527 -2.579 . . . . 0.0 104.767 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.7 t -128.68 124.25 35.21 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -77.83 168.24 20.24 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 124.603 1.19 . . . . 0.0 110.386 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.94 -10.62 80.89 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -80.04 -4.43 52.67 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.35 24.83 35.34 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 123.793 0.683 . . . . 0.0 112.312 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 87.1 m-85 -144.03 159.51 42.47 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.212 0.595 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.3 m -41.22 152.29 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.591 1.807 . . . . 0.0 113.303 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 O-C-N 124.123 0.89 . . . . 0.0 114.634 -179.724 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.2 tmtm? . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -36.32 144.4 0.06 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 p -145.92 142.27 28.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 111.526 -2.579 . . . . 0.0 111.76 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -91.48 -63.46 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.4 ' HE ' ' HG ' ' A' ' 19' ' ' SER . 30.3 ptt-85 -108.36 172.02 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.739 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.412 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 80.4 m-20 -50.23 -55.96 13.11 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.4 ' HG ' ' HE ' ' A' ' 17' ' ' ARG . 87.6 p -77.32 8.26 4.32 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.68 -12.98 60.9 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.576 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.3 t -88.61 150.42 46.16 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.961 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -66.45 156.01 67.36 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.769 1.646 . . . . 0.0 109.816 170.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 76.89 -163.1 52.24 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 120.491 -0.862 . . . . 0.0 111.748 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.19 20.87 2.57 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.939 -1.13 . . . . 0.0 108.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 88.4 m -67.35 157.33 34.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.459 HG23 ' H ' ' A' ' 27' ' ' CYS . 2.0 mm -114.21 -175.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.459 ' H ' HG23 ' A' ' 26' ' ' ILE . 37.6 t -115.87 108.98 16.98 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.471 ' NE ' HD22 ' A' ' 30' ' ' ASN . 79.7 mtm180 -59.08 170.04 0.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 -16.45 65.2 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.81 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.471 HD22 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -83.98 -7.58 59.37 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.53 21.58 43.53 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 123.777 0.673 . . . . 0.0 112.537 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -135.58 156.91 48.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 50.3 m -45.05 147.99 0.62 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.869 0 O-C-N 124.284 0.99 . . . . 0.0 115.077 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mtpp -62.13 152.16 33.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.374 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.34 122.31 26.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.095 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -73.66 -46.49 46.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.37 172.65 12.71 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 112.526 -2.125 . . . . 0.0 107.995 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 26.9 m-20 -47.78 -52.74 17.68 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.9 p -81.71 6.44 15.33 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.07 -15.68 61.06 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.965 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.0 t -88.78 149.53 43.97 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.006 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.563 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.6 Cg_exo -66.12 167.75 17.38 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.762 1.642 . . . . 0.0 110.518 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 65.53 -164.39 38.11 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.008 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.76 15.06 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.529 -1.336 . . . . 0.0 109.617 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 74.2 m -60.29 159.35 10.1 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -121.31 -169.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.1 t -118.76 126.32 51.61 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -67.35 171.54 5.83 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.332 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.37 -13.65 80.1 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.489 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.63 -6.94 59.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.23 24.06 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 123.692 0.62 . . . . 0.0 113.132 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 37.7 m-85 -140.05 160.39 40.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.836 0.827 . . . . 0.0 110.654 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -45.38 147.91 0.73 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.677 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.765 0 O-C-N 124.528 1.143 . . . . 0.0 111.724 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 2.1 mmpt? . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.81 146.76 7.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.085 0.945 . . . . 0.0 111.969 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.137 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -76.73 -40.44 48.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -137.37 171.03 15.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.667 -2.061 . . . . 0.0 107.525 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -48.58 -56.75 7.53 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.9 p -83.06 15.22 2.9 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.58 -14.99 59.51 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.414 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.582 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 49.8 t -88.95 151.39 47.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.75 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.1 Cg_exo -68.34 158.85 55.83 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.823 1.682 . . . . 0.0 110.017 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 75.18 -165.64 54.68 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.043 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.19 15.02 3.08 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.699 -1.25 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 23' ' ' GLY . 77.2 m -62.89 152.69 35.63 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.17 -177.65 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.93 123.53 49.24 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -71.63 170.23 13.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.494 1.121 . . . . 0.0 110.776 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.12 -18.44 79.73 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.1 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -81.14 -0.03 38.37 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 124.147 0.557 . . . . 0.0 112.067 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 25.35 53.47 Favored Glycine 0 N--CA 1.496 2.64 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.351 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.76 156.83 47.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.083 0.944 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 27.6 m -48.59 146.95 2.74 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.151 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 O-C-N 124.588 1.18 . . . . 0.0 112.619 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -64.39 152.16 42.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 123.873 0.733 . . . . 0.0 111.34 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.9 p -145.7 126.07 13.99 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.263 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -74.8 -49.89 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -127.6 173.94 9.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.056 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 66.0 m-20 -51.3 -55.29 19.1 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.9 p -72.29 2.29 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.63 -14.98 59.94 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 51.4 t -88.7 146.91 38.11 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.905 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 Cg_exo -69.8 163.67 37.44 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.901 1.734 . . . . 0.0 109.848 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 74.17 -158.8 52.21 Favored Glycine 0 N--CA 1.5 2.967 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.996 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.73 20.0 3.71 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.86 -1.17 . . . . 0.0 108.372 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.579 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.7 m -65.8 168.85 7.25 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 113.255 -1.793 . . . . 0.0 115.694 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.94 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.085 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 45.8 t -139.27 129.0 24.68 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 88.3 mtm180 -81.36 170.51 15.91 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.074 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.06 -11.24 78.95 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.593 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -81.06 -2.14 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.327 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' N ' HD21 ' A' ' 30' ' ' ASN . . . 86.34 23.97 41.9 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.541 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 91.1 m-85 -143.45 152.98 42.18 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.677 0.751 . . . . 0.0 110.21 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.9 m -36.03 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 112.25 -2.25 . . . . 0.0 115.143 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 O-C-N 124.324 1.015 . . . . 0.0 112.288 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.01 148.27 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.187 0.994 . . . . 0.0 113.396 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 20.0 p -143.65 128.18 18.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.483 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -86.27 -34.15 20.47 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HE ' ' HG ' ' A' ' 19' ' ' SER . 30.0 ptt-85 -130.86 166.35 21.06 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -53.43 -44.82 69.11 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.438 ' HG ' ' HE ' ' A' ' 17' ' ' ARG . 89.3 p -91.17 26.0 2.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.1 -11.55 32.65 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 42.8 t -88.81 148.65 41.99 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.866 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.9 Cg_exo -66.23 157.32 60.55 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.877 1.718 . . . . 0.0 109.961 171.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 -167.33 54.45 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.63 17.97 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.844 -1.178 . . . . 0.0 110.167 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 78.8 m -49.3 151.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -118.14 172.15 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.03 128.26 49.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -69.43 169.95 11.44 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.608 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.18 -16.35 80.64 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.266 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -1.91 56.55 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.29 24.21 37.71 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 123.691 0.619 . . . . 0.0 113.409 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 95.0 m-85 -137.74 155.32 49.21 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.062 0.934 . . . . 0.0 111.013 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.7 m -48.67 152.93 0.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 112.48 -2.146 . . . . 0.0 114.669 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 O-C-N 124.758 1.286 . . . . 0.0 113.163 179.45 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 68.5 mttm . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -97.97 152.45 19.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.1 p -144.19 124.78 14.03 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.787 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -84.34 -49.68 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.55 169.74 12.75 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.704 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 8.7 m-20 -50.9 -47.6 60.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -89.1 28.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -94.76 -17.52 22.09 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 113.575 -1.648 . . . . 0.0 107.308 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 45.4 t -88.95 148.22 40.68 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.541 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.7 Cg_endo -73.56 165.67 31.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.237 1.958 . . . . 0.0 110.23 173.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.63 -163.71 54.75 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.903 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.05 14.83 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.874 -1.163 . . . . 0.0 109.212 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 79.3 m -66.89 161.04 24.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 -171.65 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 102.65 -3.093 . . . . 0.0 102.65 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.401 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -113.07 130.46 56.16 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 1.8 mmp_? -69.59 172.65 7.05 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 -13.68 82.98 Favored Glycine 0 N--CA 1.494 2.525 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.658 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -89.46 -9.6 49.5 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.97 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.12 33.32 7.78 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 11.4 m-85 -137.66 155.78 48.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 19.9 m -51.75 149.36 4.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.458 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.6 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.594 179.613 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.569 ' H ' HH21 ' A' ' 28' ' ' ARG . 58.5 p . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.03 -124.48 3.02 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 t -150.63 165.18 34.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.098 0.528 . . . . 0.0 110.179 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 49.97 46.74 24.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.315 1.009 . . . . 0.0 110.791 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.77 -29.22 5.23 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.04 87.67 0.67 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.9 129.43 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t -150.31 140.8 14.25 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 124.189 0.931 . . . . 0.0 110.624 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.48 -159.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.782 2.321 . . . . 0.0 109.816 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -50.31 138.48 16.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 123.626 0.579 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.06 114.06 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.831 1.3 . . . . 0.0 112.131 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 12' ' ' LEU . 1.8 pt? -162.64 24.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.442 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -118.28 121.5 40.59 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.677 -2.056 . . . . 0.0 105.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -62.84 150.33 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.021 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.516 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 22.3 p -138.41 135.83 35.66 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.546 -2.116 . . . . 0.0 111.759 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -84.76 -57.73 3.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -115.32 173.48 6.49 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.874 -1.966 . . . . 0.0 106.882 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.5 m-20 -56.31 -52.06 65.93 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -73.6 5.64 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.61 -16.7 59.51 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.77 147.02 38.2 Favored Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.15 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.2 Cg_exo -70.7 165.86 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.829 1.686 . . . . 0.0 109.703 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 71.67 -160.51 54.07 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.53 20.26 2.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.622 -1.289 . . . . 0.0 108.729 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 65.6 m -67.43 170.8 6.85 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 113.628 -1.624 . . . . 0.0 114.139 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.58 -167.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.2 t -126.35 128.12 46.58 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.569 HH21 ' H ' ' A' ' 1' ' ' SER . 27.5 mmt85 -77.37 170.18 17.0 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.284 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.94 -12.55 83.89 Favored Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.597 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -79.63 -5.62 55.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.37 40.45 Favored Glycine 0 N--CA 1.496 2.692 0 O-C-N 123.723 0.64 . . . . 0.0 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 53.2 m-85 -141.14 159.8 41.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.114 0.537 . . . . 0.0 109.749 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.3 m -40.69 159.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.533 1.771 . . . . 0.0 114.663 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 CA-C-N 115.402 -0.817 . . . . 0.0 114.557 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.8 38.27 89.32 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -89.83 132.94 35.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.052 0.501 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 52.48 24.31 2.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.418 1.074 . . . . 0.0 111.914 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.71 138.41 2.71 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.3 143.49 5.9 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.17 146.63 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -150.03 140.11 13.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.659 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.41 137.11 16.38 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 122.675 2.25 . . . . 0.0 108.936 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -59.04 108.14 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.408 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.8 161.39 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.666 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -107.27 41.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.308 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.48 143.25 26.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -81.2 153.52 27.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.331 -0.947 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.6 p -143.03 134.52 26.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.404 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -93.88 -41.86 9.39 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -128.59 167.4 17.21 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.499 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -49.15 -51.29 33.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 88.8 p -90.06 27.08 1.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -86.24 -15.82 39.6 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.272 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.605 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 t -88.85 151.64 47.63 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.2 Cg_endo -73.93 164.65 34.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.182 1.921 . . . . 0.0 109.733 169.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -162.36 54.4 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.938 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.1 21.54 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.923 -1.139 . . . . 0.0 108.153 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 96.4 m -71.63 153.17 42.28 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 174.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 44.2 t -100.97 118.98 38.05 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.236 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -66.42 170.77 5.64 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.23 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.09 -14.93 74.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.868 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -84.59 -10.52 57.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.934 0.432 . . . . 0.0 111.742 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.65 13.51 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 123.786 0.679 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.0 m-85 -141.71 155.01 45.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.49 0.662 . . . . 0.0 109.747 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.8 m -48.75 146.32 3.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.597 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 O-C-N 124.287 0.992 . . . . 0.0 115.063 179.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.532 ' HG ' ' H ' ' A' ' 8' ' ' CYS . 23.8 t . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.22 -6.6 0.06 OUTLIER Glycine 0 N--CA 1.499 2.885 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.815 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -89.55 145.82 25.01 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 117.538 0.669 . . . . 0.0 111.59 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.26 -15.76 63.46 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.732 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.4 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.0 -139.12 3.45 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.97 133.81 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' H ' ' HG ' ' A' ' 1' ' ' SER . 49.6 t -90.05 128.91 47.96 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.424 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -69.73 109.78 2.39 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 106.17 -2.281 . . . . 0.0 106.17 163.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.05 124.46 23.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 123.876 0.735 . . . . 0.0 112.686 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 HD11 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -138.09 171.91 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.164 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.488 ' H ' HD21 ' A' ' 12' ' ' LEU . 1.1 pt? -87.19 36.78 0.75 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.224 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -95.97 129.88 43.11 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.519 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -75.79 152.91 37.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.116 0.885 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.573 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 19.0 p -139.56 133.27 30.54 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.966 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.7 -34.8 18.27 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -134.8 169.26 17.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.472 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.3 m-20 -53.21 -54.33 37.62 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.1 p -72.52 1.44 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -76.06 -12.64 60.16 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.1 t -89.0 146.85 37.37 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.887 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.557 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.3 Cg_exo -68.54 162.69 39.79 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.882 1.722 . . . . 0.0 110.124 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.01 -160.39 54.01 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.672 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.1 18.17 3.22 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.966 -1.117 . . . . 0.0 108.684 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.563 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.4 m -62.57 168.83 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.74 -166.48 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.53 -2.577 . . . . 0.0 104.365 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.3 t -132.77 131.5 41.21 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -88.45 168.33 12.71 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.717 1.26 . . . . 0.0 111.755 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -12.52 56.63 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 112.805 -1.998 . . . . 0.0 114.377 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.483 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -79.56 -8.61 59.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.835 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.6 24.86 27.09 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 57.0 m-85 -143.49 158.63 43.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -37.71 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.794 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.484 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.76 -122.13 2.26 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 m -143.36 174.02 11.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.228 0.605 . . . . 0.0 109.932 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 52.06 67.14 1.02 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 124.255 0.972 . . . . 0.0 108.861 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.53 -11.34 59.16 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.171 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.95 81.9 1.37 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.08 127.65 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 10.6 t -150.7 157.51 36.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 124.202 0.939 . . . . 0.0 110.769 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HD2' ' SG ' ' A' ' 8' ' ' CYS . 10.4 Cg_endo -68.98 -167.89 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.467 2.112 . . . . 0.0 109.414 158.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -122.94 58.54 1.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.058 0.933 . . . . 0.0 109.507 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 pt -89.89 152.95 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.002 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' H ' HD21 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -94.84 46.02 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.813 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -89.68 121.95 32.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 151.78 28.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.574 -1.251 . . . . 0.0 113.66 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.0 p -141.19 129.63 22.51 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.557 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.81 -62.92 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -110.94 174.3 5.93 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.36 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.453 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.8 m-20 -54.42 -53.53 52.86 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.2 p -73.84 3.81 6.12 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -72.65 -16.89 61.7 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 49.2 t -88.65 146.7 37.79 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.739 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 Cg_exo -69.62 164.24 35.15 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.885 1.724 . . . . 0.0 109.748 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.5 -160.97 54.0 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.852 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.23 19.82 3.02 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.777 -1.212 . . . . 0.0 108.679 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.571 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 75.6 m -65.1 171.01 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.807 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -169.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 46.6 t -123.39 126.96 47.76 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.65 169.55 17.82 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -13.96 75.2 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.021 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -79.63 -6.06 56.34 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.754 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.79 23.62 38.31 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 123.82 0.7 . . . . 0.0 112.131 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 83.7 m-85 -144.78 157.24 44.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.169 0.57 . . . . 0.0 109.902 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 56.5 m -37.31 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.598 0 CA-C-N 114.851 -1.068 . . . . 0.0 115.192 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.463 ' H ' ' NH2' ' A' ' 28' ' ' ARG . 59.6 p . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.428 ' H ' HD13 ' A' ' 26' ' ' ILE . . . 163.91 27.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.728 0 C-N-CA 119.088 -1.53 . . . . 0.0 116.552 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.5 p -150.25 -136.0 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 118.474 1.137 . . . . 0.0 110.065 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -49.05 -40.06 29.9 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 123.779 0.674 . . . . 0.0 110.149 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.88 -54.38 3.65 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.63 2.53 6.1 Favored Glycine 0 N--CA 1.498 2.791 0 CA-C-N 114.833 -0.683 . . . . 0.0 113.098 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.29 141.22 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -150.34 136.22 10.5 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 2.7 Cg_exo -54.62 102.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.492 2.128 . . . . 0.0 109.43 167.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -63.65 83.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.506 -1.679 . . . . 0.0 112.592 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.26 145.96 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.167 -1.378 . . . . 0.0 107.305 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' H ' HD13 ' A' ' 12' ' ' LEU . 5.4 mp -70.35 86.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 124.097 0.873 . . . . 0.0 110.26 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.41 149.44 49.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -92.0 154.98 18.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.981 0.801 . . . . 0.0 110.24 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.1 p -150.35 125.92 10.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.632 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -55.06 5.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -117.55 173.95 6.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.025 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.8 m-20 -50.19 -55.19 16.21 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.8 p -75.96 1.36 15.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.33 -17.22 62.45 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.554 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 t -88.48 145.69 36.01 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.049 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.6 Cg_exo -68.87 164.4 33.7 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.85 1.7 . . . . 0.0 109.931 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -158.95 52.72 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.102 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.92 18.13 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.719 -1.24 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 85.3 m -63.47 160.89 15.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.428 HD13 ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -122.91 -168.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.46 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.9 t -131.15 129.9 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.079 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' NH2' ' H ' ' A' ' 1' ' ' SER . 41.1 mmt180 -71.23 168.0 18.21 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.145 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.07 -14.5 80.35 Favored Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.846 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -81.18 -8.09 59.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 21.92 30.68 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 123.804 0.69 . . . . 0.0 112.252 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 8.7 m-85 -134.31 153.57 51.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -40.93 154.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.363 1.664 . . . . 0.0 115.317 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.574 0 CA-C-N 114.931 -1.031 . . . . 0.0 114.498 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.26 44.35 3.27 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 5' ' ' GLY . 50.3 m -89.82 121.42 31.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.8 t70 69.33 -22.88 0.15 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 124.9 1.375 . . . . 0.0 113.413 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 3' ' ' SER . . . -81.92 -75.6 1.12 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.23 -142.16 7.66 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.3 t -141.16 148.57 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.5 t -150.04 119.17 3.74 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.01 -161.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.798 2.332 . . . . 0.0 112.213 171.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -46.51 141.64 3.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -130.63 124.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.256 1.026 . . . . 0.0 113.375 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -173.79 21.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.195 -1.82 . . . . 0.0 107.781 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -111.4 140.67 45.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 112.575 -2.102 . . . . 0.0 107.494 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 14' ' ' LYS . 10.0 mptt -74.55 149.22 40.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.352 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.7 p -134.45 127.41 31.43 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -80.42 -59.24 2.77 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -114.09 171.27 7.71 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.665 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 59.0 m-20 -51.59 -52.36 48.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -80.61 9.66 5.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.37 -15.47 61.37 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.635 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.598 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.75 149.15 43.27 Favored Pre-proline 0 N--CA 1.485 1.309 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.9 Cg_exo -65.14 154.66 72.43 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.892 1.728 . . . . 0.0 110.335 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.81 -165.97 54.49 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.54 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.85 16.36 0.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.652 -1.274 . . . . 0.0 109.676 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.531 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 93.8 m -63.36 154.56 31.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -178.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.5 t -111.89 115.59 29.25 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.068 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -65.39 168.58 6.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.491 1.119 . . . . 0.0 111.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.87 73.18 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.836 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -82.11 -4.06 56.11 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 19.93 48.45 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 123.631 0.582 . . . . 0.0 113.138 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -139.4 158.45 44.12 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.757 0.789 . . . . 0.0 110.478 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.9 m -41.14 153.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 112.511 -2.131 . . . . 0.0 114.808 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.96 0 O-C-N 124.071 0.857 . . . . 0.0 114.204 179.591 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.442 ' H ' ' NH2' ' A' ' 28' ' ' ARG . 77.4 p . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.462 0.649 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.39 77.93 1.04 Allowed Glycine 0 N--CA 1.495 2.573 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.733 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.497 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 21.2 t -89.91 -133.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.497 ' H ' ' HG ' ' A' ' 3' ' ' SER . 7.5 m-20 -65.77 -23.1 66.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 25.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.848 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.27 -159.65 18.87 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.9 t -150.06 163.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 113.035 -1.582 . . . . 0.0 108.768 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.3 t -130.97 141.58 42.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -70.94 157.39 58.24 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.506 2.138 . . . . 0.0 109.998 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -78.94 94.45 5.24 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.76 145.43 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.224 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.8 mt -89.83 38.32 0.91 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.042 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HZ1' ' HZ3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -89.77 126.6 35.73 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.298 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 2.0 mppt? -72.17 154.2 41.19 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.225 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.6 p -138.61 130.32 27.79 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.686 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -82.16 -49.17 10.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 -128.13 173.4 10.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.517 -2.128 . . . . 0.0 106.79 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 18.5 m-20 -53.45 -53.2 54.74 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.4 p -74.32 4.47 5.77 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -77.22 -14.06 59.83 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.57 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 52.3 t -88.84 148.63 41.89 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.113 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.545 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.61 166.46 28.57 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.93 1.753 . . . . 0.0 109.65 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.02 -161.06 54.32 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.99 16.85 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.159 -1.02 . . . . 0.0 108.696 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 63.3 m -61.15 171.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.26 -163.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.47 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -130.75 129.31 42.34 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' NH2' ' H ' ' A' ' 1' ' ' SER . 40.2 mmt180 -78.58 170.13 17.14 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.775 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.32 84.7 Favored Glycine 0 N--CA 1.496 2.652 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -80.0 -5.16 55.24 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.57 20.85 39.27 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 123.747 0.655 . . . . 0.0 112.541 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.3 m-85 -141.12 157.6 45.06 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.612 0.72 . . . . 0.0 110.17 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.1 m -39.95 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 112.704 -2.043 . . . . 0.0 114.957 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.954 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.511 0.672 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.67 -13.73 18.97 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.433 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -145.17 153.88 41.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.71 -33.0 73.25 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.15 80.59 1.7 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.43 101.07 0.85 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.1 t -89.43 126.71 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.42 ' SG ' ' HA2' ' A' ' 34' ' ' GLY . 43.2 t -95.44 135.43 23.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.164 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 Cg_endo -56.45 87.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.662 1.575 . . . . 0.0 108.684 142.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -56.09 115.79 2.63 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.14 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.4 pt -143.3 156.63 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 124.033 0.833 . . . . 0.0 109.448 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -86.13 39.77 0.83 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.969 0.793 . . . . 0.0 112.246 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 88.2 tttt -89.78 150.3 22.33 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -81.59 152.57 27.13 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.267 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.35 127.54 24.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.697 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 ttm-85 -80.04 -60.05 2.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -116.31 172.91 6.89 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 113.027 -1.897 . . . . 0.0 107.007 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 12.8 m-20 -57.13 -52.37 65.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.228 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.0 p -74.37 12.67 0.71 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.91 -18.48 50.46 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 39.1 t -89.02 148.75 41.8 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.311 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -71.53 159.83 50.15 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.338 2.025 . . . . 0.0 110.887 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.49 -163.33 54.77 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.872 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.26 17.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.877 -1.162 . . . . 0.0 109.443 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 68.9 m -67.67 167.22 13.57 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.167 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.67 -175.53 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.481 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 19.6 t -105.16 124.12 49.0 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -70.42 170.56 11.7 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.405 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.41 77.97 Favored Glycine 0 N--CA 1.495 2.602 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -82.67 -9.82 59.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.003 0.473 . . . . 0.0 111.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.25 23.7 28.66 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 123.929 0.768 . . . . 0.0 112.727 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -137.56 158.11 45.08 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.158 0.504 . . . . 0.0 109.841 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 21.4 m -46.1 150.1 0.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.75 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.375 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.469 ' H ' HH21 ' A' ' 28' ' ' ARG . 69.5 p . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.408 ' N ' HD13 ' A' ' 26' ' ' ILE . . . 73.05 113.04 0.06 OUTLIER Glycine 0 N--CA 1.498 2.774 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.613 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 p -150.29 -48.83 0.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.221 1.01 . . . . 0.0 109.326 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.15 -32.12 3.74 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.814 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.99 105.99 0.23 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.15 154.39 7.64 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.8 145.29 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t -149.83 143.89 17.16 Favored Pre-proline 0 N--CA 1.495 1.79 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.252 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.46 179.46 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.817 2.345 . . . . 0.0 110.256 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -93.91 89.99 6.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.434 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.467 ' H ' HD11 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -128.53 163.88 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.698 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.423 ' H ' HD21 ' A' ' 12' ' ' LEU . 1.2 pt? -110.94 47.96 0.95 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.877 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.533 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.3 mmtm -89.19 128.2 35.8 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.034 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -69.16 149.37 48.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.949 0.781 . . . . 0.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.576 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 29.0 p -146.25 133.6 20.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.522 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -93.17 -37.05 12.31 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -132.09 169.47 16.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.6 m-20 -53.81 -51.61 62.96 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -75.73 5.01 6.78 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.83 -12.19 59.78 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.9 t -88.89 150.3 45.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.782 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.69 166.3 29.22 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.919 1.746 . . . . 0.0 109.727 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.68 -163.02 52.08 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.235 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.63 16.59 3.13 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.857 -1.171 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.59 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 62.8 m -61.72 168.92 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -131.04 -159.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 179.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 44.8 t -138.25 128.25 25.56 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.469 HH21 ' H ' ' A' ' 1' ' ' SER . 41.8 mmt180 -79.32 169.08 18.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.268 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.4 -8.49 66.41 Favored Glycine 0 N--CA 1.495 2.619 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.537 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -84.96 -8.17 58.86 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.604 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' HD21 ' A' ' 30' ' ' ASN . . . 91.5 26.35 20.81 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 20.2 m-85 -141.19 152.33 44.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 66.0 m -40.62 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.266 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.002 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.22 -124.71 5.47 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.072 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -142.32 -16.67 0.74 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.326 0.662 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.03 -29.38 60.8 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.726 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.82 -58.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.52 64.53 Favored Glycine 0 N--CA 1.495 2.61 0 CA-C-N 114.676 -0.762 . . . . 0.0 112.664 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.16 44.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.97 140.8 22.6 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.271 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 10.1 Cg_endo -67.23 173.03 9.16 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.489 2.126 . . . . 0.0 110.746 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -94.98 93.06 7.18 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.627 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -134.62 149.27 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.358 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -104.96 49.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -89.8 139.69 30.33 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.787 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.6 151.04 37.9 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.499 -1.281 . . . . 0.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.7 p -138.09 136.19 36.54 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.255 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.451 HH12 HH22 ' A' ' 17' ' ' ARG . 34.3 mtp-105 -87.65 -65.53 1.01 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.451 HH22 HH12 ' A' ' 16' ' ' ARG . 9.6 ptp85 -105.21 173.62 6.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.9 m-20 -59.02 -46.84 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 85.5 p -81.77 13.82 3.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.006 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.83 -14.3 59.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 48.7 t -89.27 151.57 46.66 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.438 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -71.73 161.59 44.69 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.104 1.869 . . . . 0.0 110.216 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.68 -164.93 54.71 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.312 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.5 14.39 2.55 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.729 -1.236 . . . . 0.0 109.561 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.497 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.7 m -61.28 166.26 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.23 170.43 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.414 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 36.8 t -102.51 122.88 45.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.22 166.77 22.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -13.07 61.53 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.811 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -81.03 -10.04 59.75 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.513 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.04 26.78 23.15 Favored Glycine 0 N--CA 1.496 2.649 0 O-C-N 123.895 0.747 . . . . 0.0 111.591 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.487 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 58.7 m-85 -142.83 157.24 44.8 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.543 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.7 m -46.78 161.15 0.07 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.029 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' H ' HG13 ' A' ' 26' ' ' ILE . . . 159.0 -38.08 0.5 Allowed Glycine 0 N--CA 1.499 2.85 0 O-C-N 123.541 0.526 . . . . 0.0 112.494 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 m -88.96 170.59 10.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.9 t70 63.35 16.91 9.88 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 123.798 0.686 . . . . 0.0 111.587 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.36 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.89 -96.8 0.1 Allowed Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.854 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.09 160.41 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -148.89 140.53 14.4 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.55 -173.02 1.47 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.953 2.435 . . . . 0.0 110.595 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -98.35 116.76 31.26 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.086 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -141.87 173.39 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.48 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -122.79 34.76 5.05 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.91 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -89.89 142.24 27.89 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.607 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -76.84 153.57 34.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 123.816 0.697 . . . . 0.0 111.212 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.6 p -142.19 120.64 12.42 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.56 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 -37.82 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.18 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ptt180 -132.75 166.47 22.15 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.26 -52.83 32.92 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.312 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.0 p -86.75 32.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -93.65 -18.55 22.04 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 113.326 -1.761 . . . . 0.0 106.828 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 20.8 t -88.96 150.52 45.55 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.381 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.2 Cg_endo -76.1 168.14 24.64 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.288 1.992 . . . . 0.0 110.05 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.56 -160.47 53.69 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.764 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.24 18.74 4.83 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 71.2 m -71.24 162.11 29.98 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.4 HG13 ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -134.77 -178.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 46.8 t -104.01 130.11 51.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.402 HH21 ' HB2' ' A' ' 32' ' ' TYR . 88.1 mtm180 -81.3 170.88 15.5 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.1 -13.41 83.25 Favored Glycine 0 N--CA 1.495 2.59 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -81.63 -7.2 59.56 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.58 26.0 28.71 Favored Glycine 0 N--CA 1.498 2.786 0 O-C-N 123.83 0.707 . . . . 0.0 111.899 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 34.2 m-85 -142.97 154.12 43.71 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.765 0.793 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.0 m -48.43 153.89 0.7 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.611 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 O-C-N 124.221 0.95 . . . . 0.0 114.1 179.703 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.17 58.85 0.15 Allowed Glycine 0 N--CA 1.498 2.804 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.9 p -150.56 -152.76 0.45 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.51 -29.36 61.76 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.77 -145.76 4.66 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.95 56.51 0.08 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.06 37.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.87 144.86 32.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.954 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.6 Cg_exo -64.35 -157.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.803 2.335 . . . . 0.0 112.087 173.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 33.0 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.479 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -89.42 135.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.723 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.464 ' H ' HD11 ' A' ' 12' ' ' LEU . 5.9 mp -60.7 106.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.167 0.917 . . . . 0.0 110.434 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -145.46 150.16 36.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 2.0 mptp? -101.31 152.76 20.31 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.986 0.898 . . . . 0.0 112.632 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.5 p -144.46 142.08 30.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.333 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.87 -34.27 9.87 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.85 167.11 21.49 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.431 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 14.0 m-20 -51.99 -52.79 48.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.7 p -79.62 20.88 0.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -87.07 -19.83 28.02 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.568 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 38.1 t -88.76 146.78 37.71 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.4 Cg_endo -75.53 167.34 26.73 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.202 1.934 . . . . 0.0 110.177 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.07 -162.53 54.48 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.002 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.56 14.12 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.514 -1.343 . . . . 0.0 109.467 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.8 m -67.71 170.7 7.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.825 1.298 . . . . 0.0 114.455 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.9 -175.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.431 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.7 t -113.16 126.14 55.11 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -69.01 171.43 8.15 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.168 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.27 -18.09 77.9 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.93 8.26 18.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.062 0.507 . . . . 0.0 111.811 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.8 25.43 75.75 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.789 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 16.4 m-85 -131.09 153.49 49.28 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 m -47.6 157.24 0.25 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 C-N-CA 119.268 -1.444 . . . . 0.0 116.114 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.08 -59.86 0.16 Allowed Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -89.78 -148.02 0.19 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 123.91 0.418 . . . . 0.0 110.732 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -50.4 -22.42 1.86 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -51.29 -71.02 0.71 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 124.312 1.008 . . . . 0.0 111.791 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.99 -71.62 2.58 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.42 125.4 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.6 t -150.27 136.05 10.39 Favored Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.591 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.3 Cg_endo -64.2 95.41 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.808 1.672 . . . . 0.0 108.899 158.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.2 54.11 3.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -89.01 164.59 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.013 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.464 ' H ' HD11 ' A' ' 12' ' ' LEU . 5.4 mp -67.3 81.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.293 0.996 . . . . 0.0 109.984 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 107.94 8.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.24 149.16 38.62 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.847 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -135.22 128.74 32.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.944 -1.935 . . . . 0.0 112.047 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -81.85 -58.7 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -111.53 171.74 7.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.252 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.2 m-20 -56.38 -49.29 74.89 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -81.49 13.15 3.18 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.485 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -75.93 -16.39 60.02 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.856 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.585 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -88.79 151.16 47.16 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.475 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.4 Cg_exo -72.42 162.56 41.13 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.036 1.824 . . . . 0.0 110.058 170.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.55 -166.82 54.83 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.053 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.47 7.38 6.72 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.007 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 71.4 m -54.68 166.19 0.5 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.67 171.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.403 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.8 t -101.81 119.97 39.63 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -72.21 168.98 17.12 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.911 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.14 68.69 Favored Glycine 0 N--CA 1.495 2.568 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.639 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.9 p30 -81.94 -7.63 59.62 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.602 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.43 19.74 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -145.87 154.66 42.21 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.744 0.783 . . . . 0.0 110.097 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -44.49 154.35 0.13 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.54 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 C-N-CA 119.642 -1.266 . . . . 0.0 115.633 179.68 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.2 120.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 O-C-N 124.136 0.897 . . . . 0.0 114.039 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.43 ' HG ' HH12 ' A' ' 28' ' ' ARG . 48.8 m -88.97 125.12 34.84 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.3 t70 56.76 49.67 13.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.362 1.039 . . . . 0.0 110.006 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.55 136.76 3.62 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.81 148.26 23.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.4 t -144.04 134.15 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 124.266 0.627 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 t -150.68 145.57 18.52 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 123.952 0.782 . . . . 0.0 109.007 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -71.54 -173.88 1.11 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -81.94 67.38 7.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 13' ' ' LYS . 72.5 mt -89.67 123.42 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.752 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.0 mt -102.37 36.22 2.21 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.887 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' H ' HG22 ' A' ' 11' ' ' ILE . 35.0 mtmm -96.88 136.05 37.99 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.57 149.94 49.73 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.457 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 25.4 p -130.37 133.78 46.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.113 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -84.93 -45.65 12.02 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -132.32 172.11 12.85 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 112.766 -2.015 . . . . 0.0 107.29 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 10.5 m-20 -53.82 -53.37 53.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -73.98 3.25 7.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -72.09 -18.14 61.94 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.613 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.3 t -89.11 148.95 42.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.614 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.613 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.5 Cg_endo -73.06 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.166 1.911 . . . . 0.0 110.355 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.432 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.33 -157.82 53.4 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.408 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.33 18.85 2.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.648 -1.276 . . . . 0.0 108.348 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.584 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 69.3 m -65.95 164.36 15.26 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.83 -1.532 . . . . 0.0 114.732 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.461 ' N ' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -131.63 -165.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 111.527 -2.579 . . . . 0.0 104.767 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.474 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.7 t -128.68 124.25 35.21 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.43 HH12 ' HG ' ' A' ' 3' ' ' SER . 22.6 mmm180 -77.83 168.24 20.24 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 124.603 1.19 . . . . 0.0 110.386 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.94 -10.62 80.89 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -80.04 -4.43 52.67 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.35 24.83 35.34 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 123.793 0.683 . . . . 0.0 112.312 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 87.1 m-85 -144.03 159.51 42.47 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.212 0.595 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.3 m -41.22 152.29 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.591 1.807 . . . . 0.0 113.303 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 O-C-N 124.123 0.89 . . . . 0.0 114.634 -179.724 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 122.293 1.044 . . . . 0.0 112.152 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.06 19.65 0.1 Allowed Glycine 0 N--CA 1.494 2.511 0 CA-C-N 112.886 -1.961 . . . . 0.0 112.138 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -89.48 -15.96 31.88 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.285 0.565 . . . . 0.0 111.049 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.98 -1.69 58.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.488 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.78 122.59 4.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.14 126.89 2.92 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.18 143.26 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.471 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.4 t -103.19 146.82 33.16 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.543 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 6.0 Cg_exo -61.4 159.14 32.62 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 109.533 159.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -80.04 90.57 5.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.225 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.4 pt -135.11 173.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.671 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.406 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.7 pt? -139.2 49.01 1.85 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.687 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.2 tmtm? -89.6 117.58 28.59 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -36.32 144.4 0.06 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 p -145.92 142.27 28.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 111.526 -2.579 . . . . 0.0 111.76 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -91.48 -63.46 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.4 ' HE ' ' HG ' ' A' ' 19' ' ' SER . 30.3 ptt-85 -108.36 172.02 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.739 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.412 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 80.4 m-20 -50.23 -55.96 13.11 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.4 ' HG ' ' HE ' ' A' ' 17' ' ' ARG . 87.6 p -77.32 8.26 4.32 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.68 -12.98 60.9 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.576 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.3 t -88.61 150.42 46.16 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.961 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -66.45 156.01 67.36 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.769 1.646 . . . . 0.0 109.816 170.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 76.89 -163.1 52.24 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 120.491 -0.862 . . . . 0.0 111.748 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.19 20.87 2.57 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.939 -1.13 . . . . 0.0 108.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.543 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 88.4 m -67.35 157.33 34.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.459 HG23 ' H ' ' A' ' 27' ' ' CYS . 2.0 mm -114.21 -175.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.459 ' H ' HG23 ' A' ' 26' ' ' ILE . 37.6 t -115.87 108.98 16.98 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.471 ' NE ' HD22 ' A' ' 30' ' ' ASN . 79.7 mtm180 -59.08 170.04 0.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 -16.45 65.2 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.81 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.471 HD22 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -83.98 -7.58 59.37 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.53 21.58 43.53 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 123.777 0.673 . . . . 0.0 112.537 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -135.58 156.91 48.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 50.3 m -45.05 147.99 0.62 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.869 0 O-C-N 124.284 0.99 . . . . 0.0 115.077 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.505 2.297 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.72 62.06 4.56 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -89.85 128.93 36.27 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.8 t70 55.18 22.62 4.76 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.358 1.036 . . . . 0.0 111.41 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.2 119.8 0.62 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.06 117.36 0.24 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.34 143.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.1 t -141.01 85.43 12.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.095 0.872 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.67 28.03 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.053 2.502 . . . . 0.0 112.891 172.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.85 151.13 24.04 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.167 0.984 . . . . 0.0 111.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.424 ' CD1' ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -89.34 -171.07 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.369 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.96 70.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 126.174 2.171 . . . . 0.0 114.631 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -112.03 119.81 39.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mtpp -62.13 152.16 33.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.374 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.34 122.31 26.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.095 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -73.66 -46.49 46.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -135.37 172.65 12.71 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 112.526 -2.125 . . . . 0.0 107.995 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 26.9 m-20 -47.78 -52.74 17.68 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.9 p -81.71 6.44 15.33 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -74.07 -15.68 61.06 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.965 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.563 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.0 t -88.78 149.53 43.97 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.006 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.563 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.6 Cg_exo -66.12 167.75 17.38 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.762 1.642 . . . . 0.0 110.518 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 65.53 -164.39 38.11 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.008 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.76 15.06 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.529 -1.336 . . . . 0.0 109.617 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 74.2 m -60.29 159.35 10.1 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -121.31 -169.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.424 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.1 t -118.76 126.32 51.61 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -67.35 171.54 5.83 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.332 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.37 -13.65 80.1 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.489 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.63 -6.94 59.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.23 24.06 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 123.692 0.62 . . . . 0.0 113.132 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 37.7 m-85 -140.05 160.39 40.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.836 0.827 . . . . 0.0 110.654 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -45.38 147.91 0.73 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.677 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.765 0 O-C-N 124.528 1.143 . . . . 0.0 111.724 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.03 96.85 2.09 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.0 m -89.47 -115.29 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.21 -20.84 64.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.405 0.441 . . . . 0.0 110.062 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.11 21.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.32 90.1 0.08 OUTLIER Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.24 48.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.71 141.69 28.64 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -75.17 157.29 42.15 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.596 2.197 . . . . 0.0 109.198 164.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -79.89 82.65 5.94 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.9 mm -100.83 158.59 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.316 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.9 mt -112.8 36.0 3.65 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.56 -1.655 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 2.1 mmpt? -90.66 122.21 33.25 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.81 146.76 7.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.085 0.945 . . . . 0.0 111.969 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.137 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -76.73 -40.44 48.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -137.37 171.03 15.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.667 -2.061 . . . . 0.0 107.525 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -48.58 -56.75 7.53 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.9 p -83.06 15.22 2.9 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -77.58 -14.99 59.51 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.414 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.582 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 49.8 t -88.95 151.39 47.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.75 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.1 Cg_exo -68.34 158.85 55.83 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.823 1.682 . . . . 0.0 110.017 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 75.18 -165.64 54.68 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.043 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.19 15.02 3.08 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.699 -1.25 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 23' ' ' GLY . 77.2 m -62.89 152.69 35.63 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.17 -177.65 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.93 123.53 49.24 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 85.6 mtm180 -71.63 170.23 13.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.494 1.121 . . . . 0.0 110.776 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.12 -18.44 79.73 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.1 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -81.14 -0.03 38.37 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 124.147 0.557 . . . . 0.0 112.067 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 25.35 53.47 Favored Glycine 0 N--CA 1.496 2.64 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.351 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.76 156.83 47.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.083 0.944 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 27.6 m -48.59 146.95 2.74 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.151 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 O-C-N 124.588 1.18 . . . . 0.0 112.619 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.0 p . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.393 0.616 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.66 84.84 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 CA-C-N 114.246 -1.343 . . . . 0.0 116.139 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.459 ' HG ' ' H ' ' A' ' 4' ' ' ASP . 18.1 t -150.99 -127.18 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.459 ' H ' ' HG ' ' A' ' 3' ' ' SER . 5.5 p-10 -66.75 -9.73 39.84 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -119.49 -118.49 2.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.26 -151.02 8.46 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.92 164.43 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 114.099 -1.05 . . . . 0.0 109.512 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.7 t -145.71 149.34 39.59 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.083 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -72.38 136.25 26.02 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.361 2.041 . . . . 0.0 108.284 160.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.67 91.51 1.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.837 0.711 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -115.95 151.01 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.065 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.65 39.43 0.84 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.302 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -89.54 124.78 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -64.39 152.16 42.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 123.873 0.733 . . . . 0.0 111.34 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.9 p -145.7 126.07 13.99 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.263 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -74.8 -49.89 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -127.6 173.94 9.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.056 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 66.0 m-20 -51.3 -55.29 19.1 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.9 p -72.29 2.29 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.63 -14.98 59.94 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 51.4 t -88.7 146.91 38.11 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.905 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 Cg_exo -69.8 163.67 37.44 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.901 1.734 . . . . 0.0 109.848 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 74.17 -158.8 52.21 Favored Glycine 0 N--CA 1.5 2.967 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.996 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.73 20.0 3.71 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.86 -1.17 . . . . 0.0 108.372 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.7 m -65.8 168.85 7.25 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 113.255 -1.793 . . . . 0.0 115.694 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.94 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.085 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 45.8 t -139.27 129.0 24.68 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 88.3 mtm180 -81.36 170.51 15.91 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.074 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.06 -11.24 78.95 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.593 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -81.06 -2.14 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.327 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' N ' HD21 ' A' ' 30' ' ' ASN . . . 86.34 23.97 41.9 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.541 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 91.1 m-85 -143.45 152.98 42.18 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.677 0.751 . . . . 0.0 110.21 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.9 m -36.03 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 112.25 -2.25 . . . . 0.0 115.143 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 O-C-N 124.324 1.015 . . . . 0.0 112.288 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.45 113.55 0.97 Allowed Glycine 0 N--CA 1.495 2.585 0 O-C-N 123.756 0.66 . . . . 0.0 112.482 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -150.36 -135.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.84 -37.35 81.76 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.43 39.0 2.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.2 11.99 1.33 Allowed Glycine 0 N--CA 1.499 2.844 0 CA-C-N 115.246 -0.477 . . . . 0.0 114.268 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 t -92.22 48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.84 140.61 27.85 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.779 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -71.56 159.13 52.08 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.663 2.242 . . . . 0.0 109.515 167.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -80.85 94.44 6.46 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.266 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.79 142.65 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.684 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.73 47.3 0.88 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.541 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -89.94 121.53 32.13 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -52.01 148.27 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.187 0.994 . . . . 0.0 113.396 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 20.0 p -143.65 128.18 18.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.483 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -86.27 -34.15 20.47 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HE ' ' HG ' ' A' ' 19' ' ' SER . 30.0 ptt-85 -130.86 166.35 21.06 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -53.43 -44.82 69.11 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.438 ' HG ' ' HE ' ' A' ' 17' ' ' ARG . 89.3 p -91.17 26.0 2.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.1 -11.55 32.65 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 42.8 t -88.81 148.65 41.99 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.866 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.9 Cg_exo -66.23 157.32 60.55 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.877 1.718 . . . . 0.0 109.961 171.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 -167.33 54.45 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.63 17.97 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.844 -1.178 . . . . 0.0 110.167 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 78.8 m -49.3 151.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -118.14 172.15 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.03 128.26 49.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -69.43 169.95 11.44 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.608 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.18 -16.35 80.64 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.266 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -1.91 56.55 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.29 24.21 37.71 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 123.691 0.619 . . . . 0.0 113.409 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 95.0 m-85 -137.74 155.32 49.21 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.062 0.934 . . . . 0.0 111.013 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.7 m -48.67 152.93 0.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 112.48 -2.146 . . . . 0.0 114.669 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 O-C-N 124.758 1.286 . . . . 0.0 113.163 179.45 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.807 0.813 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.99 83.22 0.16 Allowed Glycine 0 N--CA 1.493 2.453 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.065 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -89.58 -10.7 45.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.228 0.605 . . . . 0.0 110.458 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -127.29 -30.54 2.63 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.161 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.27 -24.75 0.05 OUTLIER Glycine 0 N--CA 1.494 2.544 0 O-C-N 124.223 0.952 . . . . 0.0 111.084 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.81 51.26 8.06 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.62 46.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.03 134.31 20.16 Favored Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.973 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.97 119.35 6.01 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.382 2.054 . . . . 0.0 108.868 166.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.24 94.79 1.61 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.915 0.759 . . . . 0.0 110.248 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.54 152.22 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.943 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' H ' HD13 ' A' ' 12' ' ' LEU . 5.5 mp -67.7 86.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.08 0.862 . . . . 0.0 109.766 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 68.5 mttm -133.48 150.88 51.71 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.291 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -97.97 152.45 19.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.1 p -144.19 124.78 14.03 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.787 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -84.34 -49.68 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -126.55 169.74 12.75 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.704 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 8.7 m-20 -50.9 -47.6 60.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -89.1 28.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -94.76 -17.52 22.09 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 113.575 -1.648 . . . . 0.0 107.308 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 45.4 t -88.95 148.22 40.68 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.541 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.7 Cg_endo -73.56 165.67 31.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.237 1.958 . . . . 0.0 110.23 173.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.414 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.63 -163.71 54.75 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.903 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.05 14.83 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.874 -1.163 . . . . 0.0 109.212 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 79.3 m -66.89 161.04 24.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 -171.65 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 102.65 -3.093 . . . . 0.0 102.65 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.401 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -113.07 130.46 56.16 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 1.8 mmp_? -69.59 172.65 7.05 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 -13.68 82.98 Favored Glycine 0 N--CA 1.494 2.525 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.658 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -89.46 -9.6 49.5 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.97 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.12 33.32 7.78 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 11.4 m-85 -137.66 155.78 48.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 19.9 m -51.75 149.36 4.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.458 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.6 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.594 179.613 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 58.8 mtpt -62.84 150.33 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.021 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.516 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 22.3 p -138.41 135.83 35.66 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.546 -2.116 . . . . 0.0 111.759 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -84.76 -57.73 3.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.4 ptt-85 -115.32 173.48 6.49 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.874 -1.966 . . . . 0.0 106.882 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.5 m-20 -56.31 -52.06 65.93 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -73.6 5.64 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.1 t70 -76.61 -16.7 59.51 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.77 147.02 38.2 Favored Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.15 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.2 Cg_exo -70.7 165.86 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.829 1.686 . . . . 0.0 109.703 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.67 -160.51 54.07 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.29 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.53 20.26 2.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.622 -1.289 . . . . 0.0 108.729 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 65.6 m -67.43 170.8 6.85 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 113.628 -1.624 . . . . 0.0 114.139 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -136.58 -167.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.2 t -126.35 128.12 46.58 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -77.37 170.18 17.0 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.284 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.94 -12.55 83.89 Favored Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.597 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -79.63 -5.62 55.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.37 40.45 Favored Glycine 0 N--CA 1.496 2.692 0 O-C-N 123.723 0.64 . . . . 0.0 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 53.2 m-85 -141.14 159.8 41.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.114 0.537 . . . . 0.0 109.749 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.3 m -40.69 159.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.533 1.771 . . . . 0.0 114.663 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 CA-C-N 115.402 -0.817 . . . . 0.0 114.557 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -81.2 153.52 27.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.331 -0.947 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.6 p -143.03 134.52 26.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.404 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -93.88 -41.86 9.39 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -128.59 167.4 17.21 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.499 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 22.3 m-20 -49.15 -51.29 33.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 88.8 p -90.06 27.08 1.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.5 t70 -86.24 -15.82 39.6 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.272 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 t -88.85 151.64 47.63 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.2 Cg_endo -73.93 164.65 34.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.182 1.921 . . . . 0.0 109.733 169.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -162.36 54.4 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.938 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.1 21.54 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.923 -1.139 . . . . 0.0 108.153 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 96.4 m -71.63 153.17 42.28 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 174.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.405 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 44.2 t -100.97 118.98 38.05 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NE ' HD21 ' A' ' 30' ' ' ASN . 87.4 mtm180 -66.42 170.77 5.64 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.09 -14.93 74.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.868 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.413 HD21 ' NE ' ' A' ' 28' ' ' ARG . 21.1 p30 -84.59 -10.52 57.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.934 0.432 . . . . 0.0 111.742 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.65 13.51 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 123.786 0.679 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.0 m-85 -141.71 155.01 45.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.49 0.662 . . . . 0.0 109.747 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.8 m -48.75 146.32 3.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.597 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 O-C-N 124.287 0.992 . . . . 0.0 115.063 179.709 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -75.79 152.91 37.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.116 0.885 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.573 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 19.0 p -139.56 133.27 30.54 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.966 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.7 -34.8 18.27 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -134.8 169.26 17.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.3 m-20 -53.21 -54.33 37.62 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.1 p -72.52 1.44 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -76.06 -12.64 60.16 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.1 t -89.0 146.85 37.37 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.887 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.3 Cg_exo -68.54 162.69 39.79 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.882 1.722 . . . . 0.0 110.124 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.01 -160.39 54.01 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.672 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.1 18.17 3.22 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.966 -1.117 . . . . 0.0 108.684 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.4 m -62.57 168.83 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -131.74 -166.48 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.53 -2.577 . . . . 0.0 104.365 179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.3 t -132.77 131.5 41.21 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.501 HH22 HD22 ' A' ' 30' ' ' ASN . 41.7 mtm105 -88.45 168.33 12.71 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.717 1.26 . . . . 0.0 111.755 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -12.52 56.63 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 112.805 -1.998 . . . . 0.0 114.377 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.501 HD22 HH22 ' A' ' 28' ' ' ARG . 42.4 p-10 -79.56 -8.61 59.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.835 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.6 24.86 27.09 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 57.0 m-85 -143.49 158.63 43.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -37.71 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.794 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.484 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 151.78 28.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.574 -1.251 . . . . 0.0 113.66 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.0 p -141.19 129.63 22.51 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.557 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -82.81 -62.92 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 15.7 ptm180 -110.94 174.3 5.93 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.36 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.8 m-20 -54.42 -53.53 52.86 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.2 p -73.84 3.81 6.12 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.5 t70 -72.65 -16.89 61.7 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 49.2 t -88.65 146.7 37.79 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.739 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 Cg_exo -69.62 164.24 35.15 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.885 1.724 . . . . 0.0 109.748 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.5 -160.97 54.0 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.852 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.23 19.82 3.02 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.777 -1.212 . . . . 0.0 108.679 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.571 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 75.6 m -65.1 171.01 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.807 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.72 -169.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 46.6 t -123.39 126.96 47.76 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.65 169.55 17.82 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -13.96 75.2 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.021 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -79.63 -6.06 56.34 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.754 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.79 23.62 38.31 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 123.82 0.7 . . . . 0.0 112.131 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 83.7 m-85 -144.78 157.24 44.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.169 0.57 . . . . 0.0 109.902 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 56.5 m -37.31 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.598 0 CA-C-N 114.851 -1.068 . . . . 0.0 115.192 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -92.0 154.98 18.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.981 0.801 . . . . 0.0 110.24 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.1 p -150.35 125.92 10.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.632 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -55.06 5.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -117.55 173.95 6.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.025 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.8 m-20 -50.19 -55.19 16.21 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.8 p -75.96 1.36 15.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.33 -17.22 62.45 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 t -88.48 145.69 36.01 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.049 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.6 Cg_exo -68.87 164.4 33.7 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.85 1.7 . . . . 0.0 109.931 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -158.95 52.72 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.102 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.92 18.13 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.719 -1.24 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 85.3 m -63.47 160.89 15.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.91 -168.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.9 t -131.15 129.9 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.079 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.23 168.0 18.21 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.145 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.07 -14.5 80.35 Favored Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.846 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -81.18 -8.09 59.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 21.92 30.68 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 123.804 0.69 . . . . 0.0 112.252 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 8.7 m-85 -134.31 153.57 51.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -40.93 154.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.363 1.664 . . . . 0.0 115.317 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.574 0 CA-C-N 114.931 -1.031 . . . . 0.0 114.498 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 mttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 10.0 mptt -74.55 149.22 40.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.352 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.7 p -134.45 127.41 31.43 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -80.42 -59.24 2.77 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -114.09 171.27 7.71 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.665 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 59.0 m-20 -51.59 -52.36 48.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -80.61 9.66 5.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.7 t70 -73.37 -15.47 61.37 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.635 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.614 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.75 149.15 43.27 Favored Pre-proline 0 N--CA 1.485 1.309 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.614 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.9 Cg_exo -65.14 154.66 72.43 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.892 1.728 . . . . 0.0 110.335 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.81 -165.97 54.49 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.54 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.85 16.36 0.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.652 -1.274 . . . . 0.0 109.676 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.531 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 93.8 m -63.36 154.56 31.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -178.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.5 t -111.89 115.59 29.25 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.068 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -65.39 168.58 6.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.491 1.119 . . . . 0.0 111.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.87 73.18 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.836 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -82.11 -4.06 56.11 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 19.93 48.45 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 123.631 0.582 . . . . 0.0 113.138 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -139.4 158.45 44.12 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.757 0.789 . . . . 0.0 110.478 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.9 m -41.14 153.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 112.511 -2.131 . . . . 0.0 114.808 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.96 0 O-C-N 124.071 0.857 . . . . 0.0 114.204 179.591 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HA ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 2.0 mppt? -72.17 154.2 41.19 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.225 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.6 p -138.61 130.32 27.79 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.686 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -82.16 -49.17 10.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 29.3 ptt-85 -128.13 173.4 10.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.517 -2.128 . . . . 0.0 106.79 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 18.5 m-20 -53.45 -53.2 54.74 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.4 p -74.32 4.47 5.77 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.6 t70 -77.22 -14.06 59.83 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.57 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 52.3 t -88.84 148.63 41.89 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.113 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.558 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.61 166.46 28.57 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.93 1.753 . . . . 0.0 109.65 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.02 -161.06 54.32 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.99 16.85 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.159 -1.02 . . . . 0.0 108.696 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 63.3 m -61.15 171.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.26 -163.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -130.75 129.31 42.34 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.58 170.13 17.14 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.32 84.7 Favored Glycine 0 N--CA 1.496 2.652 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -80.0 -5.16 55.24 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.57 20.85 39.27 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 123.747 0.655 . . . . 0.0 112.541 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.3 m-85 -141.12 157.6 45.06 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.612 0.72 . . . . 0.0 110.17 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.1 m -39.95 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 112.704 -2.043 . . . . 0.0 114.957 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.954 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 88.2 tttt . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 37.7 mtmm -81.59 152.57 27.13 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.267 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.35 127.54 24.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.697 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 ttm-85 -80.04 -60.05 2.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 18.4 ptp180 -116.31 172.91 6.89 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 113.027 -1.897 . . . . 0.0 107.007 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.51 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 12.8 m-20 -57.13 -52.37 65.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.228 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.0 p -74.37 12.67 0.71 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 15.8 t70 -79.91 -18.48 50.46 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.598 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 39.1 t -89.02 148.75 41.8 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.311 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -71.53 159.83 50.15 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.338 2.025 . . . . 0.0 110.887 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.49 -163.33 54.77 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.872 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.26 17.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.877 -1.162 . . . . 0.0 109.443 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 68.9 m -67.67 167.22 13.57 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.167 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.67 -175.53 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 19.6 t -105.16 124.12 49.0 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -70.42 170.56 11.7 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.405 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.41 77.97 Favored Glycine 0 N--CA 1.495 2.602 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -82.67 -9.82 59.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.003 0.473 . . . . 0.0 111.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.25 23.7 28.66 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 123.929 0.768 . . . . 0.0 112.727 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 26.4 m-85 -137.56 158.11 45.08 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.158 0.504 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 21.4 m -46.1 150.1 0.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.75 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.375 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.3 mmtm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -69.16 149.37 48.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.949 0.781 . . . . 0.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.576 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 29.0 p -146.25 133.6 20.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.522 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -93.17 -37.05 12.31 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -132.09 169.47 16.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.6 m-20 -53.81 -51.61 62.96 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -75.73 5.01 6.78 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.83 -12.19 59.78 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.9 t -88.89 150.3 45.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.782 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.69 166.3 29.22 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.919 1.746 . . . . 0.0 109.727 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.68 -163.02 52.08 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.235 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.63 16.59 3.13 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.857 -1.171 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.59 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 62.8 m -61.72 168.92 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.04 -159.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 44.8 t -138.25 128.25 25.56 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -79.32 169.08 18.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.268 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.4 -8.49 66.41 Favored Glycine 0 N--CA 1.495 2.619 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.537 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -84.96 -8.17 58.86 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.604 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.5 26.35 20.81 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 20.2 m-85 -141.19 152.33 44.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 66.0 m -40.62 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.266 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.002 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.6 151.04 37.9 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.499 -1.281 . . . . 0.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.7 p -138.09 136.19 36.54 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.255 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.465 HH12 HH22 ' A' ' 17' ' ' ARG . 34.3 mtp-105 -87.65 -65.53 1.01 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 HH22 HH12 ' A' ' 16' ' ' ARG . 9.6 ptp85 -105.21 173.62 6.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.9 m-20 -59.02 -46.84 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 85.5 p -81.77 13.82 3.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.006 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 6.8 t70 -77.83 -14.3 59.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 48.7 t -89.27 151.57 46.66 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.438 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -71.73 161.59 44.69 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.104 1.869 . . . . 0.0 110.216 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.68 -164.93 54.71 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.312 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.5 14.39 2.55 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.729 -1.236 . . . . 0.0 109.561 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.497 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.7 m -61.28 166.26 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.23 170.43 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 36.8 t -102.51 122.88 45.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.22 166.77 22.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -13.07 61.53 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.811 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -81.03 -10.04 59.75 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.513 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.04 26.78 23.15 Favored Glycine 0 N--CA 1.496 2.649 0 O-C-N 123.895 0.747 . . . . 0.0 111.591 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 58.7 m-85 -142.83 157.24 44.8 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.543 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.7 m -46.78 161.15 0.07 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.029 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HZ2' ' HE2' ' A' ' 32' ' ' TYR . 46.7 mmtm -76.84 153.57 34.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 123.816 0.697 . . . . 0.0 111.212 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.6 p -142.19 120.64 12.42 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.56 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 -37.82 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.18 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.5 ptt180 -132.75 166.47 22.15 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 3.6 m-20 -50.26 -52.83 32.92 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.312 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.0 p -86.75 32.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 14.1 t70 -93.65 -18.55 22.04 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 113.326 -1.761 . . . . 0.0 106.828 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 20.8 t -88.96 150.52 45.55 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.381 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.626 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.2 Cg_endo -76.1 168.14 24.64 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.288 1.992 . . . . 0.0 110.05 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.56 -160.47 53.69 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.764 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.24 18.74 4.83 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 71.2 m -71.24 162.11 29.98 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -134.77 -178.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 46.8 t -104.01 130.11 51.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.575 ' NE ' HD22 ' A' ' 30' ' ' ASN . 88.1 mtm180 -81.3 170.88 15.5 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.1 -13.41 83.25 Favored Glycine 0 N--CA 1.495 2.59 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.575 HD22 ' NE ' ' A' ' 28' ' ' ARG . 15.6 p30 -81.63 -7.2 59.56 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.58 26.0 28.71 Favored Glycine 0 N--CA 1.498 2.786 0 O-C-N 123.83 0.707 . . . . 0.0 111.899 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB2' HH21 ' A' ' 28' ' ' ARG . 34.2 m-85 -142.97 154.12 43.71 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.765 0.793 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.0 m -48.43 153.89 0.7 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.611 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.493 2.488 0 O-C-N 124.221 0.95 . . . . 0.0 114.1 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 2.0 mptp? -101.31 152.76 20.31 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.986 0.898 . . . . 0.0 112.632 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.5 p -144.46 142.08 30.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.333 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.87 -34.27 9.87 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -134.85 167.11 21.49 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 14.0 m-20 -51.99 -52.79 48.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.7 p -79.62 20.88 0.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -87.07 -19.83 28.02 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 38.1 t -88.76 146.78 37.71 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.4 Cg_endo -75.53 167.34 26.73 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.202 1.934 . . . . 0.0 110.177 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.07 -162.53 54.48 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.002 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.56 14.12 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.514 -1.343 . . . . 0.0 109.467 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.8 m -67.71 170.7 7.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.825 1.298 . . . . 0.0 114.455 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -141.9 -175.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.7 t -113.16 126.14 55.11 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -69.01 171.43 8.15 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.168 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.27 -18.09 77.9 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -84.93 8.26 18.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.062 0.507 . . . . 0.0 111.811 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.8 25.43 75.75 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.789 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 16.4 m-85 -131.09 153.49 49.28 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 m -47.6 157.24 0.25 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 C-N-CA 119.268 -1.444 . . . . 0.0 116.114 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.24 149.16 38.62 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.847 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -135.22 128.74 32.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.944 -1.935 . . . . 0.0 112.047 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -81.85 -58.7 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt180 -111.53 171.74 7.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.252 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.2 m-20 -56.38 -49.29 74.89 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -81.49 13.15 3.18 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.485 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.7 t70 -75.93 -16.39 60.02 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.856 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -88.79 151.16 47.16 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.475 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.4 Cg_exo -72.42 162.56 41.13 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.036 1.824 . . . . 0.0 110.058 170.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.55 -166.82 54.83 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.053 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.47 7.38 6.72 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.007 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.434 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 71.4 m -54.68 166.19 0.5 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.67 171.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.8 t -101.81 119.97 39.63 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' CZ ' HD21 ' A' ' 30' ' ' ASN . 66.3 mtm180 -72.21 168.98 17.12 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.911 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.14 68.69 Favored Glycine 0 N--CA 1.495 2.568 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.639 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.414 HD21 ' CZ ' ' A' ' 28' ' ' ARG . 50.9 p30 -81.94 -7.63 59.62 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.602 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.43 19.74 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -145.87 154.66 42.21 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.744 0.783 . . . . 0.0 110.097 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -44.49 154.35 0.13 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.54 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 C-N-CA 119.642 -1.266 . . . . 0.0 115.633 179.68 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.57 149.94 49.73 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.457 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 25.4 p -130.37 133.78 46.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.113 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -84.93 -45.65 12.02 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.483 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt-85 -132.32 172.11 12.85 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 112.766 -2.015 . . . . 0.0 107.29 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 10.5 m-20 -53.82 -53.37 53.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -73.98 3.25 7.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 10.2 t70 -72.09 -18.14 61.94 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.3 t -89.11 148.95 42.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.614 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.5 Cg_endo -73.06 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.166 1.911 . . . . 0.0 110.355 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.33 -157.82 53.4 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.408 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.33 18.85 2.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.648 -1.276 . . . . 0.0 108.348 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.584 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 69.3 m -65.95 164.36 15.26 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.83 -1.532 . . . . 0.0 114.732 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -131.63 -165.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 111.527 -2.579 . . . . 0.0 104.767 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.7 t -128.68 124.25 35.21 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -77.83 168.24 20.24 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 124.603 1.19 . . . . 0.0 110.386 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.94 -10.62 80.89 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -80.04 -4.43 52.67 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.35 24.83 35.34 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 123.793 0.683 . . . . 0.0 112.312 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 87.1 m-85 -144.03 159.51 42.47 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.212 0.595 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.3 m -41.22 152.29 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.591 1.807 . . . . 0.0 113.303 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 O-C-N 124.123 0.89 . . . . 0.0 114.634 -179.724 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.2 tmtm? . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.0 mtmm -36.32 144.4 0.06 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 p -145.92 142.27 28.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 111.526 -2.579 . . . . 0.0 111.76 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -91.48 -63.46 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.3 ptt-85 -108.36 172.02 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.739 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 80.4 m-20 -50.23 -55.96 13.11 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.6 p -77.32 8.26 4.32 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 t70 -73.68 -12.98 60.9 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.3 t -88.61 150.42 46.16 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.961 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -66.45 156.01 67.36 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.769 1.646 . . . . 0.0 109.816 170.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.89 -163.1 52.24 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 120.491 -0.862 . . . . 0.0 111.748 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.19 20.87 2.57 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.939 -1.13 . . . . 0.0 108.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 88.4 m -67.35 157.33 34.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 27' ' ' CYS . 2.0 mm -114.21 -175.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 26' ' ' ILE . 37.6 t -115.87 108.98 16.98 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.51 ' NE ' HD21 ' A' ' 30' ' ' ASN . 79.7 mtm180 -59.08 170.04 0.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 -16.45 65.2 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.81 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.51 HD21 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -83.98 -7.58 59.37 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.53 21.58 43.53 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 123.777 0.673 . . . . 0.0 112.537 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' HH21 ' A' ' 28' ' ' ARG . 81.0 m-85 -135.58 156.91 48.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 50.3 m -45.05 147.99 0.62 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.869 0 O-C-N 124.284 0.99 . . . . 0.0 115.077 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mtpp -62.13 152.16 33.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.374 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.34 122.31 26.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.095 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -73.66 -46.49 46.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 11.0 ptp180 -135.37 172.65 12.71 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 112.526 -2.125 . . . . 0.0 107.995 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 26.9 m-20 -47.78 -52.74 17.68 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.9 p -81.71 6.44 15.33 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.8 t70 -74.07 -15.68 61.06 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.965 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.0 t -88.78 149.53 43.97 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.006 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.6 Cg_exo -66.12 167.75 17.38 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.762 1.642 . . . . 0.0 110.518 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.53 -164.39 38.11 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.008 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.76 15.06 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.529 -1.336 . . . . 0.0 109.617 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 74.2 m -60.29 159.35 10.1 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -121.31 -169.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.1 t -118.76 126.32 51.61 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -67.35 171.54 5.83 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.332 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.37 -13.65 80.1 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.489 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -84.63 -6.94 59.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.23 24.06 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 123.692 0.62 . . . . 0.0 113.132 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 37.7 m-85 -140.05 160.39 40.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.836 0.827 . . . . 0.0 110.654 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -45.38 147.91 0.73 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.677 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.765 0 O-C-N 124.528 1.143 . . . . 0.0 111.724 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 2.1 mmpt? . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.81 146.76 7.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.085 0.945 . . . . 0.0 111.969 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.137 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -76.73 -40.44 48.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.2 ptt85 -137.37 171.03 15.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.667 -2.061 . . . . 0.0 107.525 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -48.58 -56.75 7.53 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.9 p -83.06 15.22 2.9 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.6 t70 -77.58 -14.99 59.51 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.414 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 49.8 t -88.95 151.39 47.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.75 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.1 Cg_exo -68.34 158.85 55.83 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.823 1.682 . . . . 0.0 110.017 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 -165.64 54.68 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.043 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.19 15.02 3.08 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.699 -1.25 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 77.2 m -62.89 152.69 35.63 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.17 -177.65 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.93 123.53 49.24 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' NE ' HD21 ' A' ' 30' ' ' ASN . 85.6 mtm180 -71.63 170.23 13.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.494 1.121 . . . . 0.0 110.776 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.12 -18.44 79.73 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.1 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.43 HD21 ' NE ' ' A' ' 28' ' ' ARG . 24.3 p30 -81.14 -0.03 38.37 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 124.147 0.557 . . . . 0.0 112.067 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 25.35 53.47 Favored Glycine 0 N--CA 1.496 2.64 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.351 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.76 156.83 47.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.083 0.944 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 27.6 m -48.59 146.95 2.74 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.151 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 O-C-N 124.588 1.18 . . . . 0.0 112.619 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' NZ ' ' HB2' ' A' ' 14' ' ' LYS . 10.3 mtmp? -64.39 152.16 42.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 123.873 0.733 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.9 p -145.7 126.07 13.99 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.263 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -74.8 -49.89 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 34.9 ptt180 -127.6 173.94 9.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.056 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 66.0 m-20 -51.3 -55.29 19.1 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.9 p -72.29 2.29 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.0 t70 -76.63 -14.98 59.94 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 51.4 t -88.7 146.91 38.11 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.905 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 Cg_exo -69.8 163.67 37.44 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.901 1.734 . . . . 0.0 109.848 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -158.8 52.21 Favored Glycine 0 N--CA 1.5 2.967 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.996 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.73 20.0 3.71 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.86 -1.17 . . . . 0.0 108.372 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.579 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.7 m -65.8 168.85 7.25 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 113.255 -1.793 . . . . 0.0 115.694 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.94 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.085 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 45.8 t -139.27 129.0 24.68 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.627 ' CZ ' HD22 ' A' ' 30' ' ' ASN . 88.3 mtm180 -81.36 170.51 15.91 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.074 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.06 -11.24 78.95 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.593 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.627 HD22 ' CZ ' ' A' ' 28' ' ' ARG . 48.7 p30 -81.06 -2.14 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.327 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.34 23.97 41.9 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.541 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 91.1 m-85 -143.45 152.98 42.18 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.677 0.751 . . . . 0.0 110.21 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.9 m -36.03 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 112.25 -2.25 . . . . 0.0 115.143 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 O-C-N 124.324 1.015 . . . . 0.0 112.288 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 54.5 mtmt -52.01 148.27 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.187 0.994 . . . . 0.0 113.396 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 20.0 p -143.65 128.18 18.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.483 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -86.27 -34.15 20.47 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -130.86 166.35 21.06 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 9.8 m-20 -53.43 -44.82 69.11 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.3 p -91.17 26.0 2.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.1 -11.55 32.65 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 42.8 t -88.81 148.65 41.99 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.866 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.9 Cg_exo -66.23 157.32 60.55 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.877 1.718 . . . . 0.0 109.961 171.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 -167.33 54.45 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.63 17.97 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.844 -1.178 . . . . 0.0 110.167 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 78.8 m -49.3 151.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -118.14 172.15 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 37.7 t -103.03 128.26 49.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.673 ' NE ' HD22 ' A' ' 30' ' ' ASN . 80.3 mtp180 -69.43 169.95 11.44 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.608 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.18 -16.35 80.64 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.266 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.673 HD22 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -84.54 -1.91 56.55 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.29 24.21 37.71 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 123.691 0.619 . . . . 0.0 113.409 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 95.0 m-85 -137.74 155.32 49.21 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.062 0.934 . . . . 0.0 111.013 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.7 m -48.67 152.93 0.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 112.48 -2.146 . . . . 0.0 114.669 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 O-C-N 124.758 1.286 . . . . 0.0 113.163 179.45 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 68.5 mttm . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -97.97 152.45 19.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.1 p -144.19 124.78 14.03 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.787 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -84.34 -49.68 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 36.8 ptt180 -126.55 169.74 12.75 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.704 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 26' ' ' ILE . 8.7 m-20 -50.9 -47.6 60.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -89.1 28.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.1 t70 -94.76 -17.52 22.09 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 113.575 -1.648 . . . . 0.0 107.308 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 45.4 t -88.95 148.22 40.68 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.541 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.7 Cg_endo -73.56 165.67 31.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.237 1.958 . . . . 0.0 110.23 173.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.63 -163.71 54.75 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.903 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.05 14.83 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.874 -1.163 . . . . 0.0 109.212 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 79.3 m -66.89 161.04 24.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -127.13 -171.65 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 102.65 -3.093 . . . . 0.0 102.65 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -113.07 130.46 56.16 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 1.8 mmp_? -69.59 172.65 7.05 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 -13.68 82.98 Favored Glycine 0 N--CA 1.494 2.525 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.658 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -89.46 -9.6 49.5 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.97 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.12 33.32 7.78 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 11.4 m-85 -137.66 155.78 48.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 19.9 m -51.75 149.36 4.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.458 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.495 2.6 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.594 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.03 -124.48 3.02 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 t -150.63 165.18 34.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.098 0.528 . . . . 0.0 110.179 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 49.97 46.74 24.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.315 1.009 . . . . 0.0 110.791 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.77 -29.22 5.23 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.04 87.67 0.67 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.9 129.43 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t -150.31 140.8 14.25 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 124.189 0.931 . . . . 0.0 110.624 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.48 -159.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.782 2.321 . . . . 0.0 109.816 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -50.31 138.48 16.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 123.626 0.579 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.06 114.06 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.831 1.3 . . . . 0.0 112.131 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.8 pt? -162.64 24.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.442 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -118.28 121.5 40.59 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.677 -2.056 . . . . 0.0 105.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 58.8 mtpt -62.84 150.33 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.021 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.516 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 22.3 p -138.41 135.83 35.66 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.546 -2.116 . . . . 0.0 111.759 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -84.76 -57.73 3.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.4 ptt-85 -115.32 173.48 6.49 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.874 -1.966 . . . . 0.0 106.882 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.5 m-20 -56.31 -52.06 65.93 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -73.6 5.64 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.1 t70 -76.61 -16.7 59.51 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.77 147.02 38.2 Favored Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.15 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.2 Cg_exo -70.7 165.86 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.829 1.686 . . . . 0.0 109.703 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.67 -160.51 54.07 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.29 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.53 20.26 2.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.622 -1.289 . . . . 0.0 108.729 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 65.6 m -67.43 170.8 6.85 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 113.628 -1.624 . . . . 0.0 114.139 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -136.58 -167.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.2 t -126.35 128.12 46.58 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -77.37 170.18 17.0 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.284 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.94 -12.55 83.89 Favored Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.597 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -79.63 -5.62 55.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.37 40.45 Favored Glycine 0 N--CA 1.496 2.692 0 O-C-N 123.723 0.64 . . . . 0.0 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 53.2 m-85 -141.14 159.8 41.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.114 0.537 . . . . 0.0 109.749 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.3 m -40.69 159.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.533 1.771 . . . . 0.0 114.663 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 CA-C-N 115.402 -0.817 . . . . 0.0 114.557 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.42 ' H ' HG13 ' A' ' 26' ' ' ILE . . . 67.8 38.27 89.32 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -89.83 132.94 35.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.052 0.501 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 52.48 24.31 2.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.418 1.074 . . . . 0.0 111.914 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.71 138.41 2.71 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.3 143.49 5.9 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.17 146.63 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -150.03 140.11 13.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.659 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.41 137.11 16.38 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 122.675 2.25 . . . . 0.0 108.936 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -59.04 108.14 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.408 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.8 161.39 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.666 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -107.27 41.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.308 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.48 143.25 26.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -81.2 153.52 27.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.331 -0.947 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.6 p -143.03 134.52 26.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.404 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -93.88 -41.86 9.39 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -128.59 167.4 17.21 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.499 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 22.3 m-20 -49.15 -51.29 33.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 88.8 p -90.06 27.08 1.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.5 t70 -86.24 -15.82 39.6 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.272 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 t -88.85 151.64 47.63 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.2 Cg_endo -73.93 164.65 34.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.182 1.921 . . . . 0.0 109.733 169.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -162.36 54.4 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.938 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.1 21.54 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.923 -1.139 . . . . 0.0 108.153 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 96.4 m -71.63 153.17 42.28 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -120.09 174.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.405 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 44.2 t -100.97 118.98 38.05 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NE ' HD21 ' A' ' 30' ' ' ASN . 87.4 mtm180 -66.42 170.77 5.64 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.09 -14.93 74.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.868 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.413 HD21 ' NE ' ' A' ' 28' ' ' ARG . 21.1 p30 -84.59 -10.52 57.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.934 0.432 . . . . 0.0 111.742 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.65 13.51 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 123.786 0.679 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.0 m-85 -141.71 155.01 45.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.49 0.662 . . . . 0.0 109.747 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.8 m -48.75 146.32 3.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.597 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 O-C-N 124.287 0.992 . . . . 0.0 115.063 179.709 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 23.8 t . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.22 -6.6 0.06 OUTLIER Glycine 0 N--CA 1.499 2.885 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.815 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -89.55 145.82 25.01 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 117.538 0.669 . . . . 0.0 111.59 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.26 -15.76 63.46 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.732 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.4 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.0 -139.12 3.45 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.97 133.81 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 49.6 t -90.05 128.91 47.96 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.424 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -69.73 109.78 2.39 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 106.17 -2.281 . . . . 0.0 106.17 163.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.05 124.46 23.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 123.876 0.735 . . . . 0.0 112.686 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.474 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -138.09 171.91 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.164 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.1 pt? -87.19 36.78 0.75 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.224 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -95.97 129.88 43.11 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.519 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -75.79 152.91 37.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.116 0.885 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.573 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 19.0 p -139.56 133.27 30.54 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.966 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.7 -34.8 18.27 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -134.8 169.26 17.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.3 m-20 -53.21 -54.33 37.62 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.1 p -72.52 1.44 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -76.06 -12.64 60.16 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.1 t -89.0 146.85 37.37 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.887 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.3 Cg_exo -68.54 162.69 39.79 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.882 1.722 . . . . 0.0 110.124 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.01 -160.39 54.01 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.672 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.1 18.17 3.22 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.966 -1.117 . . . . 0.0 108.684 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.563 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.4 m -62.57 168.83 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -131.74 -166.48 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.53 -2.577 . . . . 0.0 104.365 179.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.3 t -132.77 131.5 41.21 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.501 HH22 HD22 ' A' ' 30' ' ' ASN . 41.7 mtm105 -88.45 168.33 12.71 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.717 1.26 . . . . 0.0 111.755 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -12.52 56.63 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 112.805 -1.998 . . . . 0.0 114.377 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.501 HD22 HH22 ' A' ' 28' ' ' ARG . 42.4 p-10 -79.56 -8.61 59.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.835 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.6 24.86 27.09 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 57.0 m-85 -143.49 158.63 43.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -37.71 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.794 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.484 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.76 -122.13 2.26 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 m -143.36 174.02 11.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.228 0.605 . . . . 0.0 109.932 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 52.06 67.14 1.02 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 124.255 0.972 . . . . 0.0 108.861 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.53 -11.34 59.16 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.171 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.95 81.9 1.37 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.08 127.65 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 10.6 t -150.7 157.51 36.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 124.202 0.939 . . . . 0.0 110.769 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.468 ' HD2' ' SG ' ' A' ' 8' ' ' CYS . 10.4 Cg_endo -68.98 -167.89 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.467 2.112 . . . . 0.0 109.414 158.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -122.94 58.54 1.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.058 0.933 . . . . 0.0 109.507 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 pt -89.89 152.95 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.002 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -94.84 46.02 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.813 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -89.68 121.95 32.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 151.78 28.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.574 -1.251 . . . . 0.0 113.66 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.0 p -141.19 129.63 22.51 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.557 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -82.81 -62.92 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 15.7 ptm180 -110.94 174.3 5.93 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.36 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.8 m-20 -54.42 -53.53 52.86 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.2 p -73.84 3.81 6.12 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.5 t70 -72.65 -16.89 61.7 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 49.2 t -88.65 146.7 37.79 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.739 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 Cg_exo -69.62 164.24 35.15 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.885 1.724 . . . . 0.0 109.748 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.5 -160.97 54.0 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.852 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.23 19.82 3.02 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.777 -1.212 . . . . 0.0 108.679 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.571 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 75.6 m -65.1 171.01 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.807 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.72 -169.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 46.6 t -123.39 126.96 47.76 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.65 169.55 17.82 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -13.96 75.2 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.021 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -79.63 -6.06 56.34 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.754 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.79 23.62 38.31 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 123.82 0.7 . . . . 0.0 112.131 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 83.7 m-85 -144.78 157.24 44.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.169 0.57 . . . . 0.0 109.902 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 56.5 m -37.31 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.598 0 CA-C-N 114.851 -1.068 . . . . 0.0 115.192 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' HD11 ' A' ' 26' ' ' ILE . . . 163.91 27.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.728 0 C-N-CA 119.088 -1.53 . . . . 0.0 116.552 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.5 p -150.25 -136.0 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 118.474 1.137 . . . . 0.0 110.065 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -49.05 -40.06 29.9 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 123.779 0.674 . . . . 0.0 110.149 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.88 -54.38 3.65 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.63 2.53 6.1 Favored Glycine 0 N--CA 1.498 2.791 0 CA-C-N 114.833 -0.683 . . . . 0.0 113.098 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.29 141.22 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -150.34 136.22 10.5 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 2.7 Cg_exo -54.62 102.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.492 2.128 . . . . 0.0 109.43 167.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -63.65 83.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.506 -1.679 . . . . 0.0 112.592 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.26 145.96 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.167 -1.378 . . . . 0.0 107.305 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.55 ' H ' HD12 ' A' ' 12' ' ' LEU . 5.4 mp -70.35 86.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 124.097 0.873 . . . . 0.0 110.26 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.41 149.44 49.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -92.0 154.98 18.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.981 0.801 . . . . 0.0 110.24 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.1 p -150.35 125.92 10.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.632 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -55.06 5.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -117.55 173.95 6.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.025 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.8 m-20 -50.19 -55.19 16.21 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.8 p -75.96 1.36 15.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.33 -17.22 62.45 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 t -88.48 145.69 36.01 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.049 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.6 Cg_exo -68.87 164.4 33.7 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.85 1.7 . . . . 0.0 109.931 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -158.95 52.72 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.102 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.92 18.13 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.719 -1.24 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 85.3 m -63.47 160.89 15.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.91 -168.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.9 t -131.15 129.9 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.079 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.23 168.0 18.21 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.145 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.07 -14.5 80.35 Favored Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.846 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -81.18 -8.09 59.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 21.92 30.68 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 123.804 0.69 . . . . 0.0 112.252 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 8.7 m-85 -134.31 153.57 51.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -40.93 154.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.363 1.664 . . . . 0.0 115.317 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.574 0 CA-C-N 114.931 -1.031 . . . . 0.0 114.498 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.26 44.35 3.27 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -89.82 121.42 31.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.8 t70 69.33 -22.88 0.15 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 124.9 1.375 . . . . 0.0 113.413 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.92 -75.6 1.12 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.23 -142.16 7.66 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.3 t -141.16 148.57 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.5 t -150.04 119.17 3.74 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.01 -161.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.798 2.332 . . . . 0.0 112.213 171.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -46.51 141.64 3.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -130.63 124.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.256 1.026 . . . . 0.0 113.375 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.7 pt? -173.79 21.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.195 -1.82 . . . . 0.0 107.781 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -111.4 140.67 45.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 112.575 -2.102 . . . . 0.0 107.494 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 10.0 mptt -74.55 149.22 40.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.352 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.7 p -134.45 127.41 31.43 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -80.42 -59.24 2.77 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -114.09 171.27 7.71 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.665 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 59.0 m-20 -51.59 -52.36 48.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -80.61 9.66 5.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.7 t70 -73.37 -15.47 61.37 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.635 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.614 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.75 149.15 43.27 Favored Pre-proline 0 N--CA 1.485 1.309 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.614 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.9 Cg_exo -65.14 154.66 72.43 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.892 1.728 . . . . 0.0 110.335 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.81 -165.97 54.49 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.54 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.85 16.36 0.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.652 -1.274 . . . . 0.0 109.676 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.531 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 93.8 m -63.36 154.56 31.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -178.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.5 t -111.89 115.59 29.25 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.068 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -65.39 168.58 6.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.491 1.119 . . . . 0.0 111.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.87 73.18 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.836 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -82.11 -4.06 56.11 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 19.93 48.45 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 123.631 0.582 . . . . 0.0 113.138 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -139.4 158.45 44.12 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.757 0.789 . . . . 0.0 110.478 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.9 m -41.14 153.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 112.511 -2.131 . . . . 0.0 114.808 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.96 0 O-C-N 124.071 0.857 . . . . 0.0 114.204 179.591 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.462 0.649 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.39 77.93 1.04 Allowed Glycine 0 N--CA 1.495 2.573 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.733 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t -89.91 -133.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.77 -23.1 66.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 25.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.848 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.27 -159.65 18.87 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 8' ' ' CYS . 60.9 t -150.06 163.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 113.035 -1.582 . . . . 0.0 108.768 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.406 ' N ' HG12 ' A' ' 7' ' ' VAL . 45.3 t -130.97 141.58 42.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -70.94 157.39 58.24 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.506 2.138 . . . . 0.0 109.998 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -78.94 94.45 5.24 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.76 145.43 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.224 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.8 mt -89.83 38.32 0.91 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.042 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HA ' ' CE ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -89.77 126.6 35.73 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.298 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 2.0 mppt? -72.17 154.2 41.19 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.225 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.6 p -138.61 130.32 27.79 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.686 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -82.16 -49.17 10.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 29.3 ptt-85 -128.13 173.4 10.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.517 -2.128 . . . . 0.0 106.79 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 18.5 m-20 -53.45 -53.2 54.74 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.4 p -74.32 4.47 5.77 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.6 t70 -77.22 -14.06 59.83 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.57 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 52.3 t -88.84 148.63 41.89 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.113 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.558 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.61 166.46 28.57 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.93 1.753 . . . . 0.0 109.65 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.02 -161.06 54.32 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.99 16.85 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.159 -1.02 . . . . 0.0 108.696 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 63.3 m -61.15 171.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.26 -163.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -130.75 129.31 42.34 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.58 170.13 17.14 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.32 84.7 Favored Glycine 0 N--CA 1.496 2.652 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -80.0 -5.16 55.24 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.57 20.85 39.27 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 123.747 0.655 . . . . 0.0 112.541 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.3 m-85 -141.12 157.6 45.06 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.612 0.72 . . . . 0.0 110.17 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.1 m -39.95 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 112.704 -2.043 . . . . 0.0 114.957 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.954 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 8' ' ' CYS . 70.3 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.511 0.672 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.67 -13.73 18.97 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.433 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.411 ' H ' HD11 ' A' ' 26' ' ' ILE . 66.4 m -145.17 153.88 41.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.71 -33.0 73.25 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.15 80.59 1.7 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.43 101.07 0.85 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.1 t -89.43 126.71 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 1' ' ' SER . 43.2 t -95.44 135.43 23.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.164 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 Cg_endo -56.45 87.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.662 1.575 . . . . 0.0 108.684 142.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -56.09 115.79 2.63 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.14 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.4 pt -143.3 156.63 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 124.033 0.833 . . . . 0.0 109.448 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -86.13 39.77 0.83 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.969 0.793 . . . . 0.0 112.246 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 88.2 tttt -89.78 150.3 22.33 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 37.7 mtmm -81.59 152.57 27.13 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.267 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.35 127.54 24.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.697 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 ttm-85 -80.04 -60.05 2.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 18.4 ptp180 -116.31 172.91 6.89 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 113.027 -1.897 . . . . 0.0 107.007 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.51 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 12.8 m-20 -57.13 -52.37 65.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.228 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.0 p -74.37 12.67 0.71 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 15.8 t70 -79.91 -18.48 50.46 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.598 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 39.1 t -89.02 148.75 41.8 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.311 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -71.53 159.83 50.15 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.338 2.025 . . . . 0.0 110.887 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.49 -163.33 54.77 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.872 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.26 17.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.877 -1.162 . . . . 0.0 109.443 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 68.9 m -67.67 167.22 13.57 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.167 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.411 HD11 ' H ' ' A' ' 3' ' ' SER . 1.1 pt -140.67 -175.53 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 19.6 t -105.16 124.12 49.0 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -70.42 170.56 11.7 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.405 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.41 77.97 Favored Glycine 0 N--CA 1.495 2.602 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -82.67 -9.82 59.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.003 0.473 . . . . 0.0 111.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.25 23.7 28.66 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 123.929 0.768 . . . . 0.0 112.727 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 26.4 m-85 -137.56 158.11 45.08 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.158 0.504 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 21.4 m -46.1 150.1 0.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.75 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.375 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.458 ' N ' HD11 ' A' ' 26' ' ' ILE . . . 73.05 113.04 0.06 OUTLIER Glycine 0 N--CA 1.498 2.774 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.613 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 p -150.29 -48.83 0.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.221 1.01 . . . . 0.0 109.326 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.15 -32.12 3.74 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.814 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.99 105.99 0.23 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.15 154.39 7.64 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.8 145.29 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t -149.83 143.89 17.16 Favored Pre-proline 0 N--CA 1.495 1.79 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.252 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.46 179.46 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.817 2.345 . . . . 0.0 110.256 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -93.91 89.99 6.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.434 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -128.53 163.88 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.698 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.2 pt? -110.94 47.96 0.95 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.877 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.3 mmtm -89.19 128.2 35.8 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.034 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -69.16 149.37 48.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.949 0.781 . . . . 0.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.576 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 29.0 p -146.25 133.6 20.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.522 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -93.17 -37.05 12.31 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -132.09 169.47 16.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.6 m-20 -53.81 -51.61 62.96 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -75.73 5.01 6.78 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.83 -12.19 59.78 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.9 t -88.89 150.3 45.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.782 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.69 166.3 29.22 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.919 1.746 . . . . 0.0 109.727 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.68 -163.02 52.08 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.235 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.63 16.59 3.13 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.857 -1.171 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.59 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 62.8 m -61.72 168.92 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.458 HD11 ' N ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -131.04 -159.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 179.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 44.8 t -138.25 128.25 25.56 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 mmt180 -79.32 169.08 18.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.268 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.4 -8.49 66.41 Favored Glycine 0 N--CA 1.495 2.619 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.537 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -84.96 -8.17 58.86 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.604 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.5 26.35 20.81 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 20.2 m-85 -141.19 152.33 44.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 66.0 m -40.62 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.266 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.002 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.22 -124.71 5.47 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.072 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -142.32 -16.67 0.74 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.326 0.662 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.03 -29.38 60.8 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.726 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.82 -58.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.52 64.53 Favored Glycine 0 N--CA 1.495 2.61 0 CA-C-N 114.676 -0.762 . . . . 0.0 112.664 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.16 44.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.97 140.8 22.6 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.271 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 10.1 Cg_endo -67.23 173.03 9.16 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.489 2.126 . . . . 0.0 110.746 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -94.98 93.06 7.18 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.627 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.617 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -134.62 149.27 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.358 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -104.96 49.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -89.8 139.69 30.33 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.787 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.6 151.04 37.9 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.499 -1.281 . . . . 0.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.7 p -138.09 136.19 36.54 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.255 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.465 HH12 HH22 ' A' ' 17' ' ' ARG . 34.3 mtp-105 -87.65 -65.53 1.01 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 HH22 HH12 ' A' ' 16' ' ' ARG . 9.6 ptp85 -105.21 173.62 6.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.9 m-20 -59.02 -46.84 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 85.5 p -81.77 13.82 3.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.006 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 6.8 t70 -77.83 -14.3 59.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 48.7 t -89.27 151.57 46.66 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.438 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -71.73 161.59 44.69 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.104 1.869 . . . . 0.0 110.216 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.68 -164.93 54.71 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.312 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.5 14.39 2.55 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.729 -1.236 . . . . 0.0 109.561 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.497 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.7 m -61.28 166.26 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.23 170.43 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 36.8 t -102.51 122.88 45.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.22 166.77 22.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -13.07 61.53 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.811 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -81.03 -10.04 59.75 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.513 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.04 26.78 23.15 Favored Glycine 0 N--CA 1.496 2.649 0 O-C-N 123.895 0.747 . . . . 0.0 111.591 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.487 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 58.7 m-85 -142.83 157.24 44.8 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.543 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.7 m -46.78 161.15 0.07 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.029 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.417 ' HB2' HG12 ' A' ' 26' ' ' ILE . 74.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 26' ' ' ILE . . . 159.0 -38.08 0.5 Allowed Glycine 0 N--CA 1.499 2.85 0 O-C-N 123.541 0.526 . . . . 0.0 112.494 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 m -88.96 170.59 10.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.9 t70 63.35 16.91 9.88 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 123.798 0.686 . . . . 0.0 111.587 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.36 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.89 -96.8 0.1 Allowed Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.854 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.09 160.41 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -148.89 140.53 14.4 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.55 -173.02 1.47 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.953 2.435 . . . . 0.0 110.595 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -98.35 116.76 31.26 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.086 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -141.87 173.39 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.48 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.5 pt? -122.79 34.76 5.05 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.91 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -89.89 142.24 27.89 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.607 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HZ2' ' HE2' ' A' ' 32' ' ' TYR . 46.7 mmtm -76.84 153.57 34.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 123.816 0.697 . . . . 0.0 111.212 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.6 p -142.19 120.64 12.42 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.56 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 -37.82 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.18 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.5 ptt180 -132.75 166.47 22.15 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 3.6 m-20 -50.26 -52.83 32.92 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.312 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.0 p -86.75 32.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 14.1 t70 -93.65 -18.55 22.04 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 113.326 -1.761 . . . . 0.0 106.828 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 20.8 t -88.96 150.52 45.55 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.381 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.626 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.2 Cg_endo -76.1 168.14 24.64 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.288 1.992 . . . . 0.0 110.05 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.56 -160.47 53.69 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.764 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.24 18.74 4.83 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 71.2 m -71.24 162.11 29.98 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.474 HG13 ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -134.77 -178.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 46.8 t -104.01 130.11 51.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.575 ' NE ' HD22 ' A' ' 30' ' ' ASN . 88.1 mtm180 -81.3 170.88 15.5 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.1 -13.41 83.25 Favored Glycine 0 N--CA 1.495 2.59 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.575 HD22 ' NE ' ' A' ' 28' ' ' ARG . 15.6 p30 -81.63 -7.2 59.56 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.58 26.0 28.71 Favored Glycine 0 N--CA 1.498 2.786 0 O-C-N 123.83 0.707 . . . . 0.0 111.899 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB2' HH21 ' A' ' 28' ' ' ARG . 34.2 m-85 -142.97 154.12 43.71 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.765 0.793 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.0 m -48.43 153.89 0.7 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.611 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.493 2.488 0 O-C-N 124.221 0.95 . . . . 0.0 114.1 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.494 ' HA ' HD11 ' A' ' 26' ' ' ILE . 66.3 m . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.17 58.85 0.15 Allowed Glycine 0 N--CA 1.498 2.804 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.9 p -150.56 -152.76 0.45 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.51 -29.36 61.76 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.77 -145.76 4.66 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.95 56.51 0.08 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.06 37.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.87 144.86 32.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.954 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.6 Cg_exo -64.35 -157.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.803 2.335 . . . . 0.0 112.087 173.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 33.0 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.479 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -89.42 135.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.723 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 12' ' ' LEU . 5.9 mp -60.7 106.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.167 0.917 . . . . 0.0 110.434 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -145.46 150.16 36.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 2.0 mptp? -101.31 152.76 20.31 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.986 0.898 . . . . 0.0 112.632 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.5 p -144.46 142.08 30.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.333 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.87 -34.27 9.87 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' N ' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -134.85 167.11 21.49 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 14.0 m-20 -51.99 -52.79 48.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.7 p -79.62 20.88 0.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -87.07 -19.83 28.02 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 38.1 t -88.76 146.78 37.71 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.4 Cg_endo -75.53 167.34 26.73 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.202 1.934 . . . . 0.0 110.177 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.07 -162.53 54.48 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.002 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.56 14.12 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.514 -1.343 . . . . 0.0 109.467 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.8 m -67.71 170.7 7.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.825 1.298 . . . . 0.0 114.455 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -141.9 -175.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.7 t -113.16 126.14 55.11 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -69.01 171.43 8.15 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.168 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.27 -18.09 77.9 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -84.93 8.26 18.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.062 0.507 . . . . 0.0 111.811 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.8 25.43 75.75 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.789 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 16.4 m-85 -131.09 153.49 49.28 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 m -47.6 157.24 0.25 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 C-N-CA 119.268 -1.444 . . . . 0.0 116.114 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.424 ' HA ' HD11 ' A' ' 26' ' ' ILE . 45.4 t . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.08 -59.86 0.16 Allowed Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -89.78 -148.02 0.19 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 123.91 0.418 . . . . 0.0 110.732 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -50.4 -22.42 1.86 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -51.29 -71.02 0.71 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 124.312 1.008 . . . . 0.0 111.791 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.99 -71.62 2.58 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.42 125.4 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.6 t -150.27 136.05 10.39 Favored Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.591 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.3 Cg_endo -64.2 95.41 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.808 1.672 . . . . 0.0 108.899 158.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.2 54.11 3.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -89.01 164.59 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.013 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 ' H ' HD12 ' A' ' 12' ' ' LEU . 5.4 mp -67.3 81.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.293 0.996 . . . . 0.0 109.984 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 107.94 8.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.24 149.16 38.62 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.847 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -135.22 128.74 32.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.944 -1.935 . . . . 0.0 112.047 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -81.85 -58.7 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt180 -111.53 171.74 7.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.252 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.2 m-20 -56.38 -49.29 74.89 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -81.49 13.15 3.18 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.485 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.7 t70 -75.93 -16.39 60.02 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.856 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -88.79 151.16 47.16 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.475 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.4 Cg_exo -72.42 162.56 41.13 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.036 1.824 . . . . 0.0 110.058 170.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.55 -166.82 54.83 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.053 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.47 7.38 6.72 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.007 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 71.4 m -54.68 166.19 0.5 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -135.67 171.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.8 t -101.81 119.97 39.63 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' CZ ' HD21 ' A' ' 30' ' ' ASN . 66.3 mtm180 -72.21 168.98 17.12 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.911 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.14 68.69 Favored Glycine 0 N--CA 1.495 2.568 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.639 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.414 HD21 ' CZ ' ' A' ' 28' ' ' ARG . 50.9 p30 -81.94 -7.63 59.62 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.602 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.43 19.74 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -145.87 154.66 42.21 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.744 0.783 . . . . 0.0 110.097 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -44.49 154.35 0.13 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.54 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 C-N-CA 119.642 -1.266 . . . . 0.0 115.633 179.68 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.2 120.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 O-C-N 124.136 0.897 . . . . 0.0 114.039 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -88.97 125.12 34.84 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.3 t70 56.76 49.67 13.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.362 1.039 . . . . 0.0 110.006 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.55 136.76 3.62 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.81 148.26 23.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.4 t -144.04 134.15 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 124.266 0.627 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 t -150.68 145.57 18.52 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 123.952 0.782 . . . . 0.0 109.007 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -71.54 -173.88 1.11 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -81.94 67.38 7.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 13' ' ' LYS . 72.5 mt -89.67 123.42 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.752 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.0 mt -102.37 36.22 2.21 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.887 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 11' ' ' ILE . 35.0 mtmm -96.88 136.05 37.99 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.57 149.94 49.73 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.457 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 25.4 p -130.37 133.78 46.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.113 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -84.93 -45.65 12.02 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.483 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt-85 -132.32 172.11 12.85 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 112.766 -2.015 . . . . 0.0 107.29 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 10.5 m-20 -53.82 -53.37 53.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -73.98 3.25 7.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 10.2 t70 -72.09 -18.14 61.94 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.3 t -89.11 148.95 42.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.614 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.5 Cg_endo -73.06 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.166 1.911 . . . . 0.0 110.355 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.33 -157.82 53.4 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.408 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.33 18.85 2.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.648 -1.276 . . . . 0.0 108.348 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.584 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 69.3 m -65.95 164.36 15.26 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.83 -1.532 . . . . 0.0 114.732 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -131.63 -165.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 111.527 -2.579 . . . . 0.0 104.767 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.7 t -128.68 124.25 35.21 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -77.83 168.24 20.24 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 124.603 1.19 . . . . 0.0 110.386 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.94 -10.62 80.89 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -80.04 -4.43 52.67 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.35 24.83 35.34 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 123.793 0.683 . . . . 0.0 112.312 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 87.1 m-85 -144.03 159.51 42.47 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.212 0.595 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.3 m -41.22 152.29 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.591 1.807 . . . . 0.0 113.303 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 O-C-N 124.123 0.89 . . . . 0.0 114.634 -179.724 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 122.293 1.044 . . . . 0.0 112.152 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.06 19.65 0.1 Allowed Glycine 0 N--CA 1.494 2.511 0 CA-C-N 112.886 -1.961 . . . . 0.0 112.138 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -89.48 -15.96 31.88 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.285 0.565 . . . . 0.0 111.049 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.98 -1.69 58.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.488 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.78 122.59 4.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.14 126.89 2.92 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.18 143.26 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.471 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.4 t -103.19 146.82 33.16 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 6.0 Cg_exo -61.4 159.14 32.62 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 109.533 159.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -80.04 90.57 5.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.225 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.4 pt -135.11 173.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.671 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.7 pt? -139.2 49.01 1.85 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.687 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.2 tmtm? -89.6 117.58 28.59 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.0 mtmm -36.32 144.4 0.06 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 p -145.92 142.27 28.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 111.526 -2.579 . . . . 0.0 111.76 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -91.48 -63.46 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.3 ptt-85 -108.36 172.02 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.739 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 80.4 m-20 -50.23 -55.96 13.11 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.6 p -77.32 8.26 4.32 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 t70 -73.68 -12.98 60.9 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.3 t -88.61 150.42 46.16 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.961 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -66.45 156.01 67.36 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.769 1.646 . . . . 0.0 109.816 170.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.89 -163.1 52.24 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 120.491 -0.862 . . . . 0.0 111.748 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.19 20.87 2.57 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.939 -1.13 . . . . 0.0 108.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 88.4 m -67.35 157.33 34.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 27' ' ' CYS . 2.0 mm -114.21 -175.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 26' ' ' ILE . 37.6 t -115.87 108.98 16.98 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.51 ' NE ' HD21 ' A' ' 30' ' ' ASN . 79.7 mtm180 -59.08 170.04 0.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 -16.45 65.2 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.81 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.51 HD21 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -83.98 -7.58 59.37 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.53 21.58 43.53 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 123.777 0.673 . . . . 0.0 112.537 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' HH21 ' A' ' 28' ' ' ARG . 81.0 m-85 -135.58 156.91 48.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 50.3 m -45.05 147.99 0.62 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.869 0 O-C-N 124.284 0.99 . . . . 0.0 115.077 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 23.3 t . . . . . 0 N--CA 1.505 2.297 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.72 62.06 4.56 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -89.85 128.93 36.27 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.8 t70 55.18 22.62 4.76 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.358 1.036 . . . . 0.0 111.41 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.2 119.8 0.62 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.06 117.36 0.24 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.34 143.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.1 t -141.01 85.43 12.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.095 0.872 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.67 28.03 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.053 2.502 . . . . 0.0 112.891 172.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.85 151.13 24.04 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.167 0.984 . . . . 0.0 111.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -89.34 -171.07 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.369 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.96 70.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 126.174 2.171 . . . . 0.0 114.631 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -112.03 119.81 39.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mtpp -62.13 152.16 33.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.374 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.34 122.31 26.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.095 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -73.66 -46.49 46.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 11.0 ptp180 -135.37 172.65 12.71 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 112.526 -2.125 . . . . 0.0 107.995 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 26.9 m-20 -47.78 -52.74 17.68 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.9 p -81.71 6.44 15.33 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.8 t70 -74.07 -15.68 61.06 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.965 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.0 t -88.78 149.53 43.97 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.006 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.6 Cg_exo -66.12 167.75 17.38 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.762 1.642 . . . . 0.0 110.518 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.53 -164.39 38.11 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.008 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.76 15.06 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.529 -1.336 . . . . 0.0 109.617 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 74.2 m -60.29 159.35 10.1 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 1' ' ' SER . 0.0 OUTLIER -121.31 -169.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.1 t -118.76 126.32 51.61 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -67.35 171.54 5.83 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.332 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.37 -13.65 80.1 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.489 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -84.63 -6.94 59.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.23 24.06 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 123.692 0.62 . . . . 0.0 113.132 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 37.7 m-85 -140.05 160.39 40.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.836 0.827 . . . . 0.0 110.654 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -45.38 147.91 0.73 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.677 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.765 0 O-C-N 124.528 1.143 . . . . 0.0 111.724 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.03 96.85 2.09 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.0 m -89.47 -115.29 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.21 -20.84 64.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.405 0.441 . . . . 0.0 110.062 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.11 21.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.32 90.1 0.08 OUTLIER Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.24 48.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.71 141.69 28.64 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -75.17 157.29 42.15 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.596 2.197 . . . . 0.0 109.198 164.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -79.89 82.65 5.94 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.9 mm -100.83 158.59 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.316 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.9 mt -112.8 36.0 3.65 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.56 -1.655 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 2.1 mmpt? -90.66 122.21 33.25 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.81 146.76 7.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.085 0.945 . . . . 0.0 111.969 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.137 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -76.73 -40.44 48.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.2 ptt85 -137.37 171.03 15.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.667 -2.061 . . . . 0.0 107.525 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -48.58 -56.75 7.53 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.9 p -83.06 15.22 2.9 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.6 t70 -77.58 -14.99 59.51 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.414 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 49.8 t -88.95 151.39 47.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.75 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.1 Cg_exo -68.34 158.85 55.83 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.823 1.682 . . . . 0.0 110.017 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 -165.64 54.68 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.043 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.19 15.02 3.08 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.699 -1.25 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 77.2 m -62.89 152.69 35.63 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.17 -177.65 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.93 123.53 49.24 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' NE ' HD21 ' A' ' 30' ' ' ASN . 85.6 mtm180 -71.63 170.23 13.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.494 1.121 . . . . 0.0 110.776 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.12 -18.44 79.73 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.1 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.43 HD21 ' NE ' ' A' ' 28' ' ' ARG . 24.3 p30 -81.14 -0.03 38.37 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 124.147 0.557 . . . . 0.0 112.067 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 25.35 53.47 Favored Glycine 0 N--CA 1.496 2.64 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.351 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.76 156.83 47.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.083 0.944 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 27.6 m -48.59 146.95 2.74 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.151 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 O-C-N 124.588 1.18 . . . . 0.0 112.619 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.0 p . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.393 0.616 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' N ' HD11 ' A' ' 26' ' ' ILE . . . 65.66 84.84 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 CA-C-N 114.246 -1.343 . . . . 0.0 116.139 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.43 ' HB3' HG13 ' A' ' 26' ' ' ILE . 18.1 t -150.99 -127.18 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.75 -9.73 39.84 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -119.49 -118.49 2.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.26 -151.02 8.46 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.92 164.43 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 114.099 -1.05 . . . . 0.0 109.512 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.7 t -145.71 149.34 39.59 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.083 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -72.38 136.25 26.02 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.361 2.041 . . . . 0.0 108.284 160.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.67 91.51 1.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.837 0.711 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -115.95 151.01 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.065 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.65 39.43 0.84 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.302 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -89.54 124.78 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' NZ ' ' HB2' ' A' ' 14' ' ' LYS . 10.3 mtmp? -64.39 152.16 42.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 123.873 0.733 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.9 p -145.7 126.07 13.99 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.263 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -74.8 -49.89 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 34.9 ptt180 -127.6 173.94 9.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.056 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 66.0 m-20 -51.3 -55.29 19.1 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.9 p -72.29 2.29 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.0 t70 -76.63 -14.98 59.94 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 51.4 t -88.7 146.91 38.11 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.905 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 Cg_exo -69.8 163.67 37.44 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.901 1.734 . . . . 0.0 109.848 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -158.8 52.21 Favored Glycine 0 N--CA 1.5 2.967 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.996 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.73 20.0 3.71 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.86 -1.17 . . . . 0.0 108.372 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.7 m -65.8 168.85 7.25 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 113.255 -1.793 . . . . 0.0 115.694 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.453 HG21 ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -130.94 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.085 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 45.8 t -139.27 129.0 24.68 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.627 ' CZ ' HD22 ' A' ' 30' ' ' ASN . 88.3 mtm180 -81.36 170.51 15.91 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.074 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.06 -11.24 78.95 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.593 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.627 HD22 ' CZ ' ' A' ' 28' ' ' ARG . 48.7 p30 -81.06 -2.14 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.327 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.34 23.97 41.9 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.541 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 91.1 m-85 -143.45 152.98 42.18 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.677 0.751 . . . . 0.0 110.21 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.9 m -36.03 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 112.25 -2.25 . . . . 0.0 115.143 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 O-C-N 124.324 1.015 . . . . 0.0 112.288 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.45 113.55 0.97 Allowed Glycine 0 N--CA 1.495 2.585 0 O-C-N 123.756 0.66 . . . . 0.0 112.482 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -150.36 -135.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.84 -37.35 81.76 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.43 39.0 2.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.2 11.99 1.33 Allowed Glycine 0 N--CA 1.499 2.844 0 CA-C-N 115.246 -0.477 . . . . 0.0 114.268 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 t -92.22 48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.84 140.61 27.85 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.779 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 11.2 Cg_endo -71.56 159.13 52.08 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.663 2.242 . . . . 0.0 109.515 167.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -80.85 94.44 6.46 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.266 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.79 142.65 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.684 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.73 47.3 0.88 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.541 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -89.94 121.53 32.13 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 54.5 mtmt -52.01 148.27 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.187 0.994 . . . . 0.0 113.396 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 20.0 p -143.65 128.18 18.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.483 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -86.27 -34.15 20.47 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -130.86 166.35 21.06 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 9.8 m-20 -53.43 -44.82 69.11 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.3 p -91.17 26.0 2.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.1 -11.55 32.65 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 42.8 t -88.81 148.65 41.99 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.866 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.9 Cg_exo -66.23 157.32 60.55 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.877 1.718 . . . . 0.0 109.961 171.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 -167.33 54.45 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.63 17.97 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.844 -1.178 . . . . 0.0 110.167 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 78.8 m -49.3 151.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -118.14 172.15 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 37.7 t -103.03 128.26 49.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.673 ' NE ' HD22 ' A' ' 30' ' ' ASN . 80.3 mtp180 -69.43 169.95 11.44 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.608 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.18 -16.35 80.64 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.266 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.673 HD22 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -84.54 -1.91 56.55 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.29 24.21 37.71 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 123.691 0.619 . . . . 0.0 113.409 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 95.0 m-85 -137.74 155.32 49.21 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.062 0.934 . . . . 0.0 111.013 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.7 m -48.67 152.93 0.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 112.48 -2.146 . . . . 0.0 114.669 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 O-C-N 124.758 1.286 . . . . 0.0 113.163 179.45 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.43 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 31.3 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.807 0.813 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.99 83.22 0.16 Allowed Glycine 0 N--CA 1.493 2.453 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.065 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -89.58 -10.7 45.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.228 0.605 . . . . 0.0 110.458 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -127.29 -30.54 2.63 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.161 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.27 -24.75 0.05 OUTLIER Glycine 0 N--CA 1.494 2.544 0 O-C-N 124.223 0.952 . . . . 0.0 111.084 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.81 51.26 8.06 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.62 46.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.03 134.31 20.16 Favored Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.973 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.97 119.35 6.01 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.382 2.054 . . . . 0.0 108.868 166.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.24 94.79 1.61 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.915 0.759 . . . . 0.0 110.248 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.54 152.22 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.943 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.561 ' H ' HD12 ' A' ' 12' ' ' LEU . 5.5 mp -67.7 86.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.08 0.862 . . . . 0.0 109.766 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 68.5 mttm -133.48 150.88 51.71 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.291 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -97.97 152.45 19.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.1 p -144.19 124.78 14.03 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.787 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -84.34 -49.68 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 36.8 ptt180 -126.55 169.74 12.75 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.704 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 26' ' ' ILE . 8.7 m-20 -50.9 -47.6 60.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -89.1 28.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.1 t70 -94.76 -17.52 22.09 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 113.575 -1.648 . . . . 0.0 107.308 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 45.4 t -88.95 148.22 40.68 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.541 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.7 Cg_endo -73.56 165.67 31.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.237 1.958 . . . . 0.0 110.23 173.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.63 -163.71 54.75 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.903 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.05 14.83 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.874 -1.163 . . . . 0.0 109.212 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 79.3 m -66.89 161.04 24.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -127.13 -171.65 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 102.65 -3.093 . . . . 0.0 102.65 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -113.07 130.46 56.16 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 1.8 mmp_? -69.59 172.65 7.05 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 -13.68 82.98 Favored Glycine 0 N--CA 1.494 2.525 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.658 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -89.46 -9.6 49.5 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.97 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.12 33.32 7.78 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 11.4 m-85 -137.66 155.78 48.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 19.9 m -51.75 149.36 4.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.458 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.495 2.6 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.594 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 58.8 mtpt -62.84 150.33 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.021 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.516 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 22.3 p -138.41 135.83 35.66 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.546 -2.116 . . . . 0.0 111.759 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -84.76 -57.73 3.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.46 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.4 ptt-85 -115.32 173.48 6.49 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.874 -1.966 . . . . 0.0 106.882 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.5 m-20 -56.31 -52.06 65.93 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -73.6 5.64 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.1 t70 -76.61 -16.7 59.51 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.77 147.02 38.2 Favored Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.15 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.2 Cg_exo -70.7 165.86 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.829 1.686 . . . . 0.0 109.703 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.67 -160.51 54.07 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.29 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.53 20.26 2.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.622 -1.289 . . . . 0.0 108.729 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 65.6 m -67.43 170.8 6.85 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 113.628 -1.624 . . . . 0.0 114.139 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -136.58 -167.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.2 t -126.35 128.12 46.58 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -77.37 170.18 17.0 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.284 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.94 -12.55 83.89 Favored Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.597 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -79.63 -5.62 55.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.37 40.45 Favored Glycine 0 N--CA 1.496 2.692 0 O-C-N 123.723 0.64 . . . . 0.0 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 53.2 m-85 -141.14 159.8 41.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.114 0.537 . . . . 0.0 109.749 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.3 m -40.69 159.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.533 1.771 . . . . 0.0 114.663 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 CA-C-N 115.402 -0.817 . . . . 0.0 114.557 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -81.2 153.52 27.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.331 -0.947 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.6 p -143.03 134.52 26.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.404 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -93.88 -41.86 9.39 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -128.59 167.4 17.21 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.499 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 22.3 m-20 -49.15 -51.29 33.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 88.8 p -90.06 27.08 1.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.5 t70 -86.24 -15.82 39.6 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.272 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 t -88.85 151.64 47.63 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.2 Cg_endo -73.93 164.65 34.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.182 1.921 . . . . 0.0 109.733 169.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -162.36 54.4 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.938 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.1 21.54 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.923 -1.139 . . . . 0.0 108.153 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 96.4 m -71.63 153.17 42.28 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.09 174.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.405 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 44.2 t -100.97 118.98 38.05 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NE ' HD21 ' A' ' 30' ' ' ASN . 87.4 mtm180 -66.42 170.77 5.64 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.09 -14.93 74.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.868 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.413 HD21 ' NE ' ' A' ' 28' ' ' ARG . 21.1 p30 -84.59 -10.52 57.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.934 0.432 . . . . 0.0 111.742 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.65 13.51 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 123.786 0.679 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.0 m-85 -141.71 155.01 45.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.49 0.662 . . . . 0.0 109.747 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.8 m -48.75 146.32 3.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.597 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 O-C-N 124.287 0.992 . . . . 0.0 115.063 179.709 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 N--CA 1.498 1.955 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -75.79 152.91 37.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.116 0.885 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.573 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 19.0 p -139.56 133.27 30.54 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.966 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.7 -34.8 18.27 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -134.8 169.26 17.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.3 m-20 -53.21 -54.33 37.62 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.1 p -72.52 1.44 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -76.06 -12.64 60.16 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.1 t -89.0 146.85 37.37 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.887 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.3 Cg_exo -68.54 162.69 39.79 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.882 1.722 . . . . 0.0 110.124 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.01 -160.39 54.01 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.672 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.1 18.17 3.22 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.966 -1.117 . . . . 0.0 108.684 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.4 m -62.57 168.83 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -131.74 -166.48 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.53 -2.577 . . . . 0.0 104.365 179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.3 t -132.77 131.5 41.21 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -88.45 168.33 12.71 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.717 1.26 . . . . 0.0 111.755 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -12.52 56.63 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 112.805 -1.998 . . . . 0.0 114.377 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -79.56 -8.61 59.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.835 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.6 24.86 27.09 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.573 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 57.0 m-85 -143.49 158.63 43.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -37.71 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.794 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.484 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 151.78 28.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.574 -1.251 . . . . 0.0 113.66 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.0 p -141.19 129.63 22.51 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.557 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -82.81 -62.92 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.43 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 15.7 ptm180 -110.94 174.3 5.93 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.36 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.8 m-20 -54.42 -53.53 52.86 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.2 p -73.84 3.81 6.12 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.5 t70 -72.65 -16.89 61.7 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 49.2 t -88.65 146.7 37.79 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.739 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 Cg_exo -69.62 164.24 35.15 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.885 1.724 . . . . 0.0 109.748 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.5 -160.97 54.0 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.852 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.23 19.82 3.02 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.777 -1.212 . . . . 0.0 108.679 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.571 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 75.6 m -65.1 171.01 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.807 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.72 -169.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 46.6 t -123.39 126.96 47.76 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.65 169.55 17.82 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -13.96 75.2 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.021 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -79.63 -6.06 56.34 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.754 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.79 23.62 38.31 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 123.82 0.7 . . . . 0.0 112.131 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 83.7 m-85 -144.78 157.24 44.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.169 0.57 . . . . 0.0 109.902 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 56.5 m -37.31 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.598 0 CA-C-N 114.851 -1.068 . . . . 0.0 115.192 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -92.0 154.98 18.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.981 0.801 . . . . 0.0 110.24 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.1 p -150.35 125.92 10.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.632 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -55.06 5.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -117.55 173.95 6.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.025 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.8 m-20 -50.19 -55.19 16.21 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.8 p -75.96 1.36 15.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.33 -17.22 62.45 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 t -88.48 145.69 36.01 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.049 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.6 Cg_exo -68.87 164.4 33.7 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.85 1.7 . . . . 0.0 109.931 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -158.95 52.72 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.102 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.92 18.13 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.719 -1.24 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 85.3 m -63.47 160.89 15.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.91 -168.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.462 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.9 t -131.15 129.9 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.079 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.23 168.0 18.21 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.145 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.07 -14.5 80.35 Favored Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.846 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -81.18 -8.09 59.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 21.92 30.68 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 123.804 0.69 . . . . 0.0 112.252 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 8.7 m-85 -134.31 153.57 51.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -40.93 154.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.363 1.664 . . . . 0.0 115.317 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.574 0 CA-C-N 114.931 -1.031 . . . . 0.0 114.498 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 mttp . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 10.0 mptt -74.55 149.22 40.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.352 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.7 p -134.45 127.41 31.43 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -80.42 -59.24 2.77 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -114.09 171.27 7.71 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.665 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 59.0 m-20 -51.59 -52.36 48.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -80.61 9.66 5.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.7 t70 -73.37 -15.47 61.37 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.635 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.614 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.75 149.15 43.27 Favored Pre-proline 0 N--CA 1.485 1.309 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.614 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.9 Cg_exo -65.14 154.66 72.43 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.892 1.728 . . . . 0.0 110.335 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.81 -165.97 54.49 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.54 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.85 16.36 0.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.652 -1.274 . . . . 0.0 109.676 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.531 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 93.8 m -63.36 154.56 31.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -178.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.5 t -111.89 115.59 29.25 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.068 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -65.39 168.58 6.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.491 1.119 . . . . 0.0 111.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.87 73.18 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.836 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -82.11 -4.06 56.11 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 19.93 48.45 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 123.631 0.582 . . . . 0.0 113.138 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -139.4 158.45 44.12 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.757 0.789 . . . . 0.0 110.478 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.9 m -41.14 153.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 112.511 -2.131 . . . . 0.0 114.808 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.96 0 O-C-N 124.071 0.857 . . . . 0.0 114.204 179.591 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' CE ' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 2.0 mppt? -72.17 154.2 41.19 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.225 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.6 p -138.61 130.32 27.79 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.686 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -82.16 -49.17 10.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 29.3 ptt-85 -128.13 173.4 10.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.517 -2.128 . . . . 0.0 106.79 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 18.5 m-20 -53.45 -53.2 54.74 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.4 p -74.32 4.47 5.77 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.6 t70 -77.22 -14.06 59.83 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.57 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 52.3 t -88.84 148.63 41.89 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.113 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.558 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.61 166.46 28.57 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.93 1.753 . . . . 0.0 109.65 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.02 -161.06 54.32 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.99 16.85 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.159 -1.02 . . . . 0.0 108.696 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.57 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 63.3 m -61.15 171.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.26 -163.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -130.75 129.31 42.34 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.58 170.13 17.14 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.32 84.7 Favored Glycine 0 N--CA 1.496 2.652 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -80.0 -5.16 55.24 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.57 20.85 39.27 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 123.747 0.655 . . . . 0.0 112.541 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.3 m-85 -141.12 157.6 45.06 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.612 0.72 . . . . 0.0 110.17 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.1 m -39.95 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 112.704 -2.043 . . . . 0.0 114.957 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.954 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 88.2 tttt . . . . . 0 N--CA 1.497 1.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 37.7 mtmm -81.59 152.57 27.13 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.267 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.35 127.54 24.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.697 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 ttm-85 -80.04 -60.05 2.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 18.4 ptp180 -116.31 172.91 6.89 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 113.027 -1.897 . . . . 0.0 107.007 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.51 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 12.8 m-20 -57.13 -52.37 65.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.228 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.0 p -74.37 12.67 0.71 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 15.8 t70 -79.91 -18.48 50.46 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.598 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 39.1 t -89.02 148.75 41.8 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.311 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -71.53 159.83 50.15 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.338 2.025 . . . . 0.0 110.887 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.49 -163.33 54.77 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.872 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.26 17.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.877 -1.162 . . . . 0.0 109.443 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 68.9 m -67.67 167.22 13.57 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.167 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.67 -175.53 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 19.6 t -105.16 124.12 49.0 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -70.42 170.56 11.7 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.405 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.41 77.97 Favored Glycine 0 N--CA 1.495 2.602 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -82.67 -9.82 59.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.003 0.473 . . . . 0.0 111.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.25 23.7 28.66 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 123.929 0.768 . . . . 0.0 112.727 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 26.4 m-85 -137.56 158.11 45.08 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.158 0.504 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 21.4 m -46.1 150.1 0.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.75 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.375 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.3 mmtm . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -69.16 149.37 48.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.949 0.781 . . . . 0.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.576 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 29.0 p -146.25 133.6 20.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.522 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -93.17 -37.05 12.31 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -132.09 169.47 16.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.6 m-20 -53.81 -51.61 62.96 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -75.73 5.01 6.78 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.83 -12.19 59.78 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.9 t -88.89 150.3 45.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.782 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.69 166.3 29.22 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.919 1.746 . . . . 0.0 109.727 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.68 -163.02 52.08 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.235 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.63 16.59 3.13 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.857 -1.171 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.59 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 62.8 m -61.72 168.92 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.04 -159.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 44.8 t -138.25 128.25 25.56 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.459 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 41.8 mmt180 -79.32 169.08 18.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.268 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.4 -8.49 66.41 Favored Glycine 0 N--CA 1.495 2.619 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.537 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.521 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -84.96 -8.17 58.86 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.604 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' N ' HD22 ' A' ' 30' ' ' ASN . . . 91.5 26.35 20.81 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 20.2 m-85 -141.19 152.33 44.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 66.0 m -40.62 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.266 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.002 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.6 151.04 37.9 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.499 -1.281 . . . . 0.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.7 p -138.09 136.19 36.54 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.255 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.465 HH12 HH22 ' A' ' 17' ' ' ARG . 34.3 mtp-105 -87.65 -65.53 1.01 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 HH22 HH12 ' A' ' 16' ' ' ARG . 9.6 ptp85 -105.21 173.62 6.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.9 m-20 -59.02 -46.84 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 85.5 p -81.77 13.82 3.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.006 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 6.8 t70 -77.83 -14.3 59.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 48.7 t -89.27 151.57 46.66 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.438 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -71.73 161.59 44.69 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.104 1.869 . . . . 0.0 110.216 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.68 -164.93 54.71 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.312 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.5 14.39 2.55 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.729 -1.236 . . . . 0.0 109.561 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.497 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.7 m -61.28 166.26 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.23 170.43 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 36.8 t -102.51 122.88 45.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.22 166.77 22.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -13.07 61.53 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.811 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -81.03 -10.04 59.75 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.513 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.04 26.78 23.15 Favored Glycine 0 N--CA 1.496 2.649 0 O-C-N 123.895 0.747 . . . . 0.0 111.591 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 58.7 m-85 -142.83 157.24 44.8 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.543 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.7 m -46.78 161.15 0.07 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.029 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HZ2' ' HE2' ' A' ' 32' ' ' TYR . 46.7 mmtm -76.84 153.57 34.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 123.816 0.697 . . . . 0.0 111.212 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.6 p -142.19 120.64 12.42 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.56 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 -37.82 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.18 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.5 ptt180 -132.75 166.47 22.15 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 3.6 m-20 -50.26 -52.83 32.92 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.312 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.0 p -86.75 32.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 14.1 t70 -93.65 -18.55 22.04 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 113.326 -1.761 . . . . 0.0 106.828 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 20.8 t -88.96 150.52 45.55 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.381 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.626 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.2 Cg_endo -76.1 168.14 24.64 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.288 1.992 . . . . 0.0 110.05 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.56 -160.47 53.69 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.764 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.24 18.74 4.83 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.437 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 71.2 m -71.24 162.11 29.98 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -134.77 -178.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 46.8 t -104.01 130.11 51.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 32' ' ' TYR . 88.1 mtm180 -81.3 170.88 15.5 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.1 -13.41 83.25 Favored Glycine 0 N--CA 1.495 2.59 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -81.63 -7.2 59.56 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.58 26.0 28.71 Favored Glycine 0 N--CA 1.498 2.786 0 O-C-N 123.83 0.707 . . . . 0.0 111.899 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 34.2 m-85 -142.97 154.12 43.71 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.765 0.793 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.0 m -48.43 153.89 0.7 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.611 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.493 2.488 0 O-C-N 124.221 0.95 . . . . 0.0 114.1 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 2.0 mptp? -101.31 152.76 20.31 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.986 0.898 . . . . 0.0 112.632 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.5 p -144.46 142.08 30.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.333 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.87 -34.27 9.87 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -134.85 167.11 21.49 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 14.0 m-20 -51.99 -52.79 48.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.7 p -79.62 20.88 0.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -87.07 -19.83 28.02 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 38.1 t -88.76 146.78 37.71 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.4 Cg_endo -75.53 167.34 26.73 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.202 1.934 . . . . 0.0 110.177 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.07 -162.53 54.48 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.002 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.56 14.12 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.514 -1.343 . . . . 0.0 109.467 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.8 m -67.71 170.7 7.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.825 1.298 . . . . 0.0 114.455 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -141.9 -175.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.7 t -113.16 126.14 55.11 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -69.01 171.43 8.15 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.168 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.27 -18.09 77.9 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.93 8.26 18.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.062 0.507 . . . . 0.0 111.811 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.8 25.43 75.75 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.789 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 16.4 m-85 -131.09 153.49 49.28 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 m -47.6 157.24 0.25 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 C-N-CA 119.268 -1.444 . . . . 0.0 116.114 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.24 149.16 38.62 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.847 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -135.22 128.74 32.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.944 -1.935 . . . . 0.0 112.047 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -81.85 -58.7 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt180 -111.53 171.74 7.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.252 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.2 m-20 -56.38 -49.29 74.89 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -81.49 13.15 3.18 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.485 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.7 t70 -75.93 -16.39 60.02 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.856 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -88.79 151.16 47.16 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.475 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.4 Cg_exo -72.42 162.56 41.13 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.036 1.824 . . . . 0.0 110.058 170.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.55 -166.82 54.83 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.053 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.47 7.38 6.72 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.007 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.434 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 71.4 m -54.68 166.19 0.5 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.67 171.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.8 t -101.81 119.97 39.63 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.414 ' CZ ' HD21 ' A' ' 30' ' ' ASN . 66.3 mtm180 -72.21 168.98 17.12 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.911 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.14 68.69 Favored Glycine 0 N--CA 1.495 2.568 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.639 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.414 HD21 ' CZ ' ' A' ' 28' ' ' ARG . 50.9 p30 -81.94 -7.63 59.62 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.602 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.43 19.74 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -145.87 154.66 42.21 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.744 0.783 . . . . 0.0 110.097 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -44.49 154.35 0.13 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.54 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 C-N-CA 119.642 -1.266 . . . . 0.0 115.633 179.68 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.57 149.94 49.73 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.457 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 25.4 p -130.37 133.78 46.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.113 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -84.93 -45.65 12.02 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.483 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt-85 -132.32 172.11 12.85 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 112.766 -2.015 . . . . 0.0 107.29 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 10.5 m-20 -53.82 -53.37 53.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -73.98 3.25 7.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 10.2 t70 -72.09 -18.14 61.94 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.3 t -89.11 148.95 42.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.614 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.5 Cg_endo -73.06 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.166 1.911 . . . . 0.0 110.355 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.33 -157.82 53.4 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.408 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.33 18.85 2.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.648 -1.276 . . . . 0.0 108.348 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.584 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 69.3 m -65.95 164.36 15.26 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.83 -1.532 . . . . 0.0 114.732 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -131.63 -165.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 111.527 -2.579 . . . . 0.0 104.767 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.7 t -128.68 124.25 35.21 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -77.83 168.24 20.24 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 124.603 1.19 . . . . 0.0 110.386 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.94 -10.62 80.89 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -80.04 -4.43 52.67 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.35 24.83 35.34 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 123.793 0.683 . . . . 0.0 112.312 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 87.1 m-85 -144.03 159.51 42.47 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.212 0.595 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.3 m -41.22 152.29 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.591 1.807 . . . . 0.0 113.303 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 O-C-N 124.123 0.89 . . . . 0.0 114.634 -179.724 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.2 tmtm? . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.0 mtmm -36.32 144.4 0.06 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 p -145.92 142.27 28.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 111.526 -2.579 . . . . 0.0 111.76 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -91.48 -63.46 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.3 ptt-85 -108.36 172.02 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.739 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 80.4 m-20 -50.23 -55.96 13.11 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.6 p -77.32 8.26 4.32 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 t70 -73.68 -12.98 60.9 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.3 t -88.61 150.42 46.16 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.961 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -66.45 156.01 67.36 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.769 1.646 . . . . 0.0 109.816 170.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.89 -163.1 52.24 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 120.491 -0.862 . . . . 0.0 111.748 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.19 20.87 2.57 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.939 -1.13 . . . . 0.0 108.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.54 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 88.4 m -67.35 157.33 34.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 27' ' ' CYS . 2.0 mm -114.21 -175.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 26' ' ' ILE . 37.6 t -115.87 108.98 16.98 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.51 ' NE ' HD21 ' A' ' 30' ' ' ASN . 79.7 mtm180 -59.08 170.04 0.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 -16.45 65.2 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.81 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.51 HD21 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -83.98 -7.58 59.37 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.53 21.58 43.53 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 123.777 0.673 . . . . 0.0 112.537 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' HH21 ' A' ' 28' ' ' ARG . 81.0 m-85 -135.58 156.91 48.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 50.3 m -45.05 147.99 0.62 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.869 0 O-C-N 124.284 0.99 . . . . 0.0 115.077 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mtpp -62.13 152.16 33.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.374 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.34 122.31 26.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.095 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -73.66 -46.49 46.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 11.0 ptp180 -135.37 172.65 12.71 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 112.526 -2.125 . . . . 0.0 107.995 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 26.9 m-20 -47.78 -52.74 17.68 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.9 p -81.71 6.44 15.33 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.8 t70 -74.07 -15.68 61.06 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.965 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.0 t -88.78 149.53 43.97 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.006 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.6 Cg_exo -66.12 167.75 17.38 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.762 1.642 . . . . 0.0 110.518 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.53 -164.39 38.11 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.008 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.76 15.06 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.529 -1.336 . . . . 0.0 109.617 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.506 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 74.2 m -60.29 159.35 10.1 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -121.31 -169.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.1 t -118.76 126.32 51.61 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -67.35 171.54 5.83 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.332 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.37 -13.65 80.1 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.489 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.63 -6.94 59.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.23 24.06 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 123.692 0.62 . . . . 0.0 113.132 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 37.7 m-85 -140.05 160.39 40.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.836 0.827 . . . . 0.0 110.654 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -45.38 147.91 0.73 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.677 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.765 0 O-C-N 124.528 1.143 . . . . 0.0 111.724 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 2.1 mmpt? . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.81 146.76 7.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.085 0.945 . . . . 0.0 111.969 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.137 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -76.73 -40.44 48.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.2 ptt85 -137.37 171.03 15.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.667 -2.061 . . . . 0.0 107.525 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -48.58 -56.75 7.53 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.9 p -83.06 15.22 2.9 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.6 t70 -77.58 -14.99 59.51 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.414 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 49.8 t -88.95 151.39 47.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.75 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.1 Cg_exo -68.34 158.85 55.83 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.823 1.682 . . . . 0.0 110.017 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 -165.64 54.68 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.043 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.19 15.02 3.08 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.699 -1.25 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 77.2 m -62.89 152.69 35.63 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.17 -177.65 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.93 123.53 49.24 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' NE ' HD21 ' A' ' 30' ' ' ASN . 85.6 mtm180 -71.63 170.23 13.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.494 1.121 . . . . 0.0 110.776 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.12 -18.44 79.73 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.1 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.43 HD21 ' NE ' ' A' ' 28' ' ' ARG . 24.3 p30 -81.14 -0.03 38.37 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 124.147 0.557 . . . . 0.0 112.067 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 25.35 53.47 Favored Glycine 0 N--CA 1.496 2.64 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.351 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.76 156.83 47.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.083 0.944 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 27.6 m -48.59 146.95 2.74 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.151 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 O-C-N 124.588 1.18 . . . . 0.0 112.619 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? . . . . . 0 N--CA 1.496 1.855 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' NZ ' ' HB2' ' A' ' 14' ' ' LYS . 10.3 mtmp? -64.39 152.16 42.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 123.873 0.733 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.541 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.9 p -145.7 126.07 13.99 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.263 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -74.8 -49.89 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 34.9 ptt180 -127.6 173.94 9.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.056 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.495 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 66.0 m-20 -51.3 -55.29 19.1 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.9 p -72.29 2.29 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.0 t70 -76.63 -14.98 59.94 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 51.4 t -88.7 146.91 38.11 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.905 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 Cg_exo -69.8 163.67 37.44 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.901 1.734 . . . . 0.0 109.848 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -158.8 52.21 Favored Glycine 0 N--CA 1.5 2.967 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.996 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.73 20.0 3.71 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.86 -1.17 . . . . 0.0 108.372 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.579 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.7 m -65.8 168.85 7.25 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 113.255 -1.793 . . . . 0.0 115.694 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.94 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.085 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.495 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 45.8 t -139.27 129.0 24.68 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 88.3 mtm180 -81.36 170.51 15.91 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.074 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.06 -11.24 78.95 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.593 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -81.06 -2.14 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.327 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' N ' HD22 ' A' ' 30' ' ' ASN . . . 86.34 23.97 41.9 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.545 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 91.1 m-85 -143.45 152.98 42.18 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.677 0.751 . . . . 0.0 110.21 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.9 m -36.03 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 112.25 -2.25 . . . . 0.0 115.143 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 O-C-N 124.324 1.015 . . . . 0.0 112.288 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 54.5 mtmt -52.01 148.27 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.187 0.994 . . . . 0.0 113.396 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 20.0 p -143.65 128.18 18.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.483 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -86.27 -34.15 20.47 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -130.86 166.35 21.06 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 9.8 m-20 -53.43 -44.82 69.11 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.3 p -91.17 26.0 2.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.1 -11.55 32.65 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 42.8 t -88.81 148.65 41.99 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.866 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.9 Cg_exo -66.23 157.32 60.55 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.877 1.718 . . . . 0.0 109.961 171.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 -167.33 54.45 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.63 17.97 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.844 -1.178 . . . . 0.0 110.167 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.423 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 78.8 m -49.3 151.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -118.14 172.15 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 37.7 t -103.03 128.26 49.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -69.43 169.95 11.44 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.608 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.18 -16.35 80.64 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.266 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -1.91 56.55 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.29 24.21 37.71 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 123.691 0.619 . . . . 0.0 113.409 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 95.0 m-85 -137.74 155.32 49.21 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.062 0.934 . . . . 0.0 111.013 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.7 m -48.67 152.93 0.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 112.48 -2.146 . . . . 0.0 114.669 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 O-C-N 124.758 1.286 . . . . 0.0 113.163 179.45 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 68.5 mttm . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -97.97 152.45 19.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.1 p -144.19 124.78 14.03 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.787 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -84.34 -49.68 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.476 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 36.8 ptt180 -126.55 169.74 12.75 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.704 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 26' ' ' ILE . 8.7 m-20 -50.9 -47.6 60.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -89.1 28.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.1 t70 -94.76 -17.52 22.09 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 113.575 -1.648 . . . . 0.0 107.308 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 45.4 t -88.95 148.22 40.68 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.541 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.7 Cg_endo -73.56 165.67 31.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.237 1.958 . . . . 0.0 110.23 173.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.63 -163.71 54.75 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.903 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.05 14.83 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.874 -1.163 . . . . 0.0 109.212 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 79.3 m -66.89 161.04 24.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -127.13 -171.65 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 102.65 -3.093 . . . . 0.0 102.65 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.418 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -113.07 130.46 56.16 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 1.8 mmp_? -69.59 172.65 7.05 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 -13.68 82.98 Favored Glycine 0 N--CA 1.494 2.525 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.658 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -89.46 -9.6 49.5 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.97 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.12 33.32 7.78 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.472 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 11.4 m-85 -137.66 155.78 48.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 19.9 m -51.75 149.36 4.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.458 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.495 2.6 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.594 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -122.03 -124.48 3.02 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 t -150.63 165.18 34.15 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 124.098 0.528 . . . . 0.0 110.179 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.3 t70 49.97 46.74 24.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.315 1.009 . . . . 0.0 110.791 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 123.77 -29.22 5.23 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.04 87.67 0.67 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -130.9 129.43 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 t -150.31 140.8 14.25 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 124.189 0.931 . . . . 0.0 110.624 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.48 -159.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.782 2.321 . . . . 0.0 109.816 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -50.31 138.48 16.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 123.626 0.579 . . . . 0.0 110.944 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 28.8 pt -113.06 114.06 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.831 1.3 . . . . 0.0 112.131 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.8 pt? -162.64 24.26 0.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 113.117 -1.856 . . . . 0.0 108.442 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -118.28 121.5 40.59 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.677 -2.056 . . . . 0.0 105.878 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 58.8 mtpt -62.84 150.33 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.021 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.516 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 22.3 p -138.41 135.83 35.66 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 112.546 -2.116 . . . . 0.0 111.759 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -84.76 -57.73 3.0 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.46 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.4 ptt-85 -115.32 173.48 6.49 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 112.874 -1.966 . . . . 0.0 106.882 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.484 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.5 m-20 -56.31 -52.06 65.93 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -73.6 5.64 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.1 t70 -76.61 -16.7 59.51 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.77 147.02 38.2 Favored Pre-proline 0 N--CA 1.486 1.362 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.15 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.2 Cg_exo -70.7 165.86 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.829 1.686 . . . . 0.0 109.703 177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.67 -160.51 54.07 Favored Glycine 0 N--CA 1.501 2.991 0 C-N-CA 120.115 -1.041 . . . . 0.0 113.29 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.53 20.26 2.53 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 113.622 -1.289 . . . . 0.0 108.729 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 65.6 m -67.43 170.8 6.85 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 113.628 -1.624 . . . . 0.0 114.139 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -136.58 -167.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 179.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.2 t -126.35 128.12 46.58 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -77.37 170.18 17.0 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.284 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.94 -12.55 83.89 Favored Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.597 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -79.63 -5.62 55.43 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.65 21.37 40.45 Favored Glycine 0 N--CA 1.496 2.692 0 O-C-N 123.723 0.64 . . . . 0.0 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 53.2 m-85 -141.14 159.8 41.46 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 124.114 0.537 . . . . 0.0 109.749 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 50.3 m -40.69 159.81 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 O-C-N 125.533 1.771 . . . . 0.0 114.663 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 CA-C-N 115.402 -0.817 . . . . 0.0 114.557 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.42 ' H ' HG13 ' A' ' 26' ' ' ILE . . . 67.8 38.27 89.32 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.0 m -89.83 132.94 35.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 124.052 0.501 . . . . 0.0 110.851 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.5 t70 52.48 24.31 2.96 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.418 1.074 . . . . 0.0 111.914 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.71 138.41 2.71 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.3 143.49 5.9 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.17 146.63 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 t -150.03 140.11 13.74 Favored Pre-proline 0 N--CA 1.494 1.766 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.659 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.41 137.11 16.38 Favored 'Trans proline' 0 C--N 1.317 -1.083 0 C-N-CA 122.675 2.25 . . . . 0.0 108.936 169.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -59.04 108.14 0.63 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.408 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.4 pt -140.8 161.39 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.666 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -107.27 41.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.308 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -89.48 143.25 26.96 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -81.2 153.52 27.15 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.331 -0.947 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.414 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.6 p -143.03 134.52 26.3 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 112.973 -1.921 . . . . 0.0 109.404 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' N ' ' HD2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -93.88 -41.86 9.39 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -128.59 167.4 17.21 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.499 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 22.3 m-20 -49.15 -51.29 33.24 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 88.8 p -90.06 27.08 1.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.5 t70 -86.24 -15.82 39.6 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.272 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 37.9 t -88.85 151.64 47.63 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 113.845 -1.525 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.2 Cg_endo -73.93 164.65 34.02 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.182 1.921 . . . . 0.0 109.733 169.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -162.36 54.4 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.524 -0.846 . . . . 0.0 111.938 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.1 21.54 2.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 113.923 -1.139 . . . . 0.0 108.153 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.492 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 96.4 m -71.63 153.17 42.28 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.42 HG13 ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -120.09 174.27 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 103.559 -2.756 . . . . 0.0 103.559 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.405 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 44.2 t -100.97 118.98 38.05 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.197 -1.001 . . . . 0.0 112.236 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NE ' HD21 ' A' ' 30' ' ' ASN . 87.4 mtm180 -66.42 170.77 5.64 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.23 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.09 -14.93 74.06 Favored Glycine 0 N--CA 1.495 2.606 0 CA-C-N 114.027 -1.442 . . . . 0.0 111.868 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.413 HD21 ' NE ' ' A' ' 28' ' ' ARG . 21.1 p30 -84.59 -10.52 57.3 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.934 0.432 . . . . 0.0 111.742 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.53 29.65 13.51 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 123.786 0.679 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.0 m-85 -141.71 155.01 45.67 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.49 0.662 . . . . 0.0 109.747 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.8 m -48.75 146.32 3.23 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.597 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.502 0 O-C-N 124.287 0.992 . . . . 0.0 115.063 179.709 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 23.8 t . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.22 -6.6 0.06 OUTLIER Glycine 0 N--CA 1.499 2.885 0 C-N-CA 119.556 -1.307 . . . . 0.0 114.815 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.2 m -89.55 145.82 25.01 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 117.538 0.669 . . . . 0.0 111.59 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -66.26 -15.76 63.46 Favored 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.732 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.16 -31.95 70.4 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.0 -139.12 3.45 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.8 t -147.97 133.81 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 1' ' ' SER . 49.6 t -90.05 128.91 47.96 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.424 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -69.73 109.78 2.39 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 N-CA-C 106.17 -2.281 . . . . 0.0 106.17 163.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -69.05 124.46 23.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 123.876 0.735 . . . . 0.0 112.686 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -138.09 171.91 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.164 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.1 pt? -87.19 36.78 0.75 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 115.076 -0.966 . . . . 0.0 113.224 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -95.97 129.88 43.11 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.519 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -75.79 152.91 37.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.116 0.885 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.573 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 19.0 p -139.56 133.27 30.54 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 113.401 -1.727 . . . . 0.0 110.966 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.7 -34.8 18.27 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -134.8 169.26 17.62 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.3 m-20 -53.21 -54.33 37.62 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 84.1 p -72.52 1.44 8.13 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -76.06 -12.64 60.16 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.1 t -89.0 146.85 37.37 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 114.223 -1.353 . . . . 0.0 107.887 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.3 Cg_exo -68.54 162.69 39.79 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.882 1.722 . . . . 0.0 110.124 177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.01 -160.39 54.01 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.672 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.1 18.17 3.22 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.966 -1.117 . . . . 0.0 108.684 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.563 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.4 m -62.57 168.83 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -131.74 -166.48 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 111.53 -2.577 . . . . 0.0 104.365 179.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.3 t -132.77 131.5 41.21 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.7 mtm105 -88.45 168.33 12.71 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 124.717 1.26 . . . . 0.0 111.755 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.6 -12.52 56.63 Favored Glycine 0 N--CA 1.495 2.587 0 CA-C-N 112.805 -1.998 . . . . 0.0 114.377 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.53 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -79.56 -8.61 59.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.835 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.6 24.86 27.09 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.573 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 57.0 m-85 -143.49 158.63 43.5 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -37.71 164.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.794 0 CA-C-N 115.106 -0.952 . . . . 0.0 114.484 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.76 -122.13 2.26 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.9 m -143.36 174.02 11.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 124.228 0.605 . . . . 0.0 109.932 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.7 t70 52.06 67.14 1.02 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 124.255 0.972 . . . . 0.0 108.861 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.53 -11.34 59.16 Favored Glycine 0 N--CA 1.494 2.563 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.171 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.95 81.9 1.37 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.08 127.65 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 10.6 t -150.7 157.51 36.02 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 124.202 0.939 . . . . 0.0 110.769 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.468 ' HD2' ' SG ' ' A' ' 8' ' ' CYS . 10.4 Cg_endo -68.98 -167.89 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.467 2.112 . . . . 0.0 109.414 158.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -122.94 58.54 1.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 122.058 0.933 . . . . 0.0 109.507 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 26.6 pt -89.89 152.95 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.002 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.8 OUTLIER -94.84 46.02 1.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 114.997 -1.001 . . . . 0.0 108.813 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 0.0 OUTLIER -89.68 121.95 32.33 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 151.78 28.42 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.574 -1.251 . . . . 0.0 113.66 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 28.0 p -141.19 129.63 22.51 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 112.294 -2.23 . . . . 0.0 112.557 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' H ' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -82.81 -62.92 1.47 Allowed 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.43 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 15.7 ptm180 -110.94 174.3 5.93 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.36 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.8 m-20 -54.42 -53.53 52.86 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 93.2 p -73.84 3.81 6.12 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.5 t70 -72.65 -16.89 61.7 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.571 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 49.2 t -88.65 146.7 37.79 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 113.943 -1.481 . . . . 0.0 107.739 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.1 Cg_exo -69.62 164.24 35.15 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.885 1.724 . . . . 0.0 109.748 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.5 -160.97 54.0 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.852 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.23 19.82 3.02 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 113.777 -1.212 . . . . 0.0 108.679 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.571 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 75.6 m -65.1 171.01 3.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.617 -1.629 . . . . 0.0 114.807 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.72 -169.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.467 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 46.6 t -123.39 126.96 47.76 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -79.65 169.55 17.82 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.198 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.73 -13.96 75.2 Favored Glycine 0 N--CA 1.494 2.53 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.021 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -79.63 -6.06 56.34 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.754 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.79 23.62 38.31 Favored Glycine 0 N--CA 1.497 2.751 0 O-C-N 123.82 0.7 . . . . 0.0 112.131 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 83.7 m-85 -144.78 157.24 44.25 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.169 0.57 . . . . 0.0 109.902 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 56.5 m -37.31 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.598 0 CA-C-N 114.851 -1.068 . . . . 0.0 115.192 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.438 ' H ' HD11 ' A' ' 26' ' ' ILE . . . 163.91 27.76 0.02 OUTLIER Glycine 0 N--CA 1.497 2.728 0 C-N-CA 119.088 -1.53 . . . . 0.0 116.552 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.5 p -150.25 -136.0 0.07 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 118.474 1.137 . . . . 0.0 110.065 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -49.05 -40.06 29.9 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 123.779 0.674 . . . . 0.0 110.149 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -80.88 -54.38 3.65 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 107.271 -2.332 . . . . 0.0 107.271 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.63 2.53 6.1 Favored Glycine 0 N--CA 1.498 2.791 0 CA-C-N 114.833 -0.683 . . . . 0.0 113.098 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.3 t -142.29 141.22 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -150.34 136.22 10.5 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 2.7 Cg_exo -54.62 102.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.492 2.128 . . . . 0.0 109.43 167.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -63.65 83.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 113.506 -1.679 . . . . 0.0 112.592 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -130.26 145.96 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 CA-C-N 114.167 -1.378 . . . . 0.0 107.305 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.55 HD12 ' H ' ' A' ' 12' ' ' LEU . 5.4 mp -70.35 86.06 0.59 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 124.097 0.873 . . . . 0.0 110.26 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -126.41 149.44 49.26 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.502 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -92.0 154.98 18.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 123.981 0.801 . . . . 0.0 110.24 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.562 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.1 p -150.35 125.92 10.25 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.632 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -55.06 5.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.3 ptm85 -117.55 173.95 6.43 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.503 -1.68 . . . . 0.0 109.025 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.462 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 17.8 m-20 -50.19 -55.19 16.21 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 95.8 p -75.96 1.36 15.5 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -71.33 -17.22 62.45 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.567 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.6 t -88.48 145.69 36.01 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-N 114.289 -1.323 . . . . 0.0 108.049 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.567 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.6 Cg_exo -68.87 164.4 33.7 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.85 1.7 . . . . 0.0 109.931 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.72 -158.95 52.72 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.102 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.92 18.13 4.39 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-N 113.719 -1.24 . . . . 0.0 108.422 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.544 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 85.3 m -63.47 160.89 15.42 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -122.91 -168.54 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.462 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.9 t -131.15 129.9 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.079 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.23 168.0 18.21 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.145 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.07 -14.5 80.35 Favored Glycine 0 N--CA 1.496 2.691 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.846 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -81.18 -8.09 59.69 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.44 21.92 30.68 Favored Glycine 0 N--CA 1.497 2.765 0 O-C-N 123.804 0.69 . . . . 0.0 112.252 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 8.7 m-85 -134.31 153.57 51.8 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -40.93 154.73 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 O-C-N 125.363 1.664 . . . . 0.0 115.317 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.574 0 CA-C-N 114.931 -1.031 . . . . 0.0 114.498 -179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.4 t . . . . . 0 N--CA 1.503 2.216 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.26 44.35 3.27 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 112.153 -0.379 . . . . 0.0 112.153 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.3 m -89.82 121.42 31.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.8 t70 69.33 -22.88 0.15 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 124.9 1.375 . . . . 0.0 113.413 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.92 -75.6 1.12 Allowed Glycine 0 N--CA 1.494 2.505 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.23 -142.16 7.66 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 87.3 t -141.16 148.57 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.5 t -150.04 119.17 3.74 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.841 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.01 -161.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.798 2.332 . . . . 0.0 112.213 171.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -46.51 141.64 3.56 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -130.63 124.54 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.256 1.026 . . . . 0.0 113.375 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.7 pt? -173.79 21.25 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.195 -1.82 . . . . 0.0 107.781 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -111.4 140.67 45.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 112.575 -2.102 . . . . 0.0 107.494 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 10.0 mptt -74.55 149.22 40.27 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.352 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.7 p -134.45 127.41 31.43 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 113.493 -1.685 . . . . 0.0 111.086 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.8 mmt85 -80.42 -59.24 2.77 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 16.8 ptm180 -114.09 171.27 7.71 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.665 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 59.0 m-20 -51.59 -52.36 48.05 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.2 p -80.61 9.66 5.82 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 11.7 t70 -73.37 -15.47 61.37 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 114.937 -1.028 . . . . 0.0 108.635 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.614 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 52.4 t -88.75 149.15 43.27 Favored Pre-proline 0 N--CA 1.485 1.309 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.193 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.614 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 6.9 Cg_exo -65.14 154.66 72.43 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.892 1.728 . . . . 0.0 110.335 174.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 72.81 -165.97 54.49 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.54 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.85 16.36 0.9 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 113.652 -1.274 . . . . 0.0 109.676 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.531 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 93.8 m -63.36 154.56 31.51 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.38 -178.54 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 103.709 -2.7 . . . . 0.0 103.709 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.438 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.5 t -111.89 115.59 29.25 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.068 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 -65.39 168.58 6.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 124.491 1.119 . . . . 0.0 111.195 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -15.87 73.18 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 114.468 -1.242 . . . . 0.0 111.836 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -82.11 -4.06 56.11 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.07 19.93 48.45 Favored Glycine 0 N--CA 1.497 2.739 0 O-C-N 123.631 0.582 . . . . 0.0 113.138 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -139.4 158.45 44.12 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.757 0.789 . . . . 0.0 110.478 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.9 m -41.14 153.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 112.511 -2.131 . . . . 0.0 114.808 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.96 0 O-C-N 124.071 0.857 . . . . 0.0 114.204 179.591 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.4 p . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.462 0.649 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.39 77.93 1.04 Allowed Glycine 0 N--CA 1.495 2.573 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.733 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.2 t -89.91 -133.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -65.77 -23.1 66.65 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.29 25.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 CA-C-N 114.269 -1.332 . . . . 0.0 109.848 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.27 -159.65 18.87 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 8' ' ' CYS . 60.9 t -150.06 163.41 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-N 113.035 -1.582 . . . . 0.0 108.768 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.406 ' N ' HG12 ' A' ' 7' ' ' VAL . 45.3 t -130.97 141.58 42.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -70.94 157.39 58.24 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.506 2.138 . . . . 0.0 109.998 174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -78.94 94.45 5.24 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.3 pt -126.76 145.43 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.224 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.8 mt -89.83 38.32 0.91 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.042 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' CE ' ' HA ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -89.77 126.6 35.73 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.298 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.46 ' HD3' ' N ' ' A' ' 14' ' ' LYS . 2.0 mppt? -72.17 154.2 41.19 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.225 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.49 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 26.6 p -138.61 130.32 27.79 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.686 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -82.16 -49.17 10.44 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 29.3 ptt-85 -128.13 173.4 10.13 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.517 -2.128 . . . . 0.0 106.79 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.478 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 18.5 m-20 -53.45 -53.2 54.74 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 86.4 p -74.32 4.47 5.77 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.478 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.6 t70 -77.22 -14.06 59.83 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.57 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 52.3 t -88.84 148.63 41.89 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.113 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.558 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.61 166.46 28.57 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 121.93 1.753 . . . . 0.0 109.65 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.02 -161.06 54.32 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.99 16.85 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.159 -1.02 . . . . 0.0 108.696 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 63.3 m -61.15 171.16 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -135.26 -163.76 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -130.75 129.31 42.34 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -78.58 170.13 17.14 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.775 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.24 -12.32 84.7 Favored Glycine 0 N--CA 1.496 2.652 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.524 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -80.0 -5.16 55.24 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.57 20.85 39.27 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 123.747 0.655 . . . . 0.0 112.541 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 40.3 m-85 -141.12 157.6 45.06 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.612 0.72 . . . . 0.0 110.17 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.1 m -39.95 153.44 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 112.704 -2.043 . . . . 0.0 114.957 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.835 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.954 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 8' ' ' CYS . 70.3 p . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.511 0.672 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.67 -13.73 18.97 Favored Glycine 0 N--CA 1.499 2.889 0 CA-C-N 115.181 -0.918 . . . . 0.0 113.433 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.411 ' H ' HD11 ' A' ' 26' ' ' ILE . 66.4 m -145.17 153.88 41.84 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.71 -33.0 73.25 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.435 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.15 80.59 1.7 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 131.43 101.07 0.85 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.1 t -89.43 126.71 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 1' ' ' SER . 43.2 t -95.44 135.43 23.21 Favored Pre-proline 0 N--CA 1.491 1.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.164 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 Cg_endo -56.45 87.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.662 1.575 . . . . 0.0 108.684 142.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -56.09 115.79 2.63 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.063 -1.426 . . . . 0.0 113.14 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.4 pt -143.3 156.63 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 124.033 0.833 . . . . 0.0 109.448 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -86.13 39.77 0.83 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.969 0.793 . . . . 0.0 112.246 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 88.2 tttt -89.78 150.3 22.33 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 37.7 mtmm -81.59 152.57 27.13 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.267 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.35 127.54 24.31 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.697 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 47.0 ttm-85 -80.04 -60.05 2.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 18.4 ptp180 -116.31 172.91 6.89 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 113.027 -1.897 . . . . 0.0 107.007 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.51 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 12.8 m-20 -57.13 -52.37 65.56 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.228 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 91.0 p -74.37 12.67 0.71 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 15.8 t70 -79.91 -18.48 50.46 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.598 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 39.1 t -89.02 148.75 41.8 Favored Pre-proline 0 N--CA 1.484 1.272 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.311 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.598 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -71.53 159.83 50.15 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.338 2.025 . . . . 0.0 110.887 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 73.49 -163.33 54.77 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.872 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.26 17.76 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.877 -1.162 . . . . 0.0 109.443 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 68.9 m -67.67 167.22 13.57 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.501 -1.227 . . . . 0.0 113.167 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.411 HD11 ' H ' ' A' ' 3' ' ' SER . 1.1 pt -140.67 -175.53 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 19.6 t -105.16 124.12 49.0 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -70.42 170.56 11.7 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.412 -1.722 . . . . 0.0 111.405 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.41 77.97 Favored Glycine 0 N--CA 1.495 2.602 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.952 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -82.67 -9.82 59.2 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.003 0.473 . . . . 0.0 111.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.25 23.7 28.66 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 123.929 0.768 . . . . 0.0 112.727 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 26.4 m-85 -137.56 158.11 45.08 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.158 0.504 . . . . 0.0 109.841 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 21.4 m -46.1 150.1 0.63 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.203 -1.362 . . . . 0.0 113.75 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 C-N-CA 119.854 -1.165 . . . . 0.0 113.375 179.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.503 2.22 0 CA-C-O 121.043 0.449 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.458 ' N ' HD11 ' A' ' 26' ' ' ILE . . . 73.05 113.04 0.06 OUTLIER Glycine 0 N--CA 1.498 2.774 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.613 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.6 p -150.29 -48.83 0.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.221 1.01 . . . . 0.0 109.326 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.15 -32.12 3.74 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 112.395 -2.184 . . . . 0.0 109.814 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.99 105.99 0.23 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 105.791 -2.924 . . . . 0.0 105.791 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 163.15 154.39 7.64 Favored Glycine 0 N--CA 1.482 1.76 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.8 145.29 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.1 t -149.83 143.89 17.16 Favored Pre-proline 0 N--CA 1.495 1.79 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.252 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.46 179.46 5.88 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.817 2.345 . . . . 0.0 110.256 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -93.91 89.99 6.31 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.434 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -128.53 163.88 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.698 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.2 pt? -110.94 47.96 0.95 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.877 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 45.3 mmtm -89.19 128.2 35.8 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.034 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -69.16 149.37 48.7 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 123.949 0.781 . . . . 0.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.576 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 29.0 p -146.25 133.6 20.68 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.522 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.7 ptp180 -93.17 -37.05 12.31 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.4 ptt180 -132.09 169.47 16.33 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 16.6 m-20 -53.81 -51.61 62.96 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -75.73 5.01 6.78 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -79.83 -12.19 59.78 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.59 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 53.9 t -88.89 150.3 45.29 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 113.703 -1.59 . . . . 0.0 107.782 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 4.1 Cg_exo -70.69 166.3 29.22 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.919 1.746 . . . . 0.0 109.727 173.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 25' ' ' CYS . . . 69.68 -163.02 52.08 Favored Glycine 0 N--CA 1.502 3.065 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.235 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.63 16.59 3.13 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 113.857 -1.171 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.59 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 62.8 m -61.72 168.92 2.71 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 115.273 1.582 . . . . 0.0 115.273 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.458 HD11 ' N ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -131.04 -159.99 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 179.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 44.8 t -138.25 128.25 25.56 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.459 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 41.8 mmt180 -79.32 169.08 18.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.268 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.4 -8.49 66.41 Favored Glycine 0 N--CA 1.495 2.619 0 CA-C-N 114.209 -1.36 . . . . 0.0 113.537 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.521 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -84.96 -8.17 58.86 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.604 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' N ' HD22 ' A' ' 30' ' ' ASN . . . 91.5 26.35 20.81 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 20.2 m-85 -141.19 152.33 44.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 66.0 m -40.62 158.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.266 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.919 0 CA-C-N 115.11 -0.95 . . . . 0.0 113.002 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.22 -124.71 5.47 Favored Glycine 0 N--CA 1.494 2.555 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.072 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.4 m -142.32 -16.67 0.74 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.326 0.662 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.03 -29.38 60.8 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.726 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -158.82 -58.32 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 53.27 45.52 64.53 Favored Glycine 0 N--CA 1.495 2.61 0 CA-C-N 114.676 -0.762 . . . . 0.0 112.664 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.8 t -92.16 44.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.3 t -94.97 140.8 22.6 Favored Pre-proline 0 N--CA 1.496 1.832 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.271 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 10.1 Cg_endo -67.23 173.03 9.16 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.489 2.126 . . . . 0.0 110.746 171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -94.98 93.06 7.18 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.627 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -134.62 149.27 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.358 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.504 ' H ' HD23 ' A' ' 12' ' ' LEU . 0.9 OUTLIER -104.96 49.6 0.8 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.666 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -89.8 139.69 30.33 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.787 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -75.6 151.04 37.9 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 118.499 -1.281 . . . . 0.0 110.673 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.487 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.7 p -138.09 136.19 36.54 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.822 -1.99 . . . . 0.0 111.255 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.465 HH12 HH22 ' A' ' 17' ' ' ARG . 34.3 mtp-105 -87.65 -65.53 1.01 Allowed 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 HH22 HH12 ' A' ' 16' ' ' ARG . 9.6 ptp85 -105.21 173.62 6.23 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.446 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.9 m-20 -59.02 -46.84 87.2 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 85.5 p -81.77 13.82 3.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.006 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 6.8 t70 -77.83 -14.3 59.62 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 48.7 t -89.27 151.57 46.66 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.438 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -71.73 161.59 44.69 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.104 1.869 . . . . 0.0 110.216 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.68 -164.93 54.71 Favored Glycine 0 N--CA 1.498 2.772 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.312 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.5 14.39 2.55 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 113.729 -1.236 . . . . 0.0 109.561 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.497 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.7 m -61.28 166.26 3.95 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.473 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -136.23 170.43 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 36.8 t -102.51 122.88 45.23 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.22 166.77 22.98 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.647 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.13 -13.07 61.53 Favored Glycine 0 N--CA 1.496 2.659 0 CA-C-N 114.469 -1.242 . . . . 0.0 112.811 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -81.03 -10.04 59.75 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.513 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.04 26.78 23.15 Favored Glycine 0 N--CA 1.496 2.649 0 O-C-N 123.895 0.747 . . . . 0.0 111.591 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.487 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 58.7 m-85 -142.83 157.24 44.8 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.543 . . . . 0.0 110.033 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.7 m -46.78 161.15 0.07 Allowed 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 113.937 -1.483 . . . . 0.0 114.029 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 117.219 1.648 . . . . 0.0 117.219 179.759 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.417 ' HB2' HG12 ' A' ' 26' ' ' ILE . 74.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 26' ' ' ILE . . . 159.0 -38.08 0.5 Allowed Glycine 0 N--CA 1.499 2.85 0 O-C-N 123.541 0.526 . . . . 0.0 112.494 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 m -88.96 170.59 10.55 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.9 t70 63.35 16.91 9.88 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 123.798 0.686 . . . . 0.0 111.587 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.36 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.89 -96.8 0.1 Allowed Glycine 0 N--CA 1.496 2.66 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.854 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.09 160.41 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.3 t -148.89 140.53 14.4 Favored Pre-proline 0 N--CA 1.496 1.874 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.481 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.55 -173.02 1.47 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.953 2.435 . . . . 0.0 110.595 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -98.35 116.76 31.26 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.086 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -141.87 173.39 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.48 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' H ' HD23 ' A' ' 12' ' ' LEU . 1.5 pt? -122.79 34.76 5.05 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.453 -1.248 . . . . 0.0 109.91 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -89.89 142.24 27.89 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.607 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HZ2' ' HE2' ' A' ' 32' ' ' TYR . 46.7 mmtm -76.84 153.57 34.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 123.816 0.697 . . . . 0.0 111.212 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.424 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.6 p -142.19 120.64 12.42 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.56 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -88.44 -37.82 15.52 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.18 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.5 ptt180 -132.75 166.47 22.15 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 3.6 m-20 -50.26 -52.83 32.92 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.312 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.0 p -86.75 32.52 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 14.1 t70 -93.65 -18.55 22.04 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 113.326 -1.761 . . . . 0.0 106.828 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 20.8 t -88.96 150.52 45.55 Favored Pre-proline 0 N--CA 1.484 1.237 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.381 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.626 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.2 Cg_endo -76.1 168.14 24.64 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.288 1.992 . . . . 0.0 110.05 170.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.56 -160.47 53.69 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.764 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.24 18.74 4.83 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.437 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 71.2 m -71.24 162.11 29.98 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.843 -1.526 . . . . 0.0 114.036 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.474 HG13 ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER -134.77 -178.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 104.042 -2.577 . . . . 0.0 104.042 179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 46.8 t -104.01 130.11 51.66 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 32' ' ' TYR . 88.1 mtm180 -81.3 170.88 15.5 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.469 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.1 -13.41 83.25 Favored Glycine 0 N--CA 1.495 2.59 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -81.63 -7.2 59.56 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.58 26.0 28.71 Favored Glycine 0 N--CA 1.498 2.786 0 O-C-N 123.83 0.707 . . . . 0.0 111.899 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 34.2 m-85 -142.97 154.12 43.71 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.765 0.793 . . . . 0.0 110.301 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 46.0 m -48.43 153.89 0.7 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 112.935 -1.939 . . . . 0.0 112.611 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.493 2.488 0 O-C-N 124.221 0.95 . . . . 0.0 114.1 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.494 ' HA ' HD11 ' A' ' 26' ' ' ILE . 66.3 m . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.17 58.85 0.15 Allowed Glycine 0 N--CA 1.498 2.804 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.871 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.9 p -150.56 -152.76 0.45 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -56.51 -29.36 61.76 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -140.77 -145.76 4.66 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 107.551 -2.22 . . . . 0.0 107.551 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.95 56.51 0.08 OUTLIER Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.4 t -90.06 37.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.87 144.86 32.2 Favored Pre-proline 0 N--CA 1.495 1.776 0 CA-C-N 115.157 -0.928 . . . . 0.0 108.954 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.6 Cg_exo -64.35 -157.81 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.803 2.335 . . . . 0.0 112.087 173.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 33.0 1.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.479 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.2 mt -89.42 135.86 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.723 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.579 HD12 ' H ' ' A' ' 12' ' ' LEU . 5.9 mp -60.7 106.64 0.59 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.167 0.917 . . . . 0.0 110.434 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -145.46 150.16 36.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 14' ' ' LYS . 2.0 mptp? -101.31 152.76 20.31 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.986 0.898 . . . . 0.0 112.632 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.452 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.5 p -144.46 142.08 30.04 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 112.706 -2.043 . . . . 0.0 111.333 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -100.87 -34.27 9.87 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -134.85 167.11 21.49 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 14.0 m-20 -51.99 -52.79 48.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.7 p -79.62 20.88 0.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -87.07 -19.83 28.02 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 38.1 t -88.76 146.78 37.71 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.179 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.58 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.4 Cg_endo -75.53 167.34 26.73 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.202 1.934 . . . . 0.0 110.177 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.07 -162.53 54.48 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.002 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.56 14.12 2.21 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.514 -1.343 . . . . 0.0 109.467 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 73.8 m -67.71 170.7 7.44 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.825 1.298 . . . . 0.0 114.455 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -141.9 -175.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 41.7 t -113.16 126.14 55.11 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -69.01 171.43 8.15 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 113.586 -1.643 . . . . 0.0 110.168 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.27 -18.09 77.9 Favored Glycine 0 N--CA 1.497 2.7 0 CA-C-N 114.737 -1.119 . . . . 0.0 110.601 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.93 8.26 18.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 124.062 0.507 . . . . 0.0 111.811 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 70.8 25.43 75.75 Favored Glycine 0 N--CA 1.494 2.558 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.789 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 16.4 m-85 -131.09 153.49 49.28 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.3 m -47.6 157.24 0.25 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.435 0 C-N-CA 119.268 -1.444 . . . . 0.0 116.114 179.681 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.424 ' HA ' HD11 ' A' ' 26' ' ' ILE . 45.4 t . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.08 -59.86 0.16 Allowed Glycine 0 N--CA 1.494 2.546 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.151 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -89.78 -148.02 0.19 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 123.91 0.418 . . . . 0.0 110.732 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -50.4 -22.42 1.86 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -51.29 -71.02 0.71 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 124.312 1.008 . . . . 0.0 111.791 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.99 -71.62 2.58 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.7 t -90.42 125.4 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.6 t -150.27 136.05 10.39 Favored Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.591 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 5.3 Cg_endo -64.2 95.41 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.808 1.672 . . . . 0.0 108.899 158.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.2 54.11 3.03 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.8 mt -89.01 164.59 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.013 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD12 ' H ' ' A' ' 12' ' ' LEU . 5.4 mp -67.3 81.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 124.293 0.996 . . . . 0.0 109.984 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 107.94 8.36 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -61.24 149.16 38.62 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.847 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -135.22 128.74 32.52 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.944 -1.935 . . . . 0.0 112.047 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 -81.85 -58.7 2.87 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt180 -111.53 171.74 7.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.252 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.432 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 6.2 m-20 -56.38 -49.29 74.89 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.3 p -81.49 13.15 3.18 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.083 -0.962 . . . . 0.0 113.485 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 12.7 t70 -75.93 -16.39 60.02 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.599 -1.182 . . . . 0.0 107.856 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.7 t -88.79 151.16 47.16 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 113.847 -1.524 . . . . 0.0 109.475 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.608 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.4 Cg_exo -72.42 162.56 41.13 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.036 1.824 . . . . 0.0 110.058 170.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.55 -166.82 54.83 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.053 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.47 7.38 6.72 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 113.774 -1.213 . . . . 0.0 110.007 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 71.4 m -54.68 166.19 0.5 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.424 HD11 ' HA ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -135.67 171.68 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.8 t -101.81 119.97 39.63 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.414 ' CZ ' HD21 ' A' ' 30' ' ' ASN . 66.3 mtm180 -72.21 168.98 17.12 Favored 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.911 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 -14.14 68.69 Favored Glycine 0 N--CA 1.495 2.568 0 CA-C-N 114.0 -1.454 . . . . 0.0 112.639 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.414 HD21 ' CZ ' ' A' ' 28' ' ' ARG . 50.9 p30 -81.94 -7.63 59.62 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.602 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.22 30.43 19.74 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -145.87 154.66 42.21 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.744 0.783 . . . . 0.0 110.097 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -44.49 154.35 0.13 Allowed 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 112.934 -1.939 . . . . 0.0 114.54 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.523 0 C-N-CA 119.642 -1.266 . . . . 0.0 115.633 179.68 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.2 120.23 0.01 OUTLIER Glycine 0 N--CA 1.49 2.279 0 O-C-N 124.136 0.897 . . . . 0.0 114.039 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -88.97 125.12 34.84 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.3 t70 56.76 49.67 13.92 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.362 1.039 . . . . 0.0 110.006 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.55 136.76 3.62 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.81 148.26 23.92 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.4 t -144.04 134.15 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 124.266 0.627 . . . . 0.0 109.857 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.2 t -150.68 145.57 18.52 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 123.952 0.782 . . . . 0.0 109.007 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -71.54 -173.88 1.11 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 168.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -81.94 67.38 7.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.34 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 13' ' ' LYS . 72.5 mt -89.67 123.42 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.752 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.0 mt -102.37 36.22 2.21 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.887 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 11' ' ' ILE . 35.0 mtmm -96.88 136.05 37.99 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -66.57 149.94 49.73 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.457 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 25.4 p -130.37 133.78 46.65 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.341 -1.754 . . . . 0.0 112.113 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -84.93 -45.65 12.02 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.483 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.0 ptt-85 -132.32 172.11 12.85 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 112.766 -2.015 . . . . 0.0 107.29 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 10.5 m-20 -53.82 -53.37 53.31 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 92.8 p -73.98 3.25 7.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 10.2 t70 -72.09 -18.14 61.94 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.623 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.3 t -89.11 148.95 42.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.614 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.623 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.5 Cg_endo -73.06 168.26 25.22 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.166 1.911 . . . . 0.0 110.355 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 69.33 -157.82 53.4 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.408 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.33 18.85 2.99 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 113.648 -1.276 . . . . 0.0 108.348 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.584 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 69.3 m -65.95 164.36 15.26 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 113.83 -1.532 . . . . 0.0 114.732 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -131.63 -165.48 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 111.527 -2.579 . . . . 0.0 104.767 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.482 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 49.7 t -128.68 124.25 35.21 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -77.83 168.24 20.24 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 124.603 1.19 . . . . 0.0 110.386 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.94 -10.62 80.89 Favored Glycine 0 N--CA 1.497 2.721 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.055 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -80.04 -4.43 52.67 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.35 24.83 35.34 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 123.793 0.683 . . . . 0.0 112.312 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.46 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 87.1 m-85 -144.03 159.51 42.47 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 124.212 0.595 . . . . 0.0 110.305 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.3 m -41.22 152.29 0.06 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 125.591 1.807 . . . . 0.0 113.303 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 O-C-N 124.123 0.89 . . . . 0.0 114.634 -179.724 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 122.293 1.044 . . . . 0.0 112.152 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.06 19.65 0.1 Allowed Glycine 0 N--CA 1.494 2.511 0 CA-C-N 112.886 -1.961 . . . . 0.0 112.138 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -89.48 -15.96 31.88 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.285 0.565 . . . . 0.0 111.049 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -88.98 -1.69 58.23 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 114.093 -1.412 . . . . 0.0 110.488 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.78 122.59 4.67 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.14 126.89 2.92 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -89.18 143.26 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.471 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 32.4 t -103.19 146.82 33.16 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.465 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 6.0 Cg_exo -61.4 159.14 32.62 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.295 1.997 . . . . 0.0 109.533 159.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -80.04 90.57 5.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.225 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.4 pt -135.11 173.74 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.671 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.465 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.7 pt? -139.2 49.01 1.85 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.687 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 6.2 tmtm? -89.6 117.58 28.59 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.0 mtmm -36.32 144.4 0.06 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.856 1.799 . . . . 0.0 115.856 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.7 p -145.92 142.27 28.57 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 111.526 -2.579 . . . . 0.0 111.76 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -91.48 -63.46 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 103.894 -2.632 . . . . 0.0 103.894 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.45 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 30.3 ptt-85 -108.36 172.02 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 113.259 -1.791 . . . . 0.0 106.739 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 80.4 m-20 -50.23 -55.96 13.11 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.6 p -77.32 8.26 4.32 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.2 t70 -73.68 -12.98 60.9 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.589 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 53.3 t -88.61 150.42 46.16 Favored Pre-proline 0 C--N 1.308 -1.216 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.961 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.589 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.2 Cg_exo -66.45 156.01 67.36 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.769 1.646 . . . . 0.0 109.816 170.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.89 -163.1 52.24 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 120.491 -0.862 . . . . 0.0 111.748 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.19 20.87 2.57 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 113.939 -1.13 . . . . 0.0 108.361 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 9' ' ' PRO . 88.4 m -67.35 157.33 34.28 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 27' ' ' CYS . 2.0 mm -114.21 -175.97 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 26' ' ' ILE . 37.6 t -115.87 108.98 16.98 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.51 ' NE ' HD21 ' A' ' 30' ' ' ASN . 79.7 mtm180 -59.08 170.04 0.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.027 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 -16.45 65.2 Favored Glycine 0 N--CA 1.495 2.623 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.81 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.51 HD21 ' NE ' ' A' ' 28' ' ' ARG . 15.7 p30 -83.98 -7.58 59.37 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.53 21.58 43.53 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 123.777 0.673 . . . . 0.0 112.537 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' HH21 ' A' ' 28' ' ' ARG . 81.0 m-85 -135.58 156.91 48.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 13' ' ' LYS . 50.3 m -45.05 147.99 0.62 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.869 0 O-C-N 124.284 0.99 . . . . 0.0 115.077 179.563 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.456 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 23.3 t . . . . . 0 N--CA 1.505 2.297 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.72 62.06 4.56 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m -89.85 128.93 36.27 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.8 t70 55.18 22.62 4.76 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.358 1.036 . . . . 0.0 111.41 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.2 119.8 0.62 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.06 117.36 0.24 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.34 143.74 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.1 t -141.01 85.43 12.25 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 124.095 0.872 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -79.67 28.03 0.52 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.053 2.502 . . . . 0.0 112.891 172.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.85 151.13 24.04 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.167 0.984 . . . . 0.0 111.381 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -89.34 -171.07 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.369 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.7 mt -62.96 70.25 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 126.174 2.171 . . . . 0.0 114.631 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -112.03 119.81 39.72 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.456 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 28.2 mtpp -62.13 152.16 33.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.374 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.4 p -131.34 122.31 26.16 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 113.657 -1.61 . . . . 0.0 113.095 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -73.66 -46.49 46.3 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 11.0 ptp180 -135.37 172.65 12.71 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 112.526 -2.125 . . . . 0.0 107.995 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 26.9 m-20 -47.78 -52.74 17.68 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.9 p -81.71 6.44 15.33 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.8 t70 -74.07 -15.68 61.06 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 115.254 -0.884 . . . . 0.0 108.965 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 43.0 t -88.78 149.53 43.97 Favored Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 113.779 -1.555 . . . . 0.0 108.006 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.583 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.6 Cg_exo -66.12 167.75 17.38 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.762 1.642 . . . . 0.0 110.518 173.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 65.53 -164.39 38.11 Favored Glycine 0 N--CA 1.499 2.854 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.008 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.76 15.06 2.34 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 113.529 -1.336 . . . . 0.0 109.617 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.506 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 74.2 m -60.29 159.35 10.1 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 1' ' ' SER . 0.0 OUTLIER -121.31 -169.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 101.299 -3.593 . . . . 0.0 101.299 179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.1 t -118.76 126.32 51.61 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -67.35 171.54 5.83 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.332 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.37 -13.65 80.1 Favored Glycine 0 N--CA 1.495 2.603 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.489 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.63 -6.94 59.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.69 23.23 24.06 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 123.692 0.62 . . . . 0.0 113.132 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' CE2' ' HG2' ' A' ' 14' ' ' LYS . 37.7 m-85 -140.05 160.39 40.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.836 0.827 . . . . 0.0 110.654 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.8 m -45.38 147.91 0.73 Allowed 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 113.244 -1.798 . . . . 0.0 114.677 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.497 2.765 0 O-C-N 124.528 1.143 . . . . 0.0 111.724 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.03 96.85 2.09 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.0 m -89.47 -115.29 0.06 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -62.21 -20.84 64.61 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.405 0.441 . . . . 0.0 110.062 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -156.6 150.11 21.21 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.32 90.1 0.08 OUTLIER Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.24 48.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.7 t -89.71 141.69 28.64 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -75.17 157.29 42.15 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.596 2.197 . . . . 0.0 109.198 164.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -79.89 82.65 5.94 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.9 mm -100.83 158.59 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.316 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.9 mt -112.8 36.0 3.65 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 113.56 -1.655 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 2.1 mmpt? -90.66 122.21 33.25 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -51.81 146.76 7.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.085 0.945 . . . . 0.0 111.969 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.7 p -133.45 117.34 17.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 112.402 -2.181 . . . . 0.0 110.137 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -76.73 -40.44 48.58 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 27.2 ptt85 -137.37 171.03 15.08 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.667 -2.061 . . . . 0.0 107.525 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -48.58 -56.75 7.53 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 80.9 p -83.06 15.22 2.9 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.6 t70 -77.58 -14.99 59.51 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.414 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.601 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 49.8 t -88.95 151.39 47.06 Favored Pre-proline 0 N--CA 1.486 1.33 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.75 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 3.1 Cg_exo -68.34 158.85 55.83 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.823 1.682 . . . . 0.0 110.017 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.18 -165.64 54.68 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.043 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.19 15.02 3.08 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 113.699 -1.25 . . . . 0.0 109.366 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 77.2 m -62.89 152.69 35.63 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -115.17 -177.65 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 102.987 -2.968 . . . . 0.0 102.987 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 45.3 t -108.93 123.53 49.24 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' NE ' HD21 ' A' ' 30' ' ' ASN . 85.6 mtm180 -71.63 170.23 13.9 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.494 1.121 . . . . 0.0 110.776 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.12 -18.44 79.73 Favored Glycine 0 N--CA 1.496 2.668 0 CA-C-N 114.071 -1.422 . . . . 0.0 111.1 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.43 HD21 ' NE ' ' A' ' 28' ' ' ARG . 24.3 p30 -81.14 -0.03 38.37 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 124.147 0.557 . . . . 0.0 112.067 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.76 25.35 53.47 Favored Glycine 0 N--CA 1.496 2.64 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.351 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -137.76 156.83 47.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.083 0.944 . . . . 0.0 111.064 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.463 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 27.6 m -48.59 146.95 2.74 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.151 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 O-C-N 124.588 1.18 . . . . 0.0 112.619 179.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 79.0 p . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.393 0.616 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' N ' HD11 ' A' ' 26' ' ' ILE . . . 65.66 84.84 0.08 OUTLIER Glycine 0 N--CA 1.496 2.66 0 CA-C-N 114.246 -1.343 . . . . 0.0 116.139 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.43 ' HB3' HG13 ' A' ' 26' ' ' ILE . 18.1 t -150.99 -127.18 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.75 -9.73 39.84 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.453 ' H ' HG21 ' A' ' 26' ' ' ILE . . . -119.49 -118.49 2.73 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.26 -151.02 8.46 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.92 164.43 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 114.099 -1.05 . . . . 0.0 109.512 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.7 t -145.71 149.34 39.59 Favored Pre-proline 0 N--CA 1.495 1.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.083 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -72.38 136.25 26.02 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.361 2.041 . . . . 0.0 108.284 160.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.67 91.51 1.46 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 123.837 0.711 . . . . 0.0 109.816 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.9 mt -115.95 151.01 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.065 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -86.65 39.43 0.84 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.302 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -89.54 124.78 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' NZ ' ' HB2' ' A' ' 14' ' ' LYS . 10.3 mtmp? -64.39 152.16 42.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 123.873 0.733 . . . . 0.0 111.34 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.541 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 24.9 p -145.7 126.07 13.99 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 113.525 -1.671 . . . . 0.0 112.263 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -74.8 -49.89 19.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 34.9 ptt180 -127.6 173.94 9.47 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.18 -1.827 . . . . 0.0 108.056 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.495 ' HA ' ' N ' ' A' ' 27' ' ' CYS . 66.0 m-20 -51.3 -55.29 19.1 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.9 p -72.29 2.29 6.3 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 9.0 t70 -76.63 -14.98 59.94 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' SG ' ' CB ' ' A' ' 25' ' ' CYS . 51.4 t -88.7 146.91 38.11 Favored Pre-proline 0 N--CA 1.488 1.467 0 CA-C-N 114.351 -1.295 . . . . 0.0 107.905 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 5.4 Cg_exo -69.8 163.67 37.44 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.901 1.734 . . . . 0.0 109.848 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.17 -158.8 52.21 Favored Glycine 0 N--CA 1.5 2.967 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.996 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.73 20.0 3.71 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 113.86 -1.17 . . . . 0.0 108.372 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 76.7 m -65.8 168.85 7.25 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 113.255 -1.793 . . . . 0.0 115.694 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.453 HG21 ' H ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -130.94 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 111.411 -2.631 . . . . 0.0 104.085 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.495 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 45.8 t -139.27 129.0 24.68 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB2' ' ND2' ' A' ' 30' ' ' ASN . 88.3 mtm180 -81.36 170.51 15.91 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.074 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.06 -11.24 78.95 Favored Glycine 0 N--CA 1.493 2.472 0 CA-C-N 114.154 -1.385 . . . . 0.0 112.593 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.545 ' ND2' ' H ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -81.06 -2.14 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.327 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' N ' HD22 ' A' ' 30' ' ' ASN . . . 86.34 23.97 41.9 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.545 ' H ' ' ND2' ' A' ' 30' ' ' ASN . 91.1 m-85 -143.45 152.98 42.18 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.677 0.751 . . . . 0.0 110.21 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.9 m -36.03 148.25 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 112.25 -2.25 . . . . 0.0 115.143 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 O-C-N 124.324 1.015 . . . . 0.0 112.288 -179.935 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.45 113.55 0.97 Allowed Glycine 0 N--CA 1.495 2.585 0 O-C-N 123.756 0.66 . . . . 0.0 112.482 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.6 p -150.36 -135.22 0.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.84 -37.35 81.76 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.43 39.0 2.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.2 11.99 1.33 Allowed Glycine 0 N--CA 1.499 2.844 0 CA-C-N 115.246 -0.477 . . . . 0.0 114.268 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 t -92.22 48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -89.84 140.61 27.85 Favored Pre-proline 0 N--CA 1.496 1.849 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.779 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD2' ' SG ' ' A' ' 25' ' ' CYS . 11.2 Cg_endo -71.56 159.13 52.08 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.663 2.242 . . . . 0.0 109.515 167.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -80.85 94.44 6.46 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.266 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.79 142.65 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.684 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -103.73 47.3 0.88 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.541 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -89.94 121.53 32.13 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 54.5 mtmt -52.01 148.27 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.187 0.994 . . . . 0.0 113.396 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.429 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 20.0 p -143.65 128.18 18.02 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.483 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -86.27 -34.15 20.47 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.0 ptt-85 -130.86 166.35 21.06 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HA ' ' H ' ' A' ' 27' ' ' CYS . 9.8 m-20 -53.43 -44.82 69.11 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.3 p -91.17 26.0 2.32 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.1 -11.55 32.65 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.853 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.6 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 42.8 t -88.81 148.65 41.99 Favored Pre-proline 0 N--CA 1.487 1.394 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.866 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 2.9 Cg_exo -66.23 157.32 60.55 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 121.877 1.718 . . . . 0.0 109.961 171.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.67 -167.33 54.45 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.322 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.24 1.63 17.97 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 113.844 -1.178 . . . . 0.0 110.167 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.423 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 78.8 m -49.3 151.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -118.14 172.15 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 37.7 t -103.03 128.26 49.95 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -69.43 169.95 11.44 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.608 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.18 -16.35 80.64 Favored Glycine 0 N--CA 1.494 2.566 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.266 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.54 -1.91 56.55 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.29 24.21 37.71 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 123.691 0.619 . . . . 0.0 113.409 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 95.0 m-85 -137.74 155.32 49.21 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 122.062 0.934 . . . . 0.0 111.013 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.7 m -48.67 152.93 0.88 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 112.48 -2.146 . . . . 0.0 114.669 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 O-C-N 124.758 1.286 . . . . 0.0 113.163 179.45 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.43 ' HB2' ' HE ' ' A' ' 28' ' ' ARG . 31.3 t . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.807 0.813 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.99 83.22 0.16 Allowed Glycine 0 N--CA 1.493 2.453 0 CA-C-N 113.913 -1.494 . . . . 0.0 110.065 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.2 m -89.58 -10.7 45.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.228 0.605 . . . . 0.0 110.458 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -127.29 -30.54 2.63 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.161 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.27 -24.75 0.05 OUTLIER Glycine 0 N--CA 1.494 2.544 0 O-C-N 124.223 0.952 . . . . 0.0 111.084 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.81 51.26 8.06 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.62 46.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.03 134.31 20.16 Favored Pre-proline 0 N--CA 1.494 1.743 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.973 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -72.97 119.35 6.01 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.382 2.054 . . . . 0.0 108.868 166.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -72.24 94.79 1.61 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 123.915 0.759 . . . . 0.0 110.248 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.4 mt -121.54 152.22 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.943 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD12 ' H ' ' A' ' 12' ' ' LEU . 5.5 mp -67.7 86.33 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 124.08 0.862 . . . . 0.0 109.766 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 68.5 mttm -133.48 150.88 51.71 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.291 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -97.97 152.45 19.25 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 32' ' ' TYR . 23.1 p -144.19 124.78 14.03 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.787 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -84.34 -49.68 8.5 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' H ' ' HB2' ' A' ' 20' ' ' ASP . 36.8 ptt180 -126.55 169.74 12.75 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.704 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 26' ' ' ILE . 8.7 m-20 -50.9 -47.6 60.68 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 99.8 p -89.1 28.01 1.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' HB2' ' H ' ' A' ' 17' ' ' ARG . 13.1 t70 -94.76 -17.52 22.09 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 113.575 -1.648 . . . . 0.0 107.308 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 22' ' ' PRO . 45.4 t -88.95 148.22 40.68 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.541 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HD2' ' SG ' ' A' ' 21' ' ' CYS . 1.7 Cg_endo -73.56 165.67 31.8 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.237 1.958 . . . . 0.0 110.23 173.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.63 -163.71 54.75 Favored Glycine 0 N--CA 1.497 2.705 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.903 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.05 14.83 3.11 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.874 -1.163 . . . . 0.0 109.212 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 21' ' ' CYS . 79.3 m -66.89 161.04 24.89 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -127.13 -171.65 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 102.65 -3.093 . . . . 0.0 102.65 179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.418 ' N ' ' HA ' ' A' ' 18' ' ' ASP . 42.7 t -113.07 130.46 56.16 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 1.8 mmp_? -69.59 172.65 7.05 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.708 -1.587 . . . . 0.0 110.393 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.4 -13.68 82.98 Favored Glycine 0 N--CA 1.494 2.525 0 CA-C-N 114.254 -1.339 . . . . 0.0 111.658 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -89.46 -9.6 49.5 Favored 'General case' 0 N--CA 1.501 2.087 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.97 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.12 33.32 7.78 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.472 ' C ' ' SG ' ' A' ' 15' ' ' CYS . 11.4 m-85 -137.66 155.78 48.76 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 13' ' ' LYS . 19.9 m -51.75 149.36 4.75 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 114.605 -1.18 . . . . 0.0 113.458 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 26' ' ' ILE . . . . . . . . 0 N--CA 1.495 2.6 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.594 179.613 . . . . . . . . 1 1 . 1 stop_ save_